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Embryonic stem cells (ESCs) are derived from the inner cell mass (ICM) of the mammalian 
blastocyst. They are capable of indefinite self-renewing cell division under specific cell culture 
conditions for extended periods and they have the ability to differentiate into all cell types of the 
adult organism. This property of ESCs holds great promise for regenerative therapeutic medicine. 
The fundamental understanding of the molecular biology of ESCs will be essential for the eventual 
rational design of methods to control the self-renewal and differentiation of these cells.  
 
Oct4 and Sox2 are key transcription factors that are important in maintaining the ESC 
state. In order to understand the roles of these factors and how they collaborate with each other, it 
is essential to know which genes are directly associated with these proteins in vivo. In this study, 
chromatin immunoprecipitation (ChIP) was used in a small scale study to map the binding 
circuitry of Oct4 and Sox2 on Oct4, Sox2 and Nanog genes. Oct4 and Sox2 were shown to bind to 
the genes encoding Oct4, Sox2 and Nanog.  
 
Subsequently, the ChIP-PET (paired end ditag) technology was used to map the whole 
genome binding sites of Oct4 and Sox2. Thousands of novel Oct4 and Sox2 binding sites were 
identified, mapping to genes implicated in important cellular functions including maintenance of 
pluripotency. Oct4 and Sox2 were found to co-occupy a substantial number of genes. A fifteen 
nucleotide Sox2-Oct4 motif was identified and characterized.  
 
In order to identify other DNA binding transcription factors that may work together with 
Oct4 and Sox2, 500 bp DNA sequences centered on the sites bound by Oct4 and Sox2 were 
matched against matrices from the TRANSFAC database to reveal putative transcription factor co-
motifs. Two of the extrinsic signaling substrates, Stat3 and Smad1, were shown to bind in the 
 xii
vicinity of Oct4 and Sox2 DNA binding sites associated with genes important in cell cycle 
regulation, pluripotency and self-renewal. Stat3 and Smad1 were further demonstrated to be Oct4 
partners, revealing the connection between the intrinsic transcription factors and extrinsic 
signaling pathways in mouse embryonic stem cells (mESCs). Stat3 and Oct4 were shown to bind 
to the promoter of Nanog, and subsequent results suggest that Stat3 may regulate the transcription 
of Nanog. This may provide a link between the three transcriptional pathways in mESCs. 
Together, these results suggest that Oct4 and Sox2 (1) have multiple DNA binding sites, (2) may 
exert transcriptional effects from distal locations, (3) work in collaboration with other transcription 
factors and (4) their binding may be a pre-requisite for the binding of other transcription factors. 
 
In conclusion, this study identified the Oct4 and Sox2 DNA interactions, characterized the 
joint DNA motif, expanded the Oct4 and Sox2 transcription binding network to the Smad1 and 
Stat3 signalling networks and utilized these binding data in an attempt to answer a long standing 
hypothesis of a crosstalk between the Oct4, Stat3 and Nanog transcriptional pathways. The 
findings obtained here may contribute to the eventual mapping of the whole transcriptional 













LIST OF TABLES 
 
4.1  Molecular function of Oct4 target genes. 
7.1  List of putative Oct4 and Sox2 co-occurring motifs denoted by their TRANSFAC matrix 
ID. 
 
7.2  Function of genes associated with the binding of Oct4, Sox2, Stat3 and Smad1 in mouse 






















LIST OF FIGURES 
Figure  
1.1 A schematic view of mouse pre-implantation development. 
1.2 Mouse embryonic stem cell (mESC) culture, self-renewal and differentiation. 
1.3  A model for combinatorial extrinsic signaling and intrinsic transcription factor pathways 
in the maintenance of mESC pluripotency and self-renewal. 
1.4  Chromatin immunoprecipitation (ChIP) for the study of transcription factor DNA binding 
sites (TFBSs) in living cells. 
1.5 The Chromatin immunoprecipitation paired-end ditag (ChIP-PET) approach. 
3.1  Specificity of αOct4 and αSox2 antibodies used in ChIP. 
3.2  Oct4 and Sox2 binding to Oct4 CR4 region in mESCs. 
3.3  Oct4 and Sox2 binding reduces after retinoic acid differentiation of mESCs. 
3.4  Oct4 and Sox2 bind to the SRR2 at the 3’ enhancer of Sox2 in mESCs. 
3.5  Oct4 and Sox2 bind to the Nanog promoter in mESCs. 
3.6  OCT4 and SOX2 bind to the distal enhancer (DE)/CR4 region of OCT4, the SRR2 region 
of SOX2 and promoter region of NANOG in living human ESCs. 
3.7        Multiple alignment analysis of Oct4 and Sox2 binding sites in mESCs from this study and 
previous studies (Utf1, Fbx15, Fgf4) identified the Sox-Oct composite element. 
3.8  Oct4, Sox2 and Nanog circuitry and network motifs. 
4.1  Diagram illustrating the features of the ChIP-PET readout.  
4.2  Determination of the minimum PET cluster size as Oct4 bona fide binding sites.  
4.3   Profiles of Oct4 binding revealed by ChIP-PET. Validation of known Oct4 occupied genes 
in mESCs. 
4.4  Annotation of Oct4 binding sites in relation to genomic locations. 
4.5  Novel genes bound and potentially regulated by Oct4 in mESCs. 
 xv
4.6  Retinoic-acid induced differentiation reduces Oct4 binding levels on targets in mESCs. 
5.1  Determination of PET cluster size as Sox2 bona fide binding sites. 
5.2  Validation of Sox2 binding profiles at the Oct4 upstream regulatory regions. 
5.3  Sox2 binding on Sox2 and Nanog from the ChIP-PET data. Image captures of the T2G 
browser showing Sox2 PETs at the previously known and validated regions of (A) Sox2 
and (B) Nanog. 
5.4  Annotation of Sox2 binding sites in relation to genomic locations. 
5.5  Binding of Sox2 on microRNA genes. 
5.6  Sox2 and Oct4 ChIP-PET binding profiles at (A) Rest and (B) Mycn (C) Oct4, (D) Sox2, 
and (E) Esrrb. 
6.1  Venn diagram indicating the extent of overlap between genes associated with Sox2 and 
Oct4 binding in mESCs. 
6.2  Co-occupancy of Oct4 and Sox2 on target sites. 
6.3  ChIP-on-chip data showing co-occupancy of Oct4 and Sox2 on genes marked by 
H3K4Me3. 
6.4  Identification of the 15 nucleotide Sox2-Oct4 joint consensus motif in the Oct4 and Sox2 
ChIP-PET datasets. 
6.5  Binding of Oct4 and Sox2 overexpressed (OE) proteins on biotin-labelled DNA probes 
containing Oct4 and Sox2 binding sites using EMSA. 
6.6  Endogenous native Oct4 and Sox2 bind to the composite Sox2-Oct4 joint motif of Ebf1. 
6.7  Mutations within the Sox2-Oct4 element of Rest abolished the Sox2/Oct4-DNA complex. 
6.8  Flanking sequences of the Sox2-Oct4 joint motif do not affect Sox2 or Oct4 binding. 
6.9  Increased reporter activity conferred by the Sox2-Oct4 elements. 
6.10  Swapping the orientation of Sox2-Oct4 motifs to Oct4-Sox2 abolished enhancer activity. 
7.1  Model of the integrated roles of Oct4, Nanog and LIF (Stat3) on embryonic stem cell fate 
specification, according to different Oct4 and Nanog levels. 
 xvi
7.2  Expansion of the combined ChIP-PET data. 1507 clusters containing maximum 
overlapping PET (moPET) 2 or more from both Oct4 and Sox2 binding datasets were 
merged. 
7.3  Validation of Oct4 and Sox2 overlapping binding sites containing low PET overlaps. 
7.4  Specificity of main Stat3 and Smad1 antibodies used. 
7.5  Co-localisation of Oct4-Sox2, Stat3 and Smad1. ChIP-on-chip SignalMap diagram 
showing co-localisation of Oct4-Sox2, Stat3 and Smad1 on the Mycn and Sgk loci. 
7.6   Co-localisation of Stat3 and Smad1 on Oct4 and Sox2 overlapping binding sites. 
7.7  Co-localisation of Oct4, Sox2, Stat3 and Smad1 on 25 loci. A heat map showing ChIP-
qPCR validations of Stat3 and Smad1 co-localisation on Oct4 and Sox2 binding sites 
identified from ChIP-PET (black) and ChIP-on-chip (grey) studies. 
7.8  Co-occupancy of Oct4 with Stat3 and Smad1 on the same DNA molecule. 
7.9  Retinoic acid differentiation of mESCs reduces Oct4 and Sox2 levels and binding, and 
abolishes Stat3 and Smad1 binding. 
7.10  Knockdown of Oct4 and Sox2 in mESCs differentiates the cells, significantly reduces 
Oct4 and Sox2 protein levels and concurrently reduces Oct4 and Sox2 binding on the 
Mycn and Nanog loci.  
7.11  Knockdown of Oct4 and Sox2 in mESCs does not significantly affect Stat3 and Smad1 
protein levels but reduces Stat3 and Smad1 binding on the Mycn and Nanog loci. 
7.12 Stat3 and Smad1 are Oct4 partners. 
7.13  Feeder-free serum-free mESCs. 
7.14  Stat3 and Smad1 depletion in mESCs cultured in defined media. 
7.15 Stat3 does not regulate Oct4. 
7.16 Stat3 binds to its own gene and autoregulates. 
7.17  Stat3 regulates Nanog. 
7.18 Looping mechanism of Nanog regulation by collaborating transcription factors. 
 xvii
8.1  A chromatin hub formed by long-range interactions between the haemoglobin β-chain 
complex (Hbb) genes and the locus control region. 
8.2  Approaches used for detecting long range protein-DNA interactions are (a) the 
Chromosome Conformation Capture (3C) method and (b) the RNA tagging and recovery 
of associated proteins (RNA TRAP) method. 
 
 xviii
LIST OF ABBREVIATIONS 
Ab  antibody 
BMP  bone morphogenic protein 
bp  base pairs 
cDNA  complementary deoxyribonucleic acid 
ChIP  chromatin immunoprecipitation 
ChIP-on-chip chromatin immunoprecipitation coupled to microarray chip 
ChIP-PET chromatin immunoprecipitation coupled to paired end ditag sequencing 
Co-IP  co-immunoprecipitation 
DNA  Deoxyribonucleic acid 
dsDNA  double stranded DNA 
DTT   dithiothreitol 
EB   embryoid body 
ECC  embryonic carcinoma cells 
EDTA  ethylenediaminetetraacetic acid 
EGC  embryonic germ cells 
EMSA  electrophoretic mobility shift assay 
FBS  fetal bovine serum 
GFP  green fluorescent protein 
gp-130  glycoprotein-130 
GST  glutathione S-transferase 
hESC  human embryonic stem cell 
IB  immunoblot 
ICM  inner cell mass 
kDa  kilo Dalton 
LB  Luria-Bertani 
LIF  leukemia inhibitory factor 
LIFR  leukemia inhibitory factor receptor 
mESC  mouse embryonic stem cell 
Min  minute 
mM   milli Molar 
mRNA  messenger RNA 
MW  molecular weight 
ng  nanogram 
Oct  Octamer binding protein 
PCR  polymerase chain reaction 
PET  paired-end ditag 
Q-PCR  quantitative polymerase chain reaction 
RA   Retinoic acid 
RNA Pol II RNA polymerase II 
RNA  Ribonucleic acid 
RNAi   RNA interference 
Rpm  rotation per minute 
RT-PCR Reverse transcription polymerase chain reaction 
seqChIP Sequential chromatin immunoprecipitation 
shRNA  short hairpin RNA 
Sox  Sry-related HMG box 
Stat  signal transducer and activator of transcription 
TFBS  Transcription factor binding site 
TNF   Tumor necrosis factor 
 xix
LIST OF PUBLICATIONS (FROM THIS THESIS) 
 
 
1.  Chew JL*, Loh YH*, Zhang W*, Chen X, Tam WL, Yeap LS, Li P, Ang YS, Lim B, 
Robson P, Ng HH. 2005. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the 
Oct4/Sox2 complex in embryonic stem cells. Molecular and Cellular Biology 
25(14):6031-46.  
 
2.  Rodda DJ*, Chew JL*, Lim LH*, Loh YH, Wang B, Ng HH, Robson P. 2005. 
Transcriptional regulation of nanog by OCT4 and SOX2. Journal of Biological 
Chemistry 280(26):24731-7.  
 
3.  Loh YH*, Wu Q*, Chew JL*, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong 
B, Liu J, Wong KY, Sung KW, Lee CW, Zhao XD, Chiu KP, Lipovich L, Kuznetsov VA, 
Robson P, Stanton LW, Wei CL, Ruan Y, Lim B, Ng HH. 2006. The Oct4 and Nanog 
transcription network regulates pluripotency in mouse embryonic stem cells. Nature 
Genetics 38(4):431-40.  
 
 











1.1 Stem cells 
Stem cells are classically defined as cells that can generate daughter cells identical to their parent 
cells (self-renewal) as well as can produce progeny with restricted potential (differentiation) 
(Smith, 2001; Weissman et al., 2001). Stem cells can be isolated from the embryo, umbilical cord 
and adult tissues, with different levels of potency or differentiation ability.  
 
In early mouse embryogenesis, the zygote and blastomeres from two- to four- cell embryo 
are totipotent. Totipotent cells can differentiate into any cell types of the body including the 
placenta, and can give rise to a whole organism. As the embryo continues to cleave, the 
blastomeres lose the potential to differentiate into all cell lineages. At 3.5 days postcoitus (dpc) 
during the formation of the blastocyst, the outer cells of the embryo develop into the 
trophectoderm (TE) from which the placenta is derived. The cells on the inside are called the inner 
cell mass (ICM) that can generate all cell lineages of the embryo proper, but they cannot give rise 
to totipotent stem cells nor a whole organism, and thus are considered pluripotent. Then at 4.5dpc, 
a primitive endoderm layer is observed at the surface of the ICM, and the remaining pluripotent 
cell population that is covered by the primitive endoderm is termed as the epiblast, which would 
produce all adult tissues (Figure 1.1). After implantation, the epiblast cells start to proliferate 
rapidly and increase in size. At 6.0 dpc, apoptotic cell death occurs in the central part of the 
epiblast, resulting in the formation of an epithelialized monolayer of pluripotent cells designated 
as the primitive ectoderm. At 7.0dpc, only primordial germ cells (PGCs) retain pluripotency, from 
which embryonic germ cells (EGCs) can be established in vitro (Coucouvanis and Martin, 1995; 
Matsui et al., 1992) (Figure 1.1). Multipotent stem cells, with restricted differentiation potential, 
can be found in the umbilical cord and adult tissues such as haematopoietic stem cells that give 
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rise to blood cells (Moore and Lemischka, 2006; Petersen and Terada, 2001) (Figure 1.2). Stem 
cells, particularly embryonic stem cells (ESCs), offer enormous potential for a diverse range of 
cell-replacement therapies, in addition to their use as research tools for understanding self-renewal, 
lineage commitment and cellular differentiation. 
 
 
Figure 1.1: A schematic diagram of the mouse pre-implantation development. Pluripotent stem 
cells (green) appear in the morula as inner cells (A), which then form the inner cell mass (ICM) of 
the blastocyst (B). After giving rise to the primitive endoderm, pluripotent stem cells form the 
epiblast and start to proliferate rapidly after implantation (C). The pluripotent cells then form the 
primitive ectoderm, a monolayer epithelium that has restricted pluripotency that goes on to give 
rise to the germ cell and somatic lineages of the embryo (D). Figure was adopted from Niwa 
(2007). 
 
1.2 Embryonic stem cells (ESCs) 
Cells from the ICM can be isolated and cultured in vitro under permissive conditions as embryonic 
stem cell (ESC) lines (Bongso et al., 1994; Evans and Kaufman, 1981; Martin, 1981; Thomson et 
al., 1998) (Figure 1.2). These ESCs are able to give rise to all derivatives of the three primary 
germ layers (ectoderm, endoderm and mesoderm) as well as possessing the ability to differentiate 
into the trophectoderm lineage (Niwa et al., 2005; Niwa, 2007; Pierce et al., 1988). In vivo, ESCs 
can produce germ line chimeras. ESCs have a doubling time of about 12 hr, similar to that of the 
epiblast, and have similar expression pattern of specific marker genes (Pelton et al., 2002).  
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ESCs exhibit unique properties, including unlimited self-renewal, long term proliferation 
in vitro, stable karyotype, highly efficient and reproducible differentiation potential in vivo and in 
vitro and germ line colonization. They also exhibit clonogenicity where the cells are capable of 
growing as separate colonies. They demonstrate high versatility in the types of cells they can 
differentiate into upon specific culture conditions. These properties of ESCs provide an enormous 
potential for clinical treatments of degenerative illnesses such as Parkinson’s disease, whereby 
diseased or dysfunctional cells can be replaced with healthy, functional ones (Pera et al., 2000). 
However, fundamental to the realization of this goal is a better understanding of the nature and 
basic biology of ESCs, such as genetic switches and molecular mechanisms that govern 
pluripotency. To this end, both human ESCs (hESCs) and mouse ESCs (mESCs) can be used as 
experimental models to further our understanding of the molecular basis of differentiation.  
 
Human ESCs are relatively more difficult to culture and manipulate compared to mESCs 
(Pera et al., 2000; Reubinoff et al., 2000; Thomson et al., 1998). Notwithstanding ethical issues in 
deriving hESCs, in vivo assessment of pluripotency is not possible for hESCs as these cells must 
be reintroduced into the human body to determine their ability to produce all somatic lineages and 
germ line chimerism. These cells must also generate embryoid bodies and teratomas containing 
differentiated cells of all three germ layers. Comparatively, mESCs are easier to culture, transfect 
and differentiate; and are thus used as a convenient cellular model to study the various aspects of 
ESC biology such as the mechanisms of pluripotency. 
 
1.3 Properties of mouse ESCs (mESCs)  
mESCs were originally isolated and maintained by co-culture on a feeder layer of mitotically 
inactivated mouse embryonic fibroblasts (MEFs) (Evans and Kaufman, 1981; Martin, 1981). They 
are characterized by their expression of distinctive cellular markers and possession of functions 
that relate to their uncommitted state. When cultured mESCs are reintroduced into a developing 
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blastocyst, a chimeric mouse is produced in which ESC-derived progeny can be found in all adult 
tissues. In addition, transplantation of undifferentiated mESCs into the adult results in the 
formation of teratomas, which are tumours that contain an array of different cell types, 
representative of each of the three embryonic germ layers. Upon cell fusion, mESCs can also 
dominantly reprogram somatic cells to re-express markers of earlier embryonic stages (Tada et al., 
2001). In addition to their developmental potential in vivo, mESCs display a remarkable capacity 
to form many differentiated cell types in culture (Keller, 2005; Smith, 2001). Differentiation of 
mESCs in vitro provides a powerful model system to compare between the undifferentiated and 
differentiated states, as well as to address questions related to cell fate determination. 
 
1.3.1 Differentiation of mESCs 
Mouse ESCs can be induced to differentiate into derivatives of the three embryonic germ layers 
(Figure 1.2) by altering the growth matrix, changing the chemical composition of the culture 
medium, co-culture with cell lines, or modifying the cells by genetic manipulation. Differentiation 
of the mESCs can be observed morphologically and also measured by reduced pluripotency 
markers such as Oct4 or increased lineage-specific markers such as Cdx2. 
 
When mESCs are removed from contact with the feeder cells or gelatin and grown in 
suspension culture, they will clump together and spontaneously differentiate to form three-
dimensional colonies called embryoid bodies (EBs) (Doetschman et al., 1985; Keller, 2005; 
Smith, 2001). Cells within the EBs can differentiate into various committed cell types including 
cardiomyocytes (Maltsev et al., 1993), skeletal muscle (Miller-Hance et al., 1993), endothelial 
cells (Vittet et al., 1996), neuronal cells (Bain et al., 1995), adipocytes (Dani et al., 1997) and 
hematopoetic precursors (Schmitt et al., 1991; Smith et al., 1988). In addition, removal of factors 
crucial for the maintenance of mESCs, such as leukemia inhibitory factor (LIF), also causes the 
mESCs to differentiate (Smith et al., 1988). Besides that, addition of commonly used inducers of 
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mESCs differentiation such as retinoic acid (RA), also induces different types of differentiation 
when applied at various concentrations (Soprano et al., 2007). Lower levels of retinoic acid have 
been found to promote the formation of epithelial-like cells, whereas higher levels favored the 
differentiation of mESCs into fibroblastic-like cells (Faherty et al., 2005). Another way to induce 
differentiation of mESCs is through genetic manipulation. Some examples include the ectopic 
expression of Gata6 (into primitive endoderm) and Cdx2 (into trophectoderm), or RNAi-mediated 
depletion of factors which are important in maintaining pluripotency and self-renewal (Ding and 
Buchholz, 2006; Fujikura et al., 2002; Hay et al., 2004; Hough et al., 2006b; Lim et al., 2007; 












Figure 1.2: Mouse embryonic stem cell (mESC) culture, self-renewal and differentiation. The 
fertilized oocyte and blastomeres stage embryos are totipotent. The inner cell mass from the 
blastocyst gives rise to pluripotent mESCs. Undifferentiated mESCs can be cultured in vitro in the 
presence of LIF and FBS. Changing the culture conditions of mESC will allow differentiation into 
different cell types such as blood cells, neural cells and muscle cells. (Figure was adopted from the 






1.4 Maintaining mESCs in their undifferentiated state 
The propagation of undifferentiated mESCs is dependent on extrinsic factors that induce signalling 
pathway cascades into the cell nucleus as well as intrinsic transcription factors that control the 
expression repertoire of the cell (Figure 1.3). In this model, cell-surface receptors initiate signals 
that are conveyed to the nucleus and affect key transcription factors such as Oct4 and Nanog, as 
well as self-renewal transcription factors such as signal transducer and activator of transcription-3 




























Figure 1.3: A model for extrinsic signalling and intrinsic transcription factor pathways in the 
maintenance of mESC pluripotency and self-renewal. Leukemia inhibitory factor (LIF) and bone 
morphogenic protein (BMP) pathways send signals into the nucleus. In the nucleus, transcription 
factors such as Oct4/Sox2, Nanog and Stat3 promote the ESC state and inhibit differentiation. 
Question marks denote lack of information. GAB1: GRB2-associated binding protein-1; GSK3: 
glycogen synthase kinase-3; Id: inhibitor of differentiation; JAK: janus kinase; MEK: mitogen-
activated protein kinase (MAPK) and extracellular signal regulated kinase (ERK) protein kinase; 
SMAD: similar to mothers against decapentaplegic homologue; SHP2: SH2-domain-containing 
protein tyrosine phosphate-2; WNT: wingless type protein. Figure was adopted from Boiani and 
Scholer (2005). 
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1.4.1 Signalling pathways  
In addition to general pathways of signal transduction that operate in most cell types, such as 
extracellular matrix (ECM) signalling that originates from the cell-membrane receptors of the 
integrin family, several exogenous factors that are involved in nucleus-directed signalling 
pathways are known to modulate ESC pluripotency both in vivo and in vitro (Boiani and Scholer, 
2005).  
 
Mouse ESCs are typically cultured on fibroblast feeder cells or gelatin with serum and 
leukemia inhibitory factor (LIF), a cytokine that activates the essential gp130/Stat3 signalling 
pathway (Smith et al., 1992; Williams et al., 1988). Combined with LIF, bone morphogenetic 
proteins (BMP) support unlimited ESC self-renewal in the absence of serum or feeders via the 
BMP pathway (Ying et al., 2003). So far, the intracellular signalling cascades initiated by both LIF 
and BMP have been worked out extensively (Chambers and Smith, 2004). Other less studied 
pathways such the WNT pathway (Figure 1.3) has also been reported to be activated in ESCs (Hao 
et al., 2006; Sato et al., 2004), but it is known to have dichotomous effects on stem cells (both 
proliferative and roles in differentiation). It is likely that LIF, BMPs and other pathways exert their 
effects on mESCs by controlling the expression and activity of transcription factors such as Oct4 
and Nanog, but evidence to back these facts is still lacking.  
 
1.4.1.1 LIF-STAT3 signalling 
Leukaemia inhibitory factor (LIF; also known as differentiation inhibitory activity, Dia) is a 
member of the interleukin-6 cytokine family which helps to maintain the pluripotency of mESCs 
(Smith et al., 1988). LIF can be provided by MEFs (Rathjen et al., 1990) or as a recombinant 
protein (Williams et al., 1988). MEFs deficient for the LIF gene cannot maintain ESC self-renewal 
(Stewart et al., 1992; Stewart and Cullinan, 1997) and LIF can replace the requirement for feeders 
in mESC culture (Smith et al., 1988) and de novo derivation of mESCs (Nichols et al., 1990). The 
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removal of LIF results in differentiation of mESCs, mainly toward the primitive endoderm lineage 
(Niwa et al., 1998).   
 
In the LIF-Stat3 pathway (Figure 1.3), LIF functions by binding to LIF receptor (LIFR) at 
the cell surface, which causes the receptor to heterodimerize with another transmembrane protein, 
glycoprotein-130 (gp130). On binding LIF, the intracellular domains of the LIFR–gp130 
heterodimer can recruit the non-receptor Janus tyrosine kinase (JAK) and the anti-phospho 
tyrosine immunoreactive kinase (TIK) and become phosphorylated. The phosphorylated 
intracellular domains of the LIFR–gp130 heterodimer function as docking sites for proteins that 
contain the Src-homology-2 (SH2) domains, which include the latent transcription factor Stat3. 
Stat3 binds to the phosphotyrosine residues on the activated LIFR-gp130 and undergoes 
phosphorylation and dimerization. Subsequently, phosphorylated Stat3 dimers translocate to the 
nucleus where they function as transcription factors (Matsuda et al., 1999; Niwa et al., 1998). 
Signalling of gp130 is not limited to activation of Stat3 but includes stimulation of the Ras/ 
mitogen-activated protein kinase pathway (MAPK) which activates extracellular regulated kinase 
(ERK) when cell surface receptors are stimulated by a complex containing Grb2 adaptor and Sos 
guanine-nucleotide-exchange factor (Kolch, 2000). Activation of ERK has a pro-differentiation 
effect and is antagonistic to ESC self-renewal (Burdon et al., 1999). 
   
Activated Stat3 formed downstream of LIF induction are crucial in preventing the 
differentiation of ESCs. Previous co-immunoprecipitation studies have indicated that Stat3 is a 
component of the tyrosine-phosphorylated complex that forms upon LIF induction (Boeuf et al., 
1997; Hocke et al., 1995). Moreover, tyrosine kinase inhibitors were shown to impair the 
formation of the activated Stat3 complex and cause differentiation of ESCs (Boeuf et al., 1997). 
Blockage of activation of Stat3 by overexpression of its dominant-negative mutant in the presence 
of LIF induces mesoderm-endoderm differentiation similar to that induced by the withdrawal of 
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LIF, indicating that Stat3 is essential for LIF action (Niwa et al., 1998). Matsuda et al. (1999) 
reported that activation of Stat3 is sufficient to maintain ESC self-renewal in the presence of 
serum without LIF. 
 
The knocking-out of LIF, Stat3 or gp130 in mice results in severe developmental disorders 
indicating that these factors play important roles in embryonic development of mice. LIF mutant 
female mice are infertile as the adherence of the embryo to the uterus wall is dependent on the 
production of estrogen and LIF by the uterus (Stewart et al., 1992). Consequently, LIF-/- females 
fail to support embryonic implantation. However, LIF-/- embryos can implant and develop to full 
term foetuses in wild type mice possessing a normal uterus. LIFR-null embryos died shortly after 
birth and exhibit reduced bone mass and profound loss of motor neurons (Li et al., 1995; Ware et 
al., 1995). Embryos homozygous for the gp130 mutation died between 12-18 dpc due to placental, 
myocardial, hematological and neurological disorders (Nakashima et al., 1999; Yoshida et al., 
1996). Epiblast cells of the ICM of gp130-/- embryos differentiate into parietal endoderm and 
undergo apoptosis. Moreover, LIFR-/- and gp130-/- delayed embryos are unable to resume 
embryogenesis after 12 and 6 days of diapause (arrest of embryonic development in lactating 
mothers), respectively. Targeted disruption of the Stat3 gene in vivo also leads to embryonic 
lethality due to the failure to establish metabolic exchanges between the embryo and maternal 
blood (Takeda et al., 1997). Stat3-null embryos develop into elongated egg cylinders and 
degenerate around embryonic day (E) 7.0. Thus, Stat3 plays a unique and crucial role in 
embryonic development that cannot be compensated for by other members of the Stat family 
(Stat1, 2, 5a, 5b).  
 
Collectively, these studies show that the LIF-Stat3 pathway is important in maintaining 
pluripotency and self-renewal. However, LIF alone is not sufficient for mESC self-renewal as the 
cells still undergo differentiation when cultured without serum in the presence of LIF (Ying et al., 
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2003). Studies by Ying et al. (2003) have identified the bone morphogenic proteins (BMPs) to be 
one of the components in serum which contributes to mESC self-renewal. Together with LIF, 
BMP can maintain mESCs in their undifferentiated state without the use of serum or feeder cells 
(Ying et al., 2003). 
 
1.4.1.2 BMP signalling 
Bone morphogenic proteins (BMPs) belong to the transformation growth factor beta (TGFβ) 
superfamily. BMP4, BMP2 or growth and differentiation factor 6 (GDF6) have been demonstrated 
to suppress differentiation and results in concomitant self-renewal in mESCs by blocking neuronal 
differentiation (Finley et al., 1999; Tropepe et al., 2001; Ying et al., 2003) and promote non-
neuronal (mesoderm, endoderm, trophoblast) differentiation (Ying et al., 2003). BMP4 can also 
replace serum during de novo derivation of ESCs. Loss of BMP4 function results in embryonic 
development disorders in mice such as gastrulation defects, disorganized posterior structure and 
devoid of primordial germ cells (PGCs) (Dunn et al., 1997; Lawson et al., 1999; Winnier et al., 
1995).  
 
In the canonical BMP signalling pathway, BMPs bind to the BMP receptors (BMPRs) 
which are serine/threonine kinases composed of type I and II subtypes. Subsequently, BMPR type 
I phosphorylates the C-terminus of Smad1, Smad5 or Smad8. Upon phosphorylation, Smad1/5/8 
forms dimers and complexes with the common Smad protein, Smad4. The heterotrimeric complex 
then translocates into the nucleus and cooperates with other transcription factors to modulate the 
transcription of target genes such as Inhibitor of differentiation (Id) genes (Derynck and Zhang, 
2003; Miyazono et al., 2005; Moustakas et al., 2001; Shi and Massague, 2003; Wotton et al., 
1999; Zhang and Li, 2005). Smad1 and BMP4 are found to be crucial for mediating the embryonic 
development of mice. Smad1-/- embryos die by 10.5 dpc due to their inability to connect to the 
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placenta (Tremblay et al., 2001b). BMP4 may also be involved in the maintenance of ESCs by 
inhibition of the ERK/MAPK (Qi et al., 2004).  
  
BMP and LIF pathways are important in maintaining mESCs by cascading signals into the 
cell nucleus. However, little is known about how LIF and BMPs control intrinsic molecular 
determinants of pluripotency and self-renewal.  
 
1.4.2 Key transcription factors controlling pluripotency 
The pluripotency of ESCs is intrinsically regulated by ESC-specific transcription factors which 
includes Oct4, Sox2 and Nanog (Chambers, 2004; Chambers and Smith, 2004; Niwa, 2001; Wang 
et al., 2006). Oct4, Sox2 and Nanog-deficient ESCs are not capable of extensive self-renewal and 
spontaneously differentiate, even in the presence of LIF and serum (Chambers et al., 2003; Mitsui 
et al., 2003; Masui et al., 2007; Nichols et al., 1998). All three transcription factors including the 
substrate of LIF, Stat3, help to maintain mESCs in its undifferentiated condition (Figure 1.3). 
Nanog and LIF/Stat3 were reported to suppress primitive endoderm differentiation while Oct4 
over-expression promotes it. Oct4 and Sox2 have been shown to inhibit differentiation into the 




1.4.2.1.1 Oct4 structure 
Oct4 (also referred to as Oct-3/4), encoded by Pou5f1, is a homeodomain transcription factor 
belonging to class V of POU (Pit, Oct, Unc) factors. Two domains spanning the N- and C-terminal 
portion of Oct4 protein define the transactivation capacity of the POU transcription factor 
(Imagawa et al., 1991; Okamoto et al., 1990; Vigano and Staudt, 1996). The N-terminal region is 
a proline- and acidic residue- rich region, whereas the C-terminal region is rich in proline, serine 
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and threonine residues. The N-terminal domain can function as an activation domain in 
heterologous cell systems, while the C-terminal domain consists of a POU-domain which mediates 
cell-type specific functions (Brehm et al., 1997). In a complementation assay, Niwa et al. (2002) 
used a conditional Oct4-null ESC line to establish the essential domains of the Oct4 protein that 
are crucial in maintaining ESCs in an undifferentiated state (Niwa et al., 2002). The 
complementation assay was based on the ability of a protein to rescue the self-renewal capability 
of cells that would otherwise differentiate because of Oct4 downregulation. Oct4 was found to be 
the only POU domain containing protein to have the ability to rescue the self-renewing phenotype, 
as Oct2 and Oct6 were found to have no effect on cell fate in this system. Intriguingly, truncated 
Oct4 protein containing the Oct4 POU domain and either the C- or N-terminal domain can support 
ESC self-renewal. Gene expression analysis revealed that Oct4 transactivation domains have the 
ability to elicit the activation of different target genes such as Sox2, Fgf4, Utf1, Zfp42, Lefty1 and 
Otx2.  
 
Oct proteins have a common conserved DNA binding domain called the POU domain, 
which is a bipartite module comprising of two structurally independent subdomains: a 75 amino 
acid N-terminal POU-specific domain (POUs) and a 60 amino acid C-terminal POU homeodomain 
(POUH) connected by a flexible linker of 15-56 amino acids (Herr and Cleary, 1995). Both of 
these domains are required for DNA binding through a helix-turn-helix structure. The POU 
domain binds DNA via the POUs subdomain to an octamer DNA consensus sequence 
ATGC(A/T)AAT (Scholer, 1991). The POU domain also binds to DNA via the interaction of the 
third recognition helix of the POUH subdomain with bases in the DNA major groove at the TAAT 
core site. This DNA region interacts with the Oct proteins at a lower affinity compared to the 
earlier mentioned octamer DNA sequence. The POUs domain exhibits a site-specific, high affinity 
DNA binding and bending capability (Verrijzer et al., 1991). Besides mediating the binding of 
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POU factors to DNA, both the subdomains can also participate in protein-protein interactions 
(Brehm et al., 1999; Vigano and Staudt, 1996). 
 
1.4.2.1.2 Oct4 expression and function 
Oct4 is expressed in totipotent and pluripotent cell populations during development (Nichols et al., 
1998). It is initially expressed as a maternal transcript and is essential for the formation of the 
pluripotent ICM (Nichols et al., 1998). Oct4 is expressed at low levels in all blastomeres until the 
four-cell stage (Palmieri et al., 1994). At this particular stage, the Oct4 gene undergoes zygotic 
activation resulting in high Oct4 protein levels in the nuclei of all blastomeres until compaction 
(Yeom et al., 1991). After cavitation, Oct4 expression is maintained only in the ICM of the 
blastocyst and is downregulated in the differentiated trophectoderm (Okamoto et al., 1990; Rosner 
et al., 1990; Scholer et al., 1990). After implantation, Oct4 expression is restricted to the epiblast. 
During gastrulation at 6.0-6.5dpc, it is downregulated and from 8.5dpc, Oct4 is restricted to 
precursors of the gametes or PGCs. Oct4 is also expressed in undifferentiated mouse ESC, EGC 
and ECC (embryonic carcinoma cell) lines (Okamoto et al., 1990; Rosner et al., 1990; Smith et 
al., 1992; Yeom et al., 1996).  
 
Oct4 plays a central function in embryonic development and in maintaining 
undifferentiated ESCs. Oct4-deficient embryos die at the peri-implantation stage and form empty 
deciduas or implantation sites that contain trophoblastic cells that are devoid of yolk sac or 
embryonic structures (Nichols et al., 1998). In vitro cultures of the cells from the inner region of 
the Oct4-deficient blastocyst contain trophoblastic giant cells and not pluripotent cells nor 
extraembryonic endoderm. Moreover, a critical amount of Oct4 has been found to be crucial for 
the maintenance of ESC self-renewal (Niwa et al., 2000). In the study, Niwa et al. used ESCs with 
inactivated endogenous Oct4 alleles that were maintained by tetracycline regulated transactivator 
constructs activating a transgene expressing Oct4. They showed that downregulation of 
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endogenous Oct4 to below 50% of its original levels in undifferentiated mESCs resulted in the 
cells to be committed towards trophectoderm lineages due to the upregulation of transcription 
factors Cdx2 and Eomesodermin (Eomes) (Niwa et al., 2005). This result is consistent with Oct4-/- 
embryos (Nichols et al., 1998). On the other hand, an increase beyond 50% of the endogenous 
levels of Oct4 leads to the concomitant differentiation of ESCs into extraembryonic endoderm and 
mesoderm, similar to that observed upon LIF withdrawal (Niwa et al., 2000). Therefore, Oct4 
governs commitment of embryonic cells along three distinct cell fates: self-renewal, 
trophectoderm, extraembryonic endoderm and mesoderm.  
 
Retinoic acid triggers the rapid downregulation of Oct4 in ESC and ECC (Okamoto et al., 
1990; Rosner et al., 1990; Scholer et al., 1989). In ESCs, Oct4 activates gene transcription 
irrespective of the distance of the octamer motif from the transcriptional initiation site (Okamoto et 
al., 1990; Scholer et al., 1989). In differentiated cells, Oct4 can transactivate gene transcription 
only from a proximal location. However, interaction between adenovirus protein EA1 or human 
papillomavirus E7 oncoprotein and the Oct4 POU domain is sufficient for Oct4 to elicit 
transcriptional activation from remote binding sites (Scholer et al., 1991). E1A and E7 proteins 
would therefore mimic unidentified ESC-specific coactivators that serve a similar function in 
pluripotent cells.  
 
1.4.2.1.3 Regulation of Oct4 expression  
The Oct4 gene comprises a TATA-less proximal promoter as well as two stem-cell-specific 
regulatory elements, a distal enhancer and a proximal enhancer (Pikarsky et al., 1994; 
Schoorlemmer et al., 1994; Sylvester and Scholer, 1994; Yeom et al., 1996). Many positive and 
negative regulators are recruited to Oct4 at these sites. Among these are the Liver receptor 
homolog 1 (Lrh1 or Nr5a2) which is a putative positive regulator of Oct4. Oct4 expression is lost 
in the epiblast of Lrh1-null embryos and is quickly downregulated after the induction of 
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differentiation in Lrh1-null ESCs (Gu et al., 2005a). Conversely, the germ cell nuclear factor 
(Gcnf or Nr6a1) is a potential Oct4 negative regulator. Low Gcnf expression is detected in the 
whole mouse embryo at 6.5dpc where Oct4 expression is high. At 7.5dpc, increasing Gcnf and 
correspondingly decreasing Oct4 mRNA levels are observed in neural folds and at the posterior of 
the embryo. In Gcnf-deficient embryos, Oct4 mRNA is detected in the putative hindbrain region 
and posterior of the embryo (Chung and Cooney, 2001; Fuhrmann et al., 2001). This indicates that 
loss of Gcnf leads to loss of Oct4 repression in somatic cells and loss of Gcnf-induced restriction 
of Oct4 in the germ line. The same phenotype is observed in Gcnf-deficient mice containing a 
targeted deletion of the DNA-binding domain of Gcnf (Lan et al., 2002). Oct4 repression 
following the induction of differentiation is also delayed in Gcnf-null ESCs (Gu et al., 2005b). In 
addition to Gcnf, Chicken ovalbumin upstream promoter-transcription factors (Coup-tf) I and II, 
encoded by Nr2f1 and Nr2f2, respectively, also function as negative regulators of Oct4 expression 
(Ben Shushan et al., 1995; Gu et al., 2005b). In addition to Oct4 itself, Sox2 and Nanog have also 
been implicated to regulate Oct4 expression, which will be discussed in detail in the following 
chapters. FoxD3 has also been implicated as an activator for Oct4 expression (Pan et al., 2006). 




Sox2 is a member of the mammalian testis-determining factor Sry-related high mobility group 
(HMG box-containing) transcription factor family that binds to DNA through its 79 amino acid 
high mobility group (HMG) domain (Kamachi et al., 2000). In contrast to most DNA-binding 
proteins, which access DNA through the major groove, the HMG box interacts with the minor 
groove of the DNA helix, and introduces a bend in the DNA molecule.  
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Sox2 is indispensable for maintaining pluripotency. Sox2 is co-expressed with Oct4 in the 
ICM of preimplantation embryos, ESCs, ECCs, and EGCs (Avilion et al., 2003). Sox2 is also 
expressed in neuronal multipotent cells (Zappone et al., 2000). Sox2 homozygous null embryos 
stop development in the peri-implantation stage (as found in Oct4 mutants) and die immediately 
after implantation (Avilion et al., 2003). Using an inducible system, Masui et al. (2007) recently 
showed that Sox2 null mESCs differentiate primarily into trophectoderm-like cells. In 
concurrence, knockdown of Sox2 in mESCs also drives the cells towards the trophectodermal 
lineage (Ivanova et al., 2006). In contrast, Sox2 overexpression did not impair propagation of 
undifferentiated mESCs. However, when mESCs were released from self-renewal, they 
differentiated into the neurectoderm. More recently, Sox2 was also implicated in controlling 
transcriptional regulators of Oct4, thereby affecting Oct4 expression levels in mESCs (Masui et 
al., 2007).  
 
The two regulatory regions termed Sox2 regulatory region 1 (SRR1) and SRR2, were 
identified based on their activities in pluripotent ESCs where they exert their function specifically 
when cells are in an undifferentiated state (Tomioka et al., 2002). It was shown that SRR2 has a 
regulatory core sequence comprising octamer and Sox-2 binding sequences and that SRR2 
exhibits its activity by recruiting the Oct4-Sox2 complex to it in ESCs. The Sox2 HMG domain 
binds to the DNA recognition sequence CTTTGTT through numerous specific hydrogen bonds. 
Sox2 is able to bind to DNA on its own, but with a significantly lower affinity compared with 
binding to DNA as part of a ternary complex with POU proteins (Remenyi et al., 2003). Studies 
on Sox2 as a transcriptional regulator have mostly been in combination with Oct4, where Oct4 and 
Sox2 have been shown to interact and bind to multiple binding sites as a complex (Ambrosetti et 




1.4.2.2.1 Oct4 and Sox2 partnership 
Oct and Sox proteins selectively interact with each other via their conserved domains POU and 
HMG, respectively, which also bind to DNA. The C-terminal domains of both Sox2 and Oct4 
contribute to the functional activity of Sox2/Oct4 complex (Ambrosetti et al., 2000). The C-
terminal domain of Oct4 is active when Oct4 exists as an Oct4/Sox2 complex. The synergistic 
action of Sox2 and Oct4 results from two distinct yet concerted events. Cooperative binding of 
Sox2 and Oct4 to the DNA via their respective DNA binding domains, and upon tethering of each 
factor to the enhancer region forming a ternary complex, new DNA-protein and protein-protein 
interactions induce conformational changes that may lead to activation of latent domains and 
constitute a new, distinct platform for the recruitment of other coactivators (Dailey and Basilico, 
2001). Their functional partnership has been characterised on regulatory elements in various 
species including that of human and mice (Dailey and Basilico, 2001). Recently, the importance of 
Oct4 and Sox2 in the maintenance of pluripotency was further reinforced in an artificial system 
when Takahashi and Yamanaka (2006) reported that the expression of Oct4 and Sox2 with two 
other transcription factors, c-Myc and Klf4, could induce murine fibroblasts to become pluripotent 
ES-like cells (Takahashi and Yamanaka, 2006; Wernig et al., 2007).  
 
An example of a target gene with Sox2-Oct4 composite binding element is the Fgf4 
(fibroblast growth factor 4) enhancer, which was the first DNA element that was described to 
contain a composite DNA element binding Sox2 and Oct4 (Yuan et al., 1995). The Fgf4 enhancer 
in the untranslated region of exon 3 consists of a closely juxtaposed Oct4 binding site and Sox2 
binding site. Subsequent biochemical work showed the cooperative nature of Sox2 and Oct4 
interaction and the requirement of a specific arrangement of binding sites within the Fgf4 enhancer 
DNA (Ambrosetti et al., 1997). The different degrees of Sox2/Oct4 cooperativity on regulatory 
elements in vitro are in congruence with the regulation of Fgf4 during development, indicating that 
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varying the amount of cooperativity in complex formation could result in distinct functional 
properties in vivo, such as varying amount of transcription level production.  
 
Remenyi et al. (2003) analysed the crystal structure of the ternary Oct1/Sox2/Fgf4 
(fibroblast growth factor 4) enhancer element complex and then used homology modelling tools to 
construct an Oct4/Sox2/Fgf4 as well as an Oct4/Sox2/Utf1 structural model. These models 
revealed that the Fgf4 and the Utf1 enhancers mediate the assembly of distinct POU/HMG 
complexes, leading to different quaternary arrangements by swapping protein–protein interaction 
surfaces of Sox2. Sox2 is also able to bind with other Oct proteins in vitro and this may confer the 
specificity of Sox-Oct complexes on different target genes. For example, the POU domains of 
several family members, including the prototype member Oct1, bind cooperatively with the HMG 
domain of Sox2 onto the Fgf4 enhancer (Ambrosetti et al., 1997).  
 
The specific expression of Utf1 in ESCs is also regulated by the synergistic action of Sox2 
and Oct4, where the binding sites of these factors have no intervening spacing (Nishimoto et al., 
1999; Okuda et al., 1998) . In addition, a non-canonical binding site for Oct4 and Sox2 has been 
found in the 3’ regulatory region of the Sox2 gene, SRR2 and is involved in Sox2 expression in 
ESCs (Tomioka et al., 2002). Oct4 or Oct6 (but not Oct1) has been shown to increase Sox2 
dependent transcription of the Sox2 gene. Cooperative binding of Oct4 and Sox2 results in 
embryonic expression of the F-box containing protein 15 (Fbx15) and mutation of either binding 
site is known to abolish the activity of the enhancer (Tokuzawa et al., 2003). In addition, other 
pluripotency-associated genes such as Lefty1, Oct4, Sox2 and Nanog have been shown to be 
regulated by an enhancer element that contains the Oct4 and Sox2 binding motif and these genes 
are highly expressed in undifferentiated ESCs but not in differentiated cells (this study; Chew et 
al., 2005; Kuroda et al., 2005; Nakatake et al., 2006; Okumura-Nakanishi et al., 2005; Rodda et 
al., 2005; Tomioka et al., 2002). Chromatin immunoprecipitation (ChIP) studies have also 
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demonstrated that Oct4 and Sox2 co-occupy a few thousand regulatory sites in the genome of 
ESCs (this study; Boyer et al., 2005; Loh et al., 2006). 
 
1.4.2.3 Nanog 
Nanog was identified as another transcription factor whose functions are essential in maintaining 
the ESC state (Chambers et al., 2003; Mitsui et al., 2003). It is an NK2-family homeobox 
transcription factor containing an N-terminal domain, homeobox domain and C-terminal domain 
and is expressed in vivo in the interior cells of compacted morulae, ICM or epiblast, and germ 
cells. In vitro, Nanog is utilised as a marker for all pluripotent cell lines such as ESC, EGC and 
ECC. Nanog expression is downregulated upon differentiation of these cells.  
 
Nanog is essential for the maintenance of a pluripotent phenotype and endoderm 
specification is caused by Nanog downregulation. Nanog-deficient embryos die after implantation 
due to a failure in specification of the pluripotent epiblast, which is diverted to the endodermal 
fate. ESCs derived from Nanog-/- blastocysts differentiate into parietal-endoderm lineages (Mitsui 
et al., 2003). Knockdown of Nanog in mESCs also showed similar differentiation phenotype 
(Hough et al., 2006a; Hough et al., 2006b). However, recently, Chambers et al. (2007) reported 
that Nanog null ESCs are more susceptible to differentiation but could still proliferate as 
pluripotent stem cells, whereas Nanog expression appears to suppress differentiation. 
Overexpression of Nanog in mESC circumvents the necessity of either LIF or BMP stimulation 
(Chambers et al., 2003; Ying et al., 2003), suggesting that Nanog may be a downstream effector 
for extrinsic signalling molecules. Nanog has also been shown to reinstate pluripotency in somatic 
cells after fusion (Silva et al., 2006). Nanog expression has been reported to be positively 
regulated by Oct4 and Sox2 (Kuroda et al., 2005; Rodda et al., 2005) and FoxD3 (Pan et al., 
2006), while negatively regulated by p53 (Lin et al., 2005) and Tcf3 (Pereira et al., 2006). 
Recently, Stat3 and T (Brachyury) binding sites were also identified in the Nanog enhancer region 
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and Nanog was found to interact with Smad1 to inhibit the activity of BMP signalling (Suzuki et 
al., 2006). Wang et al. (2006) has also identified Nanog-associated proteins such as zinc finger 
proteins that form protein interaction networks in mESCs. In addition, Sall4 is another 
transcription factor that was shown to interact with Nanog and associate together at genomic sites 
in vivo (Wu et al., 2006).  
 
1.4.2.4 Other transcription factors in the maintenance of mESC 
The identification of the Oct4, Sox2, Nanog 'triad' as master regulators has been an important 
advancement in stem-cell biology, although the expression of the triad does not, in itself, 
guarantee pluripotency. For example, ECCs express these three factors at appreciable levels, but 
are able to develop along only a limited range of specific developmental pathways. This indicates 
that additional regulators are required to establish or efficiently retain the pluripotent state.  
 
Other regulators of pluripotency have been identified in screens for genes that give ESCs a 
selective advantage in self-renewal. RNAi was used to screen genes that were required to maintain 
ESCs in an undifferentiated state (Ivanova et al., 2006). This study identified four genes, estrogen-
related receptor-β (Esrrb), T-box 3 (Tbx3), T-cell lymphoma breakpoint 1 (Tcl1) and 
developmental pluripotency-associated 4 (Dppa4), in addition to Oct4, Sox2 and Nanog. By 
analysing changes in ESC transcription after the knockdown of each of these six genes, the authors 
identified three sets of target genes: 800 genes that were either up- or downregulated in response to 
most knockdowns; 474 that were affected only by the knockdowns of Oct4, Sox2 and Nanog; and 
272 that responded to the Esrrb, Tbx3, Tcl1 and Dppa4 knockdowns. These findings indicated that 
at least two separate pathways control ESC self-renewal. Zfx have also been shown to be involved 
in regulating ESC self-renewal (Galan-Caridad et al., 2007). Other studies have also characterized 
downstream targets that contribute to the maintenance of ESCs, such as Zfp206 (Wang et al., 
2007) and Zic3 (Lim et al., 2007). In a recent report, the ectopic expression of four genes, Oct4, 
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Sox2, Klf4 and c-Myc, have been shown to convert mouse embryonic fibroblasts to ES-like 
pluripotent stem cells (Takahashi and Yamanaka, 2006). However, the low frequency of this 
conversion suggests that other factors might be required for 'resetting' developmental potential. 
Alternatively, these converting factors might be effective in only a minority of fibroblasts that 
might have already acquired stem-like properties. 
 
1.5 Cell cycle and proliferation of mESCs 
Under optimized culture conditions, mESCs divide symmetrically every 12 hr. During self-
renewal, most ESCs are in the S phase of the cell cycle, with only a few in G1 (Burdon et al., 
2002; Prost et al., 1998). When ESCs begin to differentiate, the G1 phase of the cell cycle 
becomes longer and the rate of cell division slows. A number of pathways and factors have been 
reported to play a role in promoting the proliferation, survival and/or differentiation of mESCs, 
and this includes the phosphoinositide-3-kinase (PI3K)/Akt/Eras/Tcl1 signalling (Ivanova et al., 
2006; Matoba et al., 2006; Sun et al., 1999; Takahashi et al., 2003; Watanabe et al., 2006), 
transcription factor b-Myb (Iwai et al., 2001; Tanaka et al., 1999) and Myc (also known as c-Myc) 
which acts via the activation of cyclin E expression to promote G1-S transition (Cartwright et al., 
2005; Hooker and Hurlin, 2006). It was shown that c-Myc is a direct target of Stat3, and that 
overexpression of a dominant-active form of c-Myc attenuates self-renewal of mESCs independent 
of LIF, which suggests that the regulation of the G1-S transition may be linked to the maintenance 
of pluripotency (Burdon et al., 2002). In addition, mESCs with reduced expression of 
Undifferentiated embryonic cell transcription factor 1 (Utf1) and mESCs that lack Sall4 showed 
reduced proliferation ability (Nishimoto et al., 2005; Sakaki-Yumoto et al., 2006).  
 
1.6 Epigenetic modifications in mESCs 
Epigenetic processes such as DNA methylation, histone modifications and RNAi may also be 
required for proper ESC differentiation (Niwa, 2007) or to facilitate access for transcription factor 
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action (Azuara et al., 2006; Smith, 2005). Recently, studies examining specific epigenetic features 
of ESCs such as the abundance of modified histones, Polycomb group (PcG) protein-binding 
patterns, replication timing and chromatin accessibility have revealed that ESCs manage their 
pluripotent status by priming important regulator genes for future expression (Bernstein et al., 
2006; Boyer et al., 2006a; Boyer et al., 2006b; Lee et al., 2006).   
 
1.7 Building the transcriptional network in mESCs 
 
1.7.1 Transcriptional regulators 
Transcriptional regulation is controlled by the sequence-specific DNA binding activity of 
transcription factors (Tjian and Maniatis, 1994; McKnight and Tjian, 1986; Blackwood and 
Kadonaga, 1998). They determine the expression repertoire and thus the cellular phenotype of a 
cell. Regulated eukaryotic gene transcription involves the assembly of an initiation complex at the 
core promoter region and the coordinated binding of multiple transcription factors and regulatory 
complexes to the promoter and enhancer regions. Transcription factors affect the basal 
transcriptional machinery and regulate the transcriptional rate. Hence, they influence the 
expression level of the corresponding gene. Their ultimate action may be positive (activators) or 
negative (repressors). The activity of many of these transcription factors is regulated in a number 
of different ways by distinct signal transduction pathways: by changing the rate of synthesis or 
degradation of the protein, by post-translational modification of the transcription factor or by 
altering its subcellular localisation.  
 
Proximal promoter bound transcription factors are thought to play a direct role in 
transcriptional initiation, since many transcription factors contain distinct domains that directly 
contact the basal transcriptional machinery. Enhancer elements are cis-acting sequences that 
stimulate transcription in an orientation-independent manner and can operate from long distances 
 24
(Dynan and Tjian, 1985). Studies have highlighted the importance of higher order structure in 
regulating gene expression, particularly in the context of chromatin architecture (Cosma, 2002; 
Wolffe et al., 1997). Besides proximal promoter and enhancer elements, other elements such as 
locus control region, insulator and matrix attachment regions may also associate with transcription 
factors in order to facilitate gene expression (Carey and Smale, 2000). 
 
With the completion of the mouse (Waterston et al., 2002) and human (Lander et al., 
2001; Venter et al., 2001) genome, emerging studies are now defining the transcriptome to 
decipher the orchestration of gene expression, which is fundamental to the phenotype of a cell and 
ultimately the identity of the organism. Mapping and building regulatory networks in ESCs began 
with Oct4, Sox2 and Nanog as the building blocks and continued to gain impetus with the advent 
of high throughput technologies. 
 
1.7.2 Technologies for studying the transcriptome 
The transcriptome is a complex collection of transcripts, due to alternative splicing, temporal and 
spatial expression. Powerful high-throughput technologies have been developed to dissect the 
transcriptome and to identify genes potentially involved with ESC self-renewal such as (1) 
transcriptional profiling for global gene expression, (2) high-throughput RNA interference (RNAi) 
that allows systematic perturbation of biological systems, and (3) genome-wide analysis of 
protein-DNA interactions which facilitates the study of transcriptional networks (Liu, 2005; Ruan 
et al., 2004). The advent of these high-throughput tools together with computational 
bioinformatics allows the study of biological processes in a global scale.  
 
1.7.2.1 Transcriptional profiling 
Transcriptional profiling refers to the simultaneous analysis of gene expression of all the 
transcripts encoded by the genome. Techniques that are currently being used for transcriptional 
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profiling include serial analysis of gene expression (SAGE), massively parallel signature 
sequencing (MPSS), and expression microarrays (Ruan et al., 2004). SAGE is a technology 
specifically designed to digitally quantify expression of genes annotated by short cDNA tags. 
MPSS couples a SAGE-like approach with a novel restriction–ligation, bar code identification, 
and bead-based detection system to identify 17–20 bp tags of every transcript in an RNA sample 
(Brenner and Livak, 1989; Brenner et al., 2000). Both SAGE and MPSS involve the sequencing of 
transcripts. The primary feature of expression microarrays is the arrangement of DNA probes 
precisely placed on a two dimensional surface, upon which the RNA targets of analysis are 
overlaid (Stears et al., 2003).  
 
In the field of stem cells, attempts to uncover a common set of molecular properties that 
define the uncommitted state were pioneered several years ago in a series of microarray expression 
studies (Ivanova et al., 2002; Ramalho-Santos et al., 2002; Rao and Stice, 2004). Systematic, 
genome-wide interrogations have identified hundreds of genes, including several transcription 
factors, which have expression patterns tightly correlated with ESC differentiation. Examples of 
methods used include gene expression profiling (Furusawa et al., 2006; Tanaka et al., 2002), EST 
(Brandenberger et al., 2004; Palmqvist et al., 2005; Sharov et al., 2003), MPSS (Wei et al., 2005) 
and SAGE (Richards et al., 2004). In addition, global expression profiling was used to delineate 
the downstream target genes of Oct4 in Oct4-manipulated ESCs (Matoba et al., 2006). 
 
Although transcriptional profiling provides information about the genes that are expressed 
by a particular cell type and their relative abundance, it is unable to define the functional 
contribution of a particular gene to a certain biological process. In this aspect, one approach used 
to determine the role of a particular gene in a biological process is to remove, reduce or inactivate 
the gene and subsequently observing the effects on the system.  
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1.7.2.2 RNAi screen 
Classical loss-of-function genetic approaches involve the random mutagenesis of genomic DNA 
followed by identification of resulting mutant phenotypes, or targeted disruption of a desired 
genetic locus. Such forward and reverse genetic screens are time-consuming, technically 
challenging and costly (Rajewsky et al., 1996). This can be circumvented by using a technique 
called RNA interference (RNAi). RNAi is an evolutionary conserved phenomenon discovered in 
Caenorhabditis elegans (Fire et al., 1998) and has since been shown to operate in other organisms 
ranging from yeast to mammals (Sen and Blau, 2006). RNAi can be mimicked experimentally 
whereby the introduction of double-stranded RNA (dsRNA) corresponding to a particular mRNA 
causes the specific and rapid degradation of that mRNA in cells. Large-scale RNAi screens 
involving the systematic knockdown can be done in mammalian cells (Paddison et al., 2004). 
Recently, Zhang et al. (2006) used an RNAi library constructed from subtracted mESC cDNAs in 
an attempt to discover new players in maintaining the ESC state. More interestingly, (Ivanova et 
al., 2006) used short hairpin RNA (shRNA)-mediated depletion to identify Esrrb, Tbx3, Tcl1 and 
other transcripts as additional important factors for ESC self-renewal.  
 
Although loss-of-function RNAi genetic screens are useful for adding new players to the 
stem-cell regulatory network, it cannot distinguish between direct and indirect regulators of gene 
activity. To fully understand the network architecture of ESCs, we need to know much more about 
how these players interact with DNA. In this aspect, chromatin immunoprecipitation (ChIP) assays 
can be used to map out the targets of transcription regulators to better define the ESC interactome. 
 
1.7.2.3 In vivo analysis of transcription factor-DNA interactions 
An important strategy in understanding the transcriptome is to uncover its regulatory control that 
is directed by transcription factors (TFs). In silico, the DNA-binding feature of transcription 
factors were used in computational methods to predict the location of promoters and find targets of 
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transcription factors based on consensus sequences (Davuluri et al., 2001). However, information 
from this approach will remain inadequate without experimentation. Nevertheless, multiple 
bioinformatics methods have aided the experimental analysis for reconstruction of gene networks. 
 
1.7.2.3.1 Chromatin immunoprecipitation (ChIP)  
A method currently employed to identify the endogenous or in vivo direct targets of a 
transcriptional regulator is chromatin immunoprecipitation (ChIP), which was modified from the 
method described in Solomon et al. (1988). ChIP is a powerful tool for analysing target sites of 
protein binding to DNA as well as patterns of histone modifications (Orlando, 2000; Roh et al., 
2004). ChIP involves the treatment of living cells with formaldehyde, a procedure that crosslinks 
DNA to proteins that are in physical contact with it, thereby preserving the endogenous DNA-
protein interactions. Chromatin is then fragmented either by physical or enzymatic means to an 
average size of 500bp. DNA fragments associated with a particular protein are then isolated by 
immunoaffinity purification using a specific antibody against the protein. After crosslinking is 
reversed, the ChIP-enriched DNA can be analysed by quantitative polymerase chain reaction 
(qPCR) using specific primers targeting the loci of interest. ChIP-qPCR is not high-throughput and 
requires test targets or binding sites to be pre-determined or assumed. Therefore, more advanced 
technologies have been used to identify ChIP DNA (target sequences) on a genome-wide scale 





















































Figure 1.4: Diagram depicting the chromatin immunoprecipitation (ChIP) assay for the study of 
transcription factor DNA binding sites (TFBSs) in living cells. Formaldehyde is used to crosslink 
proteins to proteins and DNA. The crosslinked chromatin is then sheared by sonication or nuclease 
treatment and immunoprecipitated with specific antibodies against the factor of interest. DNA 
sequences that are bound by this factor are pulled out. After the crosslinking is reversed, the IP 
DNA can be analysed by quantitative polymerase chain reaction (qPCR). Two approaches which 
provide a bigger coverage are the ChIP-on-chip which takes advantage of genomic microarrays 
and ChIP-PET (paired-end tag) where short sequence tags of immunoprecipitated fragments are 
cloned into a plasmid library and then directly analysed by sequencing. Figure was obtained from 





1.7.2.3.2 ChIP-Paired-end ditag (PET) technology 
Chromatin immunoprecipitation - paired-end ditag (ChIP-PET) technology is a method that can be 
used in the genome-wide location analysis of protein-DNA interactions (Figure 1.5). It was 
developed by Dr Ruan Yijun’s group in GIS. The ChIP-enriched chromatin fragments are blunt-
ended before being cloned into a primary vector library that appends the cloned fragments with 
MmeI restriction sites. Using MmeI, 18 bp tags from each end of the cloned DNA fragments are 
retained. These tags are then re-ligated to generate paired-end ditags (PETs). These PETs are 
released from the primary vector library by restriction digestion before being concatenated and re-
cloned into a PET sequencing library. The PETs are subsequently sequenced and the sequences 
obtained are computationally mapped onto the genome. ChIP-PET can unambiguously assign 
enriched genomic fragments to a specific region in the genome and also define the exact length of 
each enriched genomic fragment. Due to the random sampling of DNA fragments during PET 
cloning and sequencing, genomic fragments that are enriched by ChIP are more likely to be 
sequenced and mapped. Therefore, protein-DNA interaction sites are represented by genomic loci 
that contain multiple overlapping PETs, with overlap regions demarcating the protein binding site. 
A vast amount of sequencing is required to achieve sufficient representation of 
immunoprecipitated fragments (each one must be sequenced many times in order to calculate 
relative enrichment). Nevertheless, the ChIP-PET approach allows genome-wide, high-throughput 
and unbiased identification of transcription factor binding sites. Although currently the ChIP-PET 
is expensive and labour-intensive relative to ChIP-on-chip approaches, future advances in DNA 
sequencing could redress this balance. The ChIP-PET approach was first employed to map the 
binding sites of p53 in a colorectal cancer cell line (Wei et al., 2006). It was also used in this study 

















Figure 1.5: Schematic diagram of the chromatin immunoprecipitation-paired end ditag (ChIP-
PET) approach. Cells are treated with formaldehyde to mediate covalent crosslinks that preserves 
endogenous interactions between DNA and proteins. The chromatin is fragmented followed by 
immunoprecipitation using beads coupled to a specific antibody to capture the transcription factor 
bound to target sites (shown in red). The ChIP-enriched chromatin fragments are then 
decrosslinked and subjected to proteinase digestion to liberate ChIP-enriched DNA. The DNA is 
then blut-ended and cloned into a primary plasmid-based library that affixes the fragments with 
MmeI restriction sites. Using MmeI, tags of 18 bp in length are generated from the 5’-most and 3’-
most ends of the ChIP-enriched DNA fragments. These tags are then religated to generate paired 
end ditags (PETs). These PETs are released from the primary vector library by restriction 
digestion before being concatenated and recloned into a second library called the PET sequencing 
library. This second library increases the throughput of analysis, as each sequencing read identifies 
10 to 15 PETs representative of 10 to 15 ChIP-enriched genomic fragments. Subsequently, the 
concatenated PETs are sequenced and computationally mapped to the mouse genome to demarcate 
genomic regions bound by the protein of interest (indicated by overlap regions within PET 
clusters). Figure was obtained from Lim and Ng (2007). 
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1.7.2.3.3 ChIP-on-chip  
Another approach that allows for whole genome assessment of the DNA binding sites for 
transcription factors is the coupling of chromatin immunoprecipitation with oligonucleotide 
microarrays (ChIP-on-chip). These microarrays are similar to those used for transcriptional 
profiling, except that the oligonucleotides on the microarray are designed to probe genomic 
sequences instead of transcript sequences. ChIP-on-chip uses total amplification before 
hybridization; therefore a main concern for using this approach is the introduction of bias (Buck 
and Lieb, 2004; Negre et al., 2006). 
 
ChIP-on-chip identification of bona fide targets of transcriptional regulators in a genome-
wide manner was reported in yeast (Iyer et al., 2001; Ren et al., 2000). In the mammalian context, 
early microarrays designed to analyse protein-DNA interactions only probed selected regions of 
the mammalian genome such as core promoter microarrays that probe genomic sequences flanking 
the transcription start sites of genes (Balciunaite et al., 2005; Scacheri et al., 2006), CpG 
microarrays that analyse genomic CpG islands (Weinmann et al., 2002; Wells et al., 2003), 
ENCODE microarrays (Takayama et al., 2007; Wormald et al., 2006), and tiling microarrays that 
probed the entire non-repeat regions of chromosomes 21 and 22 (Cawley et al., 2004; Euskirchen 
et al., 2004; Martone et al., 2003). Rick Young’s group used oligonucleotide-based human 
promoter arrays in ChIP-on-chip studies on transcription factors and Polycomb complexes in 
hESCs (Boyer et al., 2005; Boyer et al., 2006b; Lee et al., 2006). Kim et al. (2005) used 
microarrays containing approximately 15 million 50-mer probes covering all non-repeat regions of 
human DNA at a 100bp resolution to generate a genome-wide map of active promoters in human 
fibroblasts by determining the binding sites of transcriptional pre-initiation complexes. Very 
recently, whole mouse and human genome microarrays for ChIP-on-chip were made available 
from Nimblegen and Affymetrix. Nimblegen chips come in survey sets of 10 (human) and 10 
(mouse) covering the repeat masked regions of the human or mouse genome at an average probe 
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spacing of 100 bp, while the Affymetrix array sets cover the whole genome on 7 arrays, at 35 bp 
resolution. 
 
1.8 Aim and experimental approach 
This study focuses on Oct4 and Sox2, which are two key transcription factors that are essential in 
maintaining pluripotency of ESC. In order to gain a deeper understanding of the functions of Oct4 
and Sox2 in governing the ESC fate, it is essential to know which genes are directly targeted by 
these factors in vivo. Prior to this study, only a few Oct4 and Sox2 targets have been identified.  
 
Therefore, the main aim of this study is to map the in vivo genomic binding sites of Oct4 and Sox2 
using mouse ESC as a model. The main methodology employed is chromatin immunoprecipitation 
(ChIP). Subsequently, information is extracted from these binding datasets to elucidate how these 
factors may work in ESCs. The outline of the study is as follows:  
 
(i) Gene-by-gene ChIP-qPCR to optimize the ChIP technique and to establish the 
transcriptional network consisting of Oct4, Sox2 and Nanog  
(ii) Genome-wide mapping of the Oct4 and Sox2 binding sites using the ChIP-PET 
sequencing technology 
(iii) Identification of the Oct4 and Sox2 co-bound targets and characterization of the joint 
consensus motif by in vitro assays 
(iv) Discovery of factors collaborating with Oct4 and Sox2 at cis-regulatory elements by 
computational search, ChIP-qPCR and ChIP-on-chip 
(v) Investigation of the molecular mechanisms that provide insights into the juncture between 





MATERIALS AND METHODS 
 
2.1 Chemicals and reagents 
All chemicals and reagents used were of analytical grade unless otherwise stated. The phosphate-
buffered saline (PBS) used in all assays was composed of 137 mM NaCl, 2.7 mM KCl, 4.3 mM 
KH2PO4 and 1.4 mM K2HPO4.7H2O at pH 7.3. Luria-Bertani (LB) medium and ampicillin were 
purchased from Sigma Aldrich (St. Louis, MO). All other chemicals were purchased from either 




Sox2 (Y-17) sc-17320 goat polyclonal, Oct4 (N-19) sc-8628 goat polyclonal, Stat3 (C-20) sc-482 
rabbit polyclonal, Stat3 (K-15) sc-483 rabbit polyclonal, Smad1 (A-4) sc-7965 mouse monoclonal, 
Ap-2α (3B5) sc-12726 mouse monoclonal, AP-2α (C-17) sc-6312 goat polyclonal, E2F1 (C-20) 
sc-193 rabbit polyclonal, p53 (Pab-240) sc-100 mouse monoclonal, c-Fos (6-2H-2F) sc-447 mouse 
monoclonal, JunB (C-11) sc-8051 mouse monoclonal, NFkB p65 (c-20) sc-372 rabbit polyclonal, 
GST (Z-5) sc-459 rabbit polyclonal, GFP (FL) sc-8334 rabbit polyclonal, Ena1 (yC-20) sc-15542 
goat polyclonal and MLL (c-20) sc-18214 goat polyclonal antibodies were purchased from Santa 
Cruz Biotech, CA. Sox2 AB5603 rabbit polyclonal antibody was purchased from Chemicon (now 
Millipore Corporation). Oct4 in-house antibody was obtained from colleague, Tay Hwee Goon. 
Smad1 rabbit monoclonal [EP435E] (ab33902), histone H3 (tri methyl K4) rabbit polyclonal 
(ab8580), histone H4 (tri methyl K20) rabbit polyclonal (ab9053) and RNA polymerase II CTD 
repeat YSPTSPS (phospho S5) (ab5131) antibodies were purchased from Abcam. Anti-E2F1, 
clones KH20 & KH95 (mixed mouse monoclonal antibody) (#05-379), anti-Stat3 rabbit 
polyclonal (#06-596) and anti-Smad4/DPC4 rabbit polyclonal (#06-693) antibodies were 
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purchased from Upstate. Phospho-Smad1/5 (Ser463/465)(41D10) rabbit monoclonal (#9516) and 
phospho-Stat3 (Tyr705) rabbit polyclonal (#9131) antibodies were purchased from Cell Signaling 
Technology Inc. 
 
2.3 Recombinant DNA manipulations 
General recombination DNA manipulations were performed as described by Sambrook and 
Russell (2001). Restriction enzyme digests and other DNA modifications such as ligation of DNA 
and de-phosphorylation of cloning vectors were performed using the appropriate buffers specified 
and supplied by the manufacturers (New England Biolabs, Inc., MA). Polymerase chain reactions 
(PCR) were carried out in a thermal cycler (Thermal cycler PTC-200 from MJ Research Inc. MA) 
using high fidelity Pfu DNA polymerase (Promega, Madison, WI) or Expand High FidelityPLUS 
System (Roche Diagnostics, Germany). DNA fragments from agarose gels were purified using the 
QIAquick Gel Extraction Kit (QIAGEN, Hilden, FRG), according to the manufacturer's protocol. 
Rapid ligation kit from Roche or T4 ligase from New England Biolabs were used for DNA 
ligation. Plasmid DNA was purified using the QIAprep procedure (QIAGEN, FRG) that is based 
on alkaline lysis of bacterial cells and clearing the lysates under high salt conditions. The high salt 
concentration causes denatured proteins, cellular debris and chromosomal DNA to precipitate, 
while the plasmid DNA stays in solution. The latter is isolated by adsorption of DNA onto silica-
based columns and subsequent elution in a low salt buffer. Competent cells used were SoloPack 
Gold Supercompetent cells from Stratagene unless otherwise stated. DNA sequencing was carried 
out by the GIS Sequencing Facility with the capillary Applied Biosystems sequencers ABI 3730xl 
and Applied Biosystems Big Dye Terminator version 3.1 Sequencing kit. Analysis of DNA was 
carried out by agarose gel electrophoreses using 1-1.5% (w/v) agarose (Seakem #50004) in 1x 
TAE buffer (40 mM Tris-acetate, 10 mM EDTA) containing 1 μg/ml ethidium bromide (EtBr) at 
100V, 30 min unless otherwise stated. The DNA samples were mixed with DNA loading buffer 
[0.1% Orange G, 30% Ficoll (type 400)] and loaded onto agarose gel alongside 100bp and 1kb 
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DNA ladders from New England Biolabs, Inc., MA. The detection of the DNA bands was carried 
out using the UV trans-illuminator. Analyses of DNA sequences and design of cloning and 
sequencing primers were carried out using the Vector NTI® version 2.0 software (VNTI Suite 8.0, 
Invitrogen Corp., CA).  
    
2.4 SDS-PAGE, Western blots and immunodetection 
Protein concentrations were measured using the Protein Assay Dye Reagent Concentrate 
(Coomassie® Brilliant Blue G-250 dye) from Bio-Rad which is based on the Bradford method. 
Bovine serum albumin standards (2 mg/ml) were purchased from Pierce, IL. Proteins were 
typically analysed by means of a one-dimensional 7.5% sodium dodecyl sulphate-polyacrylamide 
gel electrophoresis (SDS-PAGE) using the Bio-Rad Mini-Protean II system, according to standard 
protocols (Sambrook and Russell, 2001). To prepare the samples for SDS-PAGE, equal volumes 
of protein samples and 2x Laemmli buffer [125 mM Tris-HCl (pH 6.8), 4% (v/v) SDS, 10% (v/v) 
β-mercaptoethanol, 20% glycerol and 0.4% (w/v) bromophenol blue] were mixed thoroughly and 
boiled at 95°C for 5 min before loading into the wells. The components of the electrophoresis 
buffer were 25 mM Tris-HCl (pH 8.3), 192 mM glycine and 0.1% SDS. 
Chromatin extracts or whole cell lysates were resolved by SDS-PAGE and 
electrophoretically transferred onto Immuno-Blot™ PDVF membranes (pre-activated with 
methanol) (Bio-Rad) using Western transfer apparatus (Bio-Rad Trans-Blot systems) in a transfer 
buffer containing 25 mM Tris-base (pH 8.3), 192 mM glycine, 10% SDS and 20% methanol for 1 
hr at 4°C. Subsequently, the membranes were incubated in blocking buffer [PBS containing 1% 
(w/v) BSA and 0.1% (v/v) polyoxyethylene-sorbitan monolaurate (Tween 20)] for at least 1 hr at 
room temperature. The membranes were then incubated for 1 hr at room temperature with primary 
antibody (0.1-1 g/ml). Unbound antibodies were removed by extensive washing in wash buffer 
(PBS containing 0.1% Tween-20). Membranes were then incubated with 0.5 μg/ml horseradish 
peroxidase-conjugated (HRP) secondary antibody for at least 1 hr at room temperature and then 
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washed in wash buffer 3 times. Membranes were then developed using an enhanced 
chemiluminescence (ECL) kit (GE Healthcare) for 1 min. HRP catalysed-oxidative degradation of 
luminal occurs, resulting in light emission at a wavelength of 428 nm, which was detected on an 
autoradiography film (GE Healthcare). Bands were also visualised using 0.1% Ponceau S (Sigma) 
in 5% acetic acid. Stripping of blots was carried out in a stripping buffer (2% SDS, 100 mM 2-
mercaptoethanol, 62.5 mM Tris pH6.7) at 50°C, 2 hr and blocked again before re-probing with 
another antibody.  
 
2.5 Cell Culture 
2.5.1 Feeder-free mESC culture 
All mESCs used in this project were E14 mESCs grown in feeder-free conditions. The HPRT-
deficient E14 mESC line were cultured without feeders on 0.1% gelatin coated plates and 
maintained in Dulbecco’s modified Eagle’s medium (DMEM; GIBCO), supplemented with 15% 
heat-inactivated ES fetal bovine serum (FBS; Invitrogen), 55 mM 2-mercaptoethanol (GIBCO), 
200 mM L-glutamine (GIBCO), 10 mM minimal essential medium with nonessential amino acids 
(GIBCO) and 1,000 U/ml of ESGRO® leukemia inhibitory factor (LIF) (Chemicon International 
CA, #ESG1107). Cells were routinely passaged at a 1:5 ratio after subjecting the cells to 0.25% 
trypsin (GIBCO) treatment at 37°C for 2 min. Cells were cultured in 500 cm2 dishes (Falcon) for 
ChIP assays, 6-well plates for protein lysate and RNA extraction, and 96-well plates for reporter 
assays.  
2.5.2 Differentiation of mESCs 
Differentiation of mESCs was induced by addition of retinoic acid, withdrawal of LIF or by 
allowing the cells to spontaneously differentiate into embryoid bodies. In retinoic acid 
differentiation assays, E14 mESCs were treated with 0.5 μM of retinoic acid (RA) (Sigma 
#R2625) in mESC media without LIF for 3, 6 and 9 days. In formation of embryoid bodies, 15 x 
106 E14 mESCs were seeded onto a 15 cm bacterial petri dish using ES media without LIF and 
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incubated in a shaker at 37°C/ 5% CO2 for up to 10 days. In LIF withdrawal assays, mESCs were 
cultured in mESC media without LIF for up to 2 days.  
2.5.3 Defined serum-free mESC culture 
ESGRO Complete™ Clonal grade medium (#SF001-500) and ESGRO Complete™ Basal medium 
(#SF002-500), Accutase™ (#SCR005) were purchased from Chemicon International. ESGRO 
Complete™ Clonal Grade Medium is a defined serum-free medium containing BMP4 and LIF 
which has been optimized to grow and maintain undifferentiated mESCs in the absence of serum. 
Adaptation of feeder-free mESCs to serum-free cell culture conditions was carried out over at least 
3 passages. E14 mESCs were grown to 60% confluence in serum-supplemented ESC medium in a 
10 cm dish in the absence of feeder cells. Cells were washed once with PBS. To dissociate cells, 1 
ml Accutase was added to mESCs and incubated at 37°C to allow cells to detach (5-10 min). 5 ml 
of Basal Medium was added, mixed and cells were spun at 1000 rpm. Pellet was resuspended in 5 
ml Clonal Grade Medium and 1x106 cells were seeded onto a pre-gelatin coated 10 cm dish 
containing 10 ml pre-warmed Clonal Grade Medium. When mESCs were about 60% confluent, a 
1 in 5 split of the 10 cm dish culture was done into another coated 10 cm dish containing Clonal 
Grade Medium.  
2.5.3.1 Low density plating assay 
Early passage E14 mESCs that had adapted to serum-free culture conditions were seeded into a 
0.1% gelatin-coated 10 cm plastic tissue culture dish at 1x103 cells/ dish in 10-20 ml of Clonal 
Grade Medium. This medium was changed every 3 days. Colony formation was observed after 
culturing the cells for 5 days. The majority of the mESC colonies showed no signs of 
differentiation. 
2.5.4 LIF and BMP treatment of serum-free, feeder-free mESC  
Human recombinant BMP4 was purchased from Sigma, MI (#B2680) and R&D Systems (#314-
BP) and ESGRO® LIF (#ESG1107) was purchased from Chemicon International. Feeder-free 
mESCs that have adapted to serum-free conditions and grown in ESGRO Complete™ Clonal 
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grade medium were washed with PBS twice and added with the following different media: (1) 
ESGRO Complete™ Clonal grade medium, (2) ESGRO Complete™ Basal medium, (3) ESGRO 
Complete™ Basal medium with 1000 U/ml ESGRO® LIF (#ESG1107), (4) ESGRO Complete™ 
Basal medium with 30 or 50 ng/ml BMP4 and (5) ESGRO Complete™ Basal medium with 1000 
U/ml LIF and 30 ng/ml BMP4. Cells were grown for specific time-points and treated in 500 cm2 
culture dishes (Falcon) for ChIP assays, and 6-well plates (Falcon) for protein lysate and RNA 
extractions. 
2.5.5 Human ESC culture 
Human ESC line HUES-6 was obtained from Doug Melton (Harvard University) and cultures 
were obtained from Yeap Leng Siew from Assoc. Prof. Lim Bing’s group, GIS. HES-3 (46X,X) 
(ES Cell International) cell cultures were obtained from Andre Choo (Biotechnology Institute, 
BTI). The cells were cultured feeder-free on matrigel with conditioned-medium from primary 
mouse embryonic fibroblasts (MEFs) in medium supplemented with basic fibroblast growth 
factor, recombinant human LIF, serum replacement, and a human plasma protein fraction 
(plasmanate) at 37°C/ 5% CO2 according to methods described in Cowan et al. (2004) and Xu et 
al. (2001).  
2.5.6 HEK293T cell culture  
Human kidney HEK-293T cells (HEK 293T/17, CRL-11268) were purchased from American 
Type Culture Collection (ATCC, MD) and cultured in Dulbecco’s modified Eagle’s medium 
(DMEM; GIBCO) supplemented with 10% heat-inactivated fetal bovine serum (FBS; GIBCO) 
and maintained at 37°C in the presence of 5% CO2. The cells were routinely passaged in a 1:5 
ratio using 0.25% trypsin. 
 
2.6 Cell Images 
Cultured cells were routinely examined on the Nikon Eclipse TS100 inverted microscope 
(objective lens magnifications: 4X, 10X, 20X, 40X; eyepiece lens magnification: 10X) and images 
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were acquired with the Nikon Coolpix 4500 digital camera attached to the microscope. Images 
were also taken using the Leica DM-IRB fluorescent microscope (objective lens magnifications: 
5X, 10X, 20X, 40X, 63X, 100X, eyepiece lens magnification: 10X).  
 
2.7 Transfection of mammalian cells 
HEK293T or mESCs were seeded at ~1 x 106 cells into 10 cm culture plates for 14 hr before they 
were subjected to transfection. Adherent cells at ~70% confluency were rinsed with PBS and 
transfected with plasmid DNA by liposome mediated transfection with LipofectamineTM 2000 
reagent (2.5 μl per 1 μg DNA) (Gibco-BRL) according to the manufacturer’s instructions. DNA 
and lipofectamine were each incubated with 1.5 ml OptiMEM (GIBCO, Invitrogen Corp) in 
separate tubes for 5 min at room temperature. Subsequently, the solutions were mixed together and 
incubated for another 20 min before adding to the cells. After 4-6 hr, the transfection reagent was 
aspirated and the cells were incubated for another 24-36 hr in complete growth medium before 
they were harvested. 
 
2.8 Preparation of nuclei extracts from mESCs 
Feeder-free E14 mESC nuclear extracts were prepared according to methods described in Dignam 
et al. (1983) with modifications as follows: mESCs were harvested in cold PBS. After 
centrifugation, cells were resuspended in high salt buffer (20 mM HEPES-KOH pH 7.9, 26% 
glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF) 
containing protease inhibitor and incubated on ice for 10 min before being subjected to lysis with a 
Wheaton dounce homogenizer. Pelleted nuclei were resuspended in low salt buffer (10 mM 
HEPES-KOH pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT and 0.2 mM PMSF) with 
protease inhibitor. They were incubated on ice for 30 min and vortexed every 10 min. After 
centrifugation, cell supernatant were dialyzed against dialysis buffer (20 mM HEPES-KOH pH 
7.9, 150 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF) at 4°C for 2 hr.  
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2.9 Preparation of whole cell lysates 
Cultured HEK293T or mESCs were rinsed twice with cold PBS before being lysed in cold HEPES 
lysis buffer [20 mM HEPES (pH 7.5); 140 mM NaCl; 10% Glycerol; 1% Triton X-100; 1.5 mM 
MgCl2; 1 mM EGTA (pH 8.0) with EDTA-free Complete protease inhibitors (Roche, Mannheim, 
FRG)] and the cells were collected by manual scraping with a cell scraper (Costar, Corning, NY). 
Whole cell lysates were clarified by centrifugation at 14000 rpm for 15 min at 4°C and the cell 
pellet was discarded. 
 
2.10 RNA extraction and Reverse Transcription (RT)-PCR 
RNA extraction was carried out using Trizol (Invitrogen, CA) according to the manufacturer’s 
protocol. In brief, cells were washed with PBS, and were lysed with Trizol for 5 min, while 
shaking at room temperature. Chloroform extraction was carried out, followed by isopropanol 
precipitation of the RNA. The pellet was resuspended in DEPC water and treated with DNase for 
30 min at 37°C. The reaction was then purified using the RNeasy Mini Kit (Qiagen, Hilden, FRG).  
20μl RT reaction containing of 1 μg RNA, 0.5 μg Oligo(dt)12-18 primer, 0.5 mM dNTP mix, 5x 
first strand buffer, 10 mM DTT, 200 U SuperScript™ II Reverse transcriptase was set up. 
Incubation was done at 65°C 10 min, 42°C 1 hr, and heat inactivation at 70°C 15 min. All reagents 
were from Invitrogen, CA. 
Real-time quantitative PCR was utilised to analyse mRNA expression in the reverse-transcribed 
cDNA samples as described in 2.14. RT-PCR primers were designed based on the 3’end of 
unigene mRNA sequences from NCBI (http://www.ncbi.nlm.nih.gov/) using OLIGO 6 with the 






2.11 Chromatin Immunoprecipitation (ChIP) 
2.11.1 Crosslinking of cells and chromatin extract preparation 
In ChIP assays, cells were grown to 70% confluency in 500 cm2 dishes and were crosslinked with 
1% formaldehyde in culture media for 10 min at room temperature. Formaldehyde was then 
inactivated by adding glycine into the medium to a final concentration of 0.2 M. Cells were 
washed with TBSE (20 mM Tris pH7, 0.15 M NaCl, 1 mM EDTA pH8) for 3 times and were 
scraped into a 50 ml tube. The cells were then washed twice with cell lysis buffer (10 mM Tris 
pH8, 0.25% Triton X-100, 10 mM EDTA pH8, 0.1 M NaCl) for 15 min, nutation at 4°C and 
centrifugation was done at 3000 rpm, 4°C, 5 min. The cell pellet was then transferred into a 50 ml 
Oakridge tube and washed once with high SDS FA lysis buffer (50 mM HEPES-KOH pH 7.5, 150 
mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% NaDOC, 1% SDS) and twice with low SDS FA 
lysis buffer (50 mM HEPES-KOH pH7.5, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% 
NaDOC, 0.1% SDS) and subjected to 30 min of nutation at 4°C and centrifugation at 20000 rpm, 
4°C for 1hr. Complete, EDTA-free protease inhibitor tablets (Roche #1873580) were added into 
all wash buffers. The chromatin pellet was then sonicated in low SDS FA lysis buffer (1ml buffer 
for every 100 μl pellet) together with 1 ml of 0.5 mm glass beads (Biospec Products Inc. 
#11079105) using the Branson sonifier with tapered tip probe to obtain DNA fragments of an 
average size of 500 bp. Optimization was carried out for different types of cells. The typical 
sonication parameters used were: 40% amplitude, 15 pulses, 1 min rest in between pulses, 4°C. 
After sonication, the chromatin extracts were centrifuged at 20000 rpm, 4°C, 1hr to remove the 
unsonicated chromatin. In order to obtain input DNA, chromatin extracts were decrosslinked at 
42°C for 2 hr, and 68°C for 6 hr, in a reaction containing 100 μl extracts, 200 μl ChIP elution 
buffer (50 mM Tris pH 7.5, 10 mM EDTA, 1% SDS), 90 μl TE buffer, 30 μl pronase (Roche, 
#11459643001). Phenol:chloroform extraction, ethanol precipitation with glycogen (Roche 
#901393) and RNAse digestion (DNAse-free Rnase, Roche #1119915) were carried out to purify 
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the DNA further. The input DNA was ran on 1.5% agarose gel, 50 V, 1hr, 1x TAE buffer to 
analyse the size distribution of the DNA fragments.  
2.11.2 Immunoprecipitation (IP) 
30 μl of protein G sepharose 4 fast flow (Amersham Biosciences, #17-0618-02) or 50 μl of 
Dynabeads® protein G (Dynal Biotech, Norway #100.03) beads were washed 3 times with low 
SDS FA lysis buffer and incubated with 6 μg antibodies of interest for 3 hr, nutating at room 
temperature. Specificity of all the antibodies was checked by Western blot before they were used 
for ChIP. After antibody binding, the beads were washed twice using low SDS FA lysis buffer. 
Subsequently, 500 ml chromatin extract which was pre-cleared (3 hr, nutating at 4°C in 100 μl 
protein G sepharose or 50 μl Dynal beads slurry) was added to the antibody-bound beads and 
nutated at 4°C, overnight. The beads were then washed 3 times with low SDS FA lysis buffer, 
once with low SDS FA lysis buffer containing 0.35 M NaCl, once with NP-40/LiCl wash buffer 
(10 mM Tris pH 8, 0.25 M LiCl, 1 mM EDTA, 0.5% NP-40, 0.5% NaDOC), once with TE buffer 
(10mM Tris, 1mM EDTA, pH8) and eluted with 270μl ChIP elution buffer at 68°C, 30 min, 1400 
rpm. 260 μl supernatant was added to a reaction containing 220 μl TE buffer and 20 μl pronase 
and incubated at 42°C for 2hr, and 68°C for 6hr. Subsequently, phenol:chloroform extraction and 
ethanol precipitation were carried out and the pellet was resuspended in 100 μl TE buffer to obtain 
the IP DNA.    
 
2.12 Picogreen DNA quantitation 
The ChIP DNA was routinely quantified using the Quant-iT™ PicoGreen® dsDNA quantitation 
kit (Molecular Probes, OR) following the manufacturer’s instructions. Fluorescence measurement 
was carried out in the TECAN GENios multidetection microplate reader (Tecan Trading AG, 
Switzerland) using the fluorescein wavelengths: excitation= 485 nm, emission= 535 nm, gain: 60, 
number of flashes: 10, measurement mode: Fluorescent Top.  
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2.13 Q-PCR primer designs 
Genomic DNA sequences with masked repeats were obtained from the UCSC genome browser 
(http://genome.ucsc.edu) for ChIP real-time quantitative PCR primer designs. The primers were 
designed using OLIGO 6 (version 6.6.4.0; Molecular Biology Insights, Inc http://www.oligo.net). 
The designs were based on ‘very high’ search stringency parameters with the following 
modifications: oligonucleotide length of 29-30 nucleotides, product length of 150-250bp, oligo 
Tm> 72°C. All primers were screened by q-PCR using mouse genomic DNA and were confirmed 
to produce a single product of the right size, as analysed by agarose gel electrophoresis and 
dissociation curve analysis. These primers also yielded no DNA bands in the no-template control. 
At least two sets of primers were selected for each region of interest. 
 
2.14 Real-time quantitative PCR (q-PCR) 
Q-PCR were carried out in a 10 μl or 20 μl reaction volume containing 0.45 μM primer pairs, at 
least 0.5 ng ChIP DNA or cDNA and 2X SYBR® Green Master Mix (Applied Biosystems, CA). 
96 and 384-well clear plates and covers were purchased from Applied Biosystems, CA and qPCR 
were performed on the ABI ABI PRISM 7900HT Sequence Detection System or the 7500 Real-
time PCR System using the SDS2.2 software. The parameters used were absolute quantitation, 
stage 1: 95°C, 10 min; stage 2: 40 cycles of 95°C, 30s, 60°C 30s, 72°C 1 min (data collection); 
melting curve stage 3: 95°C, 15s, 60°C, 15s, 2% ramp to 95°C, 15s. Relative occupancy values 
(ChIP fold enrichment) were calculated by determining the apparent immunoprecipitation 
efficiency (ratios of the amount of immunoprecipitated DNA to that of the input sample) and 
normalized to the level observed at a control region, which was set at 1.0. Relative expression 
levels (RNA transcript) were calculated by taking the ratios of the amount of DNA against that of 
the control sample and normalized to the endogenous β-actin control levels.   
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2.15 ChIP-PET (paired-end ditag) cloning and sequencing 
The ChIP-PET analysis was done in collaboration with Dr Wei Chia Lin, Cloning and Sequencing 
Group, GIS, as described in Ng et al. (2005) and Wei et al. (2006). Briefly, the ChIP DNA 
fragments were blunted and ligated to the cloning vector pGIS3 containing two MmeI recognition 
sites. The ChIP DNA library was obtained by transformation of ligated products into electro-
competent TOP10 bacterial cells. Purified plasmid prepared from the ChIP DNA library was 
digested with MmeI, end-polished with T4 DNA polymerase to remove the 3’-dinucleotide 
overhangs, and the resulting plasmids containing a signature tag from each terminal of the original 
ChIP DNA insert were self-ligated to form single-ditag plasmids. These were then transformed 
into TOP10 cells to form a “single-ditag library”. Plasmid DNA extracted from this library was 
digested with BamHI to release the 50 bp paired end ditags. The PETs were PAGE-purified, then 
concatenated and separated on 4-20% gradient TBE-PAGE. Appropriate sized fractions (1kb - 2 
kb) of the concatenated DNA were excised, extracted and cloned into BamHI-cut pZErO-1 
(Invitrogen) to form the final ChIP-PET library for sequencing. This library was then subjected to 
large-scale sequencing. PET sequences containing 18 bp from 5’ and 18 bp from 3’ ends of the 
original ChIP DNA fragments were extracted from raw sequences obtained from the PET library, 
and mapped to the mouse genome (mm5 build) assembly. The mapping criteria are that both the 5’ 
and 3’ signatures must be present on the same chromosome, on the same strand, in the correct 
orientation (5’ to 3’), with a minimal 17 bp match and within 4 kb of genomic distance. The 
locations of the ChIP-enriched DNA present in the library were visualized using the T2G browser 
(http://t2g.bii.a-star.edu.sg) developed by the Bioinformatics Institute (Singapore), which contains 
the location of the PETs based on the UCSC genome browser (mouse genomic sequences, build 
mm5). 
2.15.1 Manual and computer-assisted de novo motif search 
Sequence alignments of selected binding sites were carried out manually to identify conserved 
motifs. Genomic sequences from the product of peak primers generating the highest enrichment or 
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from PET clusters for selected loci were aligned using the multiple sequence alignment tool from 
VectorNTI. Consensus sequences resembling the Sox2 and Oct4 motifs were eye-balled from the 
alignment.  
  Computer-assisted search of enriched motifs within Oct4 and Sox2 ChIP-PET data was 
carried out by our Bioinformatics colleague, Vinsensius Vega. The masked sequences from 
clusters containing a minimum of 7 overlaps were fed into the motif discovery algorithm Weeder 
(Pavesi et al., 2004), setting MM (Mus musculus, build mm5) as the background genome, 
searching both strands, allowing multiple motif occurrences in each sequence, and running the 
most thorough search (i.e. analysis type = “extra”). As the Weeder algorithm only allows for a 
maximal motif length of 12 bp, the motif was extended by two bp upstream and one nucleotide 
downstream to obtain one that resembles a full Sox2-Oct4 site. The good quality sites (i.e. >90% 
similarity to the main discovered motif) was extracted, as determined in the Weeder output, while 
at the same time extending several bp out from each arm of the main discovered motif. From these 
sequences, a Position Weight Matrix (PWM) M was built to model the joint Sox2-Oct4 binding 
sites. This PWM was used to predict the label of a sequence. If a given sequence contained a site 
scored at least T under PWM M, the sequence was labeled as positive (i.e. contained Sox2-Oct4 
binding sites), otherwise it was labeled as negative. Next, we further refined the Sox2-Oct4 motif 
using a refinement strategy akin to the Expectation-Maximization optimization procedure 
(Dempster et al., 1977). A collection of 1000 random promoter sequences and 1000 random 
coding sequences with an average length of about 1800 bp was used as a background set (sequence 
set B1). A positive set (sequence set P1) containing the clusters with 6 or more PET sequences 
overlaps (including 10bp flanking sequences) was constructed. The following steps were done 
iteratively: 1) Use the background set B1 to calculate the appropriate PWM scoring cutoff T such 
that the false discovery rate is at most 1e-3, 2) Scan the positive set P1 for occurrences of the Sox2-
Oct4 motifs using the current PWM M and the cutoff score T, 3) Calculate the statistical 
significance (p-value) p of motif over-representation in the set P1 against B1, in terms of predicted 
 46
sites per nucleotide, using the current PWM M and cutoff score T, 4) Construct a new PWM M’ 
using the discovered sites, 5) Calculate threshold T’ for M’ using background set B1 such that the 
false discovery rate is at most 1e-3 (similar to step 1), 6) Compute the p-value, p’, of set P1 being 
enriched, in terms of predicted sites per nucleotides, for sites scoring better than T’ under the 
matrix M’, 7) If p’ is smaller than p then use M’ as M for the next iteration and go back to step 1, 
or else output M as the final matrix. Two other sets were created to test whether the refined matrix 
identified over-represented sites in the PET sequences. PET5 clusters sequences were used as the 
positive set P2 (which did not intersect with P1), while for the background/negative set B2, 
another 1000 random promoters and 1000 random coding sequences (non-overlapping to sequence 
set B1) were extracted. Varying the cutoff score T produced different sensitivity and specificity. 
The performance of the seed matrix and the refined matrix were compared by stratifying the 
threshold T and plotting the Receiver Operating Characteristic (ROC) curves. The refined matrix 
well outperformed the original seed matrix.  
2.15.2 Computational co-motif enrichment analysis  
To identify potential co-factors of Sox2-Oct4, a search for transcription factor DNA binding 
motifs was carried out on the Oct4 and Sox2 overlapping binding sites from a merged Oct4-Sox2 
ChIP-PET dataset by our Bioinformatics colleagues, Vinsensius Vega and Bernard Leong. A list 
of regions which are highly probable to be bound by both Sox2 and Oct4 was generated. Sox2 
ChIP-PET and Oct4 ChIP-PET overlap regions, each from the moPET2+ clusters, were merged. 
1507 unique locations supported by presence of both Sox2 and Oct4 ChIP-PET cluster 
overlapping regions were identified.  
500 bp regions centred on the 1507 high-confidence Sox2-Oct4 binding regions were 
extracted and scanned for other putative transcription factor binding motifs, based on the weight 
matrices provided in the TRANSFAC Professional v9.1 and its associated MATCH program and 
cutoffs criteria. TRANSFAC (Wingender et al., 2000) is a database on transcription factors, their 
corresponding genomic binding sites and DNA-binding profiles. It contains more than 18000 
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transcription factor binding sites matrices. To assess the significance of each potential co-motif, a 
1000-iteration Monte Carlo simulation (Zhou and Liu, 2004) to estimate the expected occurrences 
of each motif was done. In each iteration, a set of random background sequences of equal length as 
the input sequences were generated based on 3rd order Markov Chain model of mouse genome 
mm5. Following which, the random sequences were similarly scanned for putative binding motifs. 
To simplify the explanation, the observed count of putative binding sites from the positive dataset 
was obtained, after which, using randomly generated sequences from the specified background 
model, the expected rate of putative binding sites to occur per random bp was estimated. Then, 
using the binomial formula, the p-value was computed, where the probability of success p is the 
expected rate of putative binding sites occurrence per random bp, the number of trials N is the total 
bp in the positive dataset, and the number of success Y is the count of putative binding sites found 
in the positive dataset. More information on the binomial formula can be obtained from 
http://core.ecu.edu/psyc/wuenschk/docs30/Binomial.doc.  
 
2.16 Sequential chromatin immunoprecipitation (seqChIP) 
In this assay, chromatin extracts were subjected to ChIP twice (Geisberg and Struhl, 2004). 30 μl 
of protein G sepharose 4 fast flow beads (Amersham Biosciences) were incubated with the first 
antibody (10 μg) for 3 hr, nutating at room temperature. Subsequently, the beads were washed 
twice with low SDS FA lysis buffer, twice with Immunopure binding/wash buffer (Pierce) and 
crosslinking buffer (0.2 M triethanolamine pH 8.2). The antibodies were crosslinked to protein G 
sepharose beads using 20 mM dimethyl pimelimidate (DMP; PIERCE Biotechnology, #21666) in 
crosslinking buffer for 45 min, in the dark. The beads were then washed with blocking buffer (0.1 
M ethanolamine pH 8.2), Immunopure elution buffer (PIERCE Biotechnology), twice with 
Immunopure binding/wash buffer (Pierce) and twice with low SDS FA lysis buffer. Subsequently, 
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500 ml chromatin extract which was pre-cleared (3 hr, nutating at 4°C in 100 μl protein G 
sepharose) was added to the antibody-bound beads and nutated at 4°C, overnight. 
The next day, beads were washed as in ChIP protocol, with Tris component in all buffers 
replaced by 10 mM Hepes pH 7.9. The beads were incubated with 130 μl elution buffer (10 mM 
Hepes pH 7.5, 1 mM EDTA, 1% SDS) at 37°C, 1400 rpm for 45 min. 120 μl which was recovered 
after centrifugation and diluted into 1.1 ml FA lysis buffer (no SDS) was subjected to a second 
ChIP using another antibody. The steps for the second round of IP are the same as that described 
for the one step ChIP above. Washed beads were eluted with ChIP elution buffer at 68°C for 30 
min. 260 μl supernatant was added to a reaction containing 220 μl TE buffer and 20 μl pronase 
and incubated at 42°C for 2 hr, and 68°C for 6 hr. Phenol:chloroform extraction and ethanol 
precipitation were carried out and the pellet was resuspended in 100 μl TE buffer to obtain IP 
DNA for qPCR. Significant enrichment reflected by qPCR after the second ChIP was indicative of 
co-occupancy.  
 
2.17 ChIP on NimbleGen DNA Microarray 
Sequential ChIP for Oct4-Sox2 as well as ChIPs for H3K4Me3, Stat3 and Smad1 were amplified 
and hybridized onto customized gene microarray chips, 2005-03-23_Hui_MM5_ES_Chip 
(designed from mouse genomic sequences build mm5 by Dr Ng Huck Hui and manufactured by 
NimbleGen Systems Inc.) following the manufacturer’s ChIP-on-chip protocol. The chips (25 x 75 
mm each) contain 50-mer probes (50 bp apart) spanning the loci of 200 mouse genes, miRNAs 
and other genes, 385000 features (16 μm x 16 μm) in an array size of 17.4 mm x 13 mm.  
2.17.1 Ligation-mediated PCR 
ChIP DNA was amplified following Nimblegen’s ChIP-on-chip protocol. Briefly, 30 ng of ChIP 
DNA fragments were blunted using 0.6 U T4 DNA polymerase (New England Biolabs, Inc., MA) 
at 12°C, 20 min. The DNA was then purified by phenol:chloroform and ethanol precipitation. 
 49
Linkers were ligated to the ends of the DNA fragments in a reaction containing pre-annealed 
linkers (oJW102: 5’-GCGGTGACCCGGGAGATCTGAATTC-3’, oJW103: 5’-
GAATTCAGATC-3’ (Proligo); the pair of oligos were boiled for 10 min in a beaker containing 
3L of water and left overnight at room temperature to cool) and T4DNA ligase (New England 
Biolabs, Inc., MA) for 16 hr at 16°C. Ethanol precipitation was carried out, followed by PCR 
amplification in a 50 μl reaction containing Taq polymerase (Qiagen), Pfu Hotstar (Stratagene), 
dNTP, oligo oJW102 (Proligo). PCR program: 55°C 4 min, 72°C 5 min, 95°C 2 min; 35 cycles of 
95°C 30s, 55°C 30s, 72°C 1 min; 72°C 1 min. The PCR product was then purified using the 
QIAquick PCR purification kit (Qiagen). After amplification, ChIP DNA and control ChIP DNA 
was run on 1.5% agarose gel to ensure similarity in size distribution and absence of degradation. 
DNA concentration was determined using the ND-1000 Spectrophotometer (NanoDrop 
Technologies, DE) and the samples were tested by q-PCR to ensure that the ChIP enrichment fold 
of DNA was maintained after the amplification process.  
2.17.2 Labeling, hybridization and analyses 
Samples were labeled using Klenow fragment (3’-> 5’ exo-) (New England Biolabs, Inc., MA) and 
the Cy3 (ChIP DNA) and Cy5 (control DNA) 9-mer Wobble primers (5’-
Cy3/Cy5NNNNNNNNN-3’) were purchased from Research Biolabs, following the Nimblegen 
protocol. The labeled samples were purified using isopropanol precipitation and an equal amount 
of labeled ChIP and control DNA were mixed and dried in a speedvac. Hybridization reaction 
containing Hybridization buffer (NimbleGen array hybridization kit), Hybridization component A 
(NimbleGen), Cy3 and Cy5 CPK 50-mers [IDT, 250 nmole HPLC purified; obtained from Lee 
Yew Kok (Prof. Edison Liu’s group, GIS)] were added to the DNA and heated at 95°C 5 min 
before loading onto the array slide. Samples were hybridized at 42°C, 18 hr, mix mode: B, in the 
MAUI Mixer SL Low Temperature Hybridisation Chambers (BioMicro Systems #02-A008-03) 
and the MAUI (MicroArray User Interface) Hybridization System (BioMicro Systems, model #01-
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A002-03). Slides were washed sequentially with the Nimblegen wash buffers I, II, III according to 
manufacturer’s instructions and spun dry using the ArrayIt microarray highspeed centrifuge. Raw 
data were analyzed on GenePix analysis software version 4.0 on the GenePix 4000A scanner 
(Axon Instruments) at a 5 μm resolution. Thereafter, NimbleScan™ and SignalMap™ softwares 
from Nimblegen Systems Inc. were used for data analysis and visualization.  
 
2.18 Dual-luciferase reporter assay 
pGL3-mOct4 pp vector [an Oct4 minimal promoter driving luciferase; Oct4 minimal promoter 
upstream (BglII and NcoI sites) of the luciferase gene in the pGL3-basic vector (Promega)] was 
obtained from a colleague, Chen Xi (Wu et al., 2006). Oct4 and Sox2 binding motif elements were 
ordered as oligo pairs from Proligo. 
Oligo pairs were annealed at 95°C, 4 min, 70°C 10min, room temperature 1hr followed by 
addition of T4 Polynucleotide Kinase (New England Biolabs, Inc., MA). The phosphorylated 
probes were then cloned upstream (MluI and BglII sites) into the pGL3-mOct4 pp vector. The 
plasmids were transformed into MAX Efficiency® Stbl2™ Competent Cells (Invitrogen) and 
isolated plasmids then transfected into E14 mESCs according to the Lipofectamine 2000 
(Invitrogen) manual. In brief, 24000 mESCs were seeded per well in 96-well flat-bottom 
luminometer plates (Costar, Corning Inc., NY) 14 hr before transfection. 150 ng plasmid DNA 
was mixed with 5.5 ng of phRLSV40 (normalization control expressing Renilla luciferase, 
Promega), and incubated in 25 μl OptiMEM (GIBCO, Invitrogen Corp) for 5 min. 0.5 μl 
Lipofectamine 2000 was incubated with 25 μl OptiMEM for 5 min before adding to the plasmids 
mixture and incubated at room temperature for 20 min. The resulting solution was then added to 
ESCs. Transfections were done in triplicates. Luciferase activities were measured 36 hr after 
transfection with the Dual-Luciferase® Reporter Assay System (Promega) using Centro LB960 96-
well luminometer (Berthold Technologies). Reporter activity was calculated as ratio of the average 
of experimental readings over the average of readings in vector-transfected controls.  
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Co-transfection of the plasmids together with 150 ng Oct4 and Sox2 RNAi plasmids, 
pSUPER.puro-Oct4 shRNA or pSUPER.puro-Sox2 shRNA were carried out as described above. 
Cells were treated with mESC media containing 1 µg/ml puromycin (Sigma) to select for cells 
carrying the RNAi plasmids. Luciferase activities were measured 3 days post-transfection. Probe 
sequences containing 3x elements are listed in Appendix E. 
 
2.19 RNAi-mediated depletion of Oct 4 and Sox2 in mESCs 
pSUPER.puro-Oct4 and pSUPER.puro-Sox2 which confers ampicillin and puromycin resistance 
plasmids for RNAi were obtained from a colleague, Loh Yuin Han. In the construction of RNAi 
plasmids, 19 bp gene-specific regions for RNA interference were designed based on the work of 
Reynolds et al. (2004) and Ui-Tei et al. (2004). Oligonucleotides were cloned into pSUPER.puro 
(Oligoengine) (BglII and HindIII sites), which contains the polymerase III H1-RNA gene promoter 
for directing the synthesis of 19-nucleotide hairpin-type short hairpin RNAs (shRNAs) with a 9-
nucleotide loop. All sequences were analyzed by BLAST search to ensure that they did not have 
significant sequence similarity with other genes. For the Oct4 RNAi target sequence, the Reynolds 
score and Ui-Tei class value were 6 and class Ib, respectively. For the Sox2 RNAi target sequence, 
these were 5 and class Ia, respectively. The oligonucleotides used were as follows: for  













GG-3’. For Oct4 and Sox2 RNAi, E14 mESCs at 50% confluency were transfected with RNAi and 
plasmids. Selection with 1 µg/ml puromycin (Sigma) was initiated 24 hr after transfection and 
continued for 48 hr. The specificity of Oct4 and Sox2 knockdown was reported in Chew et al. 
(2005). Cell morphology was observed and knockdown cells were harvested for protein, RNA and 
ChIP analyses.  
 
2.20 Overexpression of Oct4 and Sox2 proteins in HEK293T cells 
Plasmids pTri-Ex 1.1 which confers ampicillin resistance and contains the Oct4 or Sox2 open 
reading frame (ORF) obtained from colleague Zhang Wensheng and the expression vector pTri-Ex 
1.1 were transfected into HEK293T cells using Lipofectamine 2000 (Invitrogen). HEK293T cells 
were seeded at ~1 x 106 cells onto 10 cm culture plates for 14 hr before transfection. These 
adherent cells at ~70% confluency were rinsed with PBS and transfected with 24 μg plasmid DNA 
containing Oct4 and Sox2 overexpression contructs or vector alone by liposome mediated 
transfection with LipofectamineTM 2000 reagent (Gibco-BRL). Plasmids were incubated in 
OptiMEM for 5 min. Lipofectamine 2000 was incubated with OptiMEM for 5 min before adding 
to the plasmids mixture. The mixture was incubated at room temperature for 20 min. The complex 
was then added to cells. At 4-6 hr post-treatment, the transfection reagent was aspirated and the 
cells were incubated for another 24-36 hr in complete growth medium before they were harvested. 
Whole cell lysates were prepared and run on Western blot to detect the Oct4 and Sox2 





2.21 Electrophoretic mobility shift assay (EMSA) 
1 μg double-stranded DNA oligonucleotides (Proligo) labeled with biotin at the 5’ termini of the 
sense strands were annealed with reverse strands in an annealing buffer (10 mM Tris-HCl, pH 8.0, 
50 mM NaCl, 1 mM EDTA) and purified with an agarose gel DNA extraction kit (Roche). The gel 
shift assays were performed using a LightShift Chemiluminescent EMSA kit (Pierce). 10 μg of 
nuclear extract or overexpressed Oct4, Sox2 and vector control were added to a final 10 μl 
reaction mixture containing 3 ng of biotin-labeled oligonucleotide and 1 μg of poly(dG-dC) 
(Amersham Biosciences). The final binding buffer composition was 60% dialysis buffer. Binding 
reaction mixtures were incubated for 10 min at room temperature. Where specified, antibodies 
were added after the initial incubation for a further 20 min. For competitive studies, 200X (600 ng) 
unlabeled double-stranded competitor were added for a further 20 min after the initial incubation. 
For cooperativity binding studies, indicated amounts of overexpressed Oct4 or Sox2 were added 
for a further 20 min after the initial incubation. Binding reaction mixtures were resolved on pre-
run 6% native polyacrylamide gels in 0.5X Tris-borate-EDTA (TBE). Gels were transferred to 
Biodyne B nylon membranes (Pierce Biotechnologies) using Western blot techniques and 
crosslinked using the Hoefer UVC 500 ultraviolet crosslinker (Amersham Biosciences) with 
energy setting: 120000 μJ/cm2, time setting: 10 s. The membranes were then subjected to 
chemiluminescence detection as described in the LightShift Chemiluminescent EMSA kit (Pierce). 
Probe sequences are listed in Chapter 6. 
 
2.22 Co-Immunoprecipitation (Co-IP) of protein complexes 
50 μl of protein G sepharose 4 fast flow beads (Amersham Biosciences, #17-0618-02) were 
washed twice with NP-40 lysis buffer (50 mM Tris pH8, 150 mM NaCl, 2 mM EDTA, 1% NP-40) 
with Complete, EDTA-free protease inhibitor (1 tablet/ 50 ml, Roche). 6 μg Oct4 antibodies (N-
19, Santa Cruz) were incubated with the beads in 0.25% Triton X-100 in 1xPBS for 3 hr at room 
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temperature, nutating. 200 μg E14 mESC nuclear extract was precleared using 100 μl of protein G 
sepharose 4 fast flow beads (Amersham Biosciences, #17-0618-02) at 4°C, 3 hr, nutating. 
Antibody-bound beads were washed 3 times with NP-40 lysis buffer plus protease inhibitor and 
precleared nuclear extract was added to the antibody-bound beads and nutated overnight at 4°C. 
Beads were washed 5 times with NP-40 lysis buffer plus protease inhibitor before 100 μl 2x 
sample buffer was added. The beads were then heated at 95°C 15 min and the eluted samples were 
loaded onto SDS-PAGE gel for Western blot analysis to detect Smad1 and Stat3 in the Oct4 
protein complex. 
 
2.23 Error bars in figures 
Error bars in figures represent either two technical replicates or two biological replicates, as stated. 
Technical replicates are duplicates included during qPCR experiments. Biological replicates are 
duplicates of the same experiment repeated twice with different cells in different experimental 
sittings. 
 
2.24 Contribution of collaborators  
All high-throughput bioinformatics analyses were done by collaborators from the Bioinformatics 
group in Genome Institute of Singapore. Their names have been added to the respective methods 
stated in this Chapter. Cloning and sequencing of ChIP DNA in the ChIP-PET approach was 
carried out by the Cloning and Sequencing group in Genome Institute of Singapore. Their names 
have been mentioned in this Chapter accordingly. All collaborators and contributors to reagents 
have also been acknowledged in the acknowledgement. Other than high-throughput bioinformatics 





Establishing the Circuitry of Oct4, Sox2 and Nanog in Embryonic Stem Cells 
 
3.1 Introduction 
Oct4, Sox2 and Nanog are transcription factors essential for the formation of the ICM during 
mouse preimplantation development and for the pluripotent and self-renewing properties of ESCs 
(Avilion et al., 2003; Chambers et al., 2003; Mitsui et al., 2003; Nichols et al., 1998; Scholer et 
al., 1990). These factors are highly expressed in both human and mouse ESCs, and its expression 
diminishes when these cells differentiate and lose pluripotency (Palmieri et al., 1994).  
 
Several targets of Oct4 were previously identified in mESCs, including Fgf4, Utf1, Opn, 
Rex1/Zfp42, Fbx15, and Sox2 (Ben Shushan et al., 1998; Botquin et al., 1998; Catena et al., 2004; 
Dailey et al., 1994; Nishimoto et al., 1999; Tokuzawa et al., 2003; Tomioka et al., 2002; Yuan et 
al., 1995). The regulatory regions of these genes contain an octamer element capable of binding 
Oct4 in vitro. These sites have been shown to be important for transcriptional activity of their 
respective genes in reporter assays. The octamer elements within the enhancers of Fgf4, Utf1, Opn, 
Fbx15, and Sox2 were also found in proximity to sox elements. Of these genes, all but Opn have 
the octamer and sox heptamer elements separated by either 0 or 3 bp. Such proximity suggested 
that Oct4 and Sox2 may interact with each other on genomic DNA. Moreover, two structures have 
been solved for a POU/HMG ternary complex bound to composite sox-oct elements where one of 
these is on an element separated by 3 bp (Remenyi et al., 2003) and the other is on an element 
separated by 0 bp (Williams, Jr. et al., 2004). Both reveal that the POU and HMG domains are 
involved in mediating specific protein-protein and DNA-protein interactions. In addition, it has 
also been demonstrated that Oct4 and Sox2 can interact in the absence of DNA and that the HMG 
and POU domains are involved in this interaction (Ambrosetti et al., 2000). Therefore, Oct4 and 
Sox2 are capable of forming heterodimers regardless of whether they are bound to DNA.  
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Previous studies have identified regulatory elements of the Oct4 and Sox2 genes. For 
Oct4, its regulatory regions are important for driving expression in early stage mouse embryos and 
were defined through analysis of LacZ reporter genes regulated by different mouse Oct4 genomic 
fragments (Yeom et al., 1996). The Oct4 regulatory regions identified were the core promoter, 
proximal enhancer and distal enhancer. The core promoter is located within the first 250 bp of the 
transcription initiation site. The proximal enhancer, located about 1.2 kb upstream, was shown to 
direct Oct4 expression in the epiblast, Oct4 downregulation in the anterior to posterior direction 
after gastrulation, and retinoic acid-dependent Oct4 downregulation in embryonic carcinoma (EC) 
cells (Okazawa et al., 1991). The distal enhancer region (located about 2 kb upstream) was shown 
to regulate Oct4 expression in preimplantation embryos (morula and ICM), primordial germ cells 
(PGCs), and in pluripotent ES, EC and embryonic germ (EG) cells. In another study, alignment of 
the upstream sequences of human, bovine, and mouse Oct4 promoters revealed four conserved 
regions, CR1 to CR4 (Nordhoff et al., 2001). Interestingly, CR4 overlaps with the distal enhancer, 
suggesting that evolutionarily conserved elements may be regulating the activity of the distal 
enhancer. However, the factors that bind and regulate these regulatory elements have not been 
identified.  
 
Sox2 is transcriptionally regulated in ESCs by an enhancer containing a composite sox-oct 
element where Oct4 and Sox2 were reported to bind in a combinatorial interaction. Two regulatory 
regions (SRR1 and SRR2) in Sox2 were reported to confer ESC-specific expression (Tomioka et 
al., 2002). SRR1 has been demonstrated to bind Oct4 at an octamer site by chromatin 
immunoprecipitation (ChIP) (Catena et al., 2004). SRR2, located 1.2 kb downstream of the Sox2 
transcription start site, contains the composite sox-oct element. Mutations within this composite 
element disrupted the in vitro formation of a DNA/protein complex and also resulted in the loss of 
SRR2 enhancer activity. More importantly, the reduction of Oct4 abolished the SRR2 activity, 
indicating that Oct4 can positively regulate SRR2. Further studies would be needed to clarify 
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whether Oct4 and Sox2 are bound to the SRR2 in ESCs and whether Sox2 binding to the SRR2 
region is required for the transcriptional activity of Sox2.  
 
Since Oct4 and Sox2 have been suggested to work together and that their binding elements 
were found in many ES-specific genes, Oct4 and Sox2 may also bind to genes encoding 
themselves as well as to the other key ESC gene, Nanog. Factors that bind to and regulate the 
transcription of Nanog gene have yet to be identified. This study employs chromatin 
immunoprecipitation (ChIP) in a small-scale gene-by-gene mapping of Oct4 and Sox2 binding 
sites in living mESCs and hESCs. Results showed that Oct4 and Sox2 bind to Oct4, Sox2 and 
Nanog loci on the composite sox-oct elements, leading to the establishment of the core 
transcription factor network circuitry in mESCs. 
 
3.2 Results 
In this study, ChIP-qPCRs were carried out to investigate the binding of Oct4 and Sox2 on 
genomic Oct4, Sox2 and Nanog DNA. Undifferentiated mESCs grown in feeder-free conditions 
were crosslinked with formaldehyde, and the fragmented chromatin lysates were subjected to 
immunoprecipitation with the Oct4 or Sox2 antibodies.  
 
3.2.1 Optimisation of the Oct4 and Sox2 ChIP assays 
Firstly, optimisation of ChIP assays using mESCs was conducted. A series of mESC chromatin 
sonication was carried out to find the optimal conditions for producing DNA fragment sizes of 
about 500 bp (data not shown). Optimal ESC chromatin fragment sizes were obtained with 
sonication conditions of: 40% amplitude, 15 pulses, 1 min rest in between pulses at 4°C. 1ml 
sonication buffer was used for every 100 μl chromatin pellet and 1ml glass beads were added to 
facilitate the fragmentation process. Minimum sonication volume in a 14 ml bacterial culture tube 
is 3 ml. For smaller sonication volumes, sonication was optimally carried out in a 2 ml volume in 
 58
an Eppendorf tube with 100 μl glass beads with sonication conditions of 40% amplitude, 4 pulses, 
1 min rest in between pulses, in an ice-filled container. In this Chapter, protein G sepharose beads 
were used. At least two different antibodies each for Oct4 (N-19 goat polyclonal antibody from 
Santa Cruz and an in-house produced Oct4 rabbit polyclonal antibody) and Sox2 (Y-17 goat 
polyclonal antibody from Santa Cruz, an in-house produced Sox2 rabbit polyclonal antibody and 
Ab5306 rabbit polyclonal antibody from Chemicon) were tested by ChIP and yielded relatively 
similar enrichment results (data not shown). This was carried out to exclude the possibility of non-
specific recognition of proteins and epitope masking that could reduce the efficiency of ChIP and 
preclude the identification of some targets. Western blots of mESC nuclear extracts showed that 
the two main antibodies used (anti-Oct4: N-19 sc-8628 and anti-Sox2: Y-17 sc-17320) detected 
proteins that had sizes that correspond to that of Oct4 (43kDa) and Sox2 (34kDa) (Figure 3.1). 
 
3.2.2 Oct4 and Sox2 bind to the distal enhancer of Oct4 in mESCs 
Ten pairs of primers which were located sequentially along the entire conserved promoter region 
and the first exon were used to quantify ChIP-enriched DNA by real-time PCR (Figure 3.2A). A 
peak representing Oct4 and Sox2 binding was observed (approximately 30-fold above 
background) at the distal enhancer, indicating that this region was specifically bound by the two 
transcription factors (Figure 3.2B and C). A control antibody (glutathione-S-transferase; GST) 
showed no significant enrichment over the entire surveyed region (Figure 3.2D). Similar results 
were obtained when polyclonal antibodies against other epitopes of Oct4 and Sox2 were used, 
further confirming the specificity of this binding (data not shown). Thus, Oct4 distal enhancer is a 
bona fide target of Oct4 and Sox2 in undifferentiated mESCs.  
 
Retinoic-acid (RA) treatment overrides the self-renewal properties of mESCs and induces 
their differentiation. There is a corresponding decrease in endogenous levels of Oct4 and Sox2 
(Figure 3.3A). The binding profiles of Oct4 and Sox2 on Oct4 in this RA-induced differentiation 
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model were examined, as this also allowed us to determine the specificity of the antibodies by 
analyzing the binding in cells deficient in these factors. Mouse ESCs at different periods of RA 
treatment were crosslinked with formaldehyde, and the occupancies of Oct4 and Sox2 on the Oct4 
promoter were analyzed by ChIP. Upon differentiation, the binding of Oct4 and Sox2 to the Oct4 
distal enhancer was reduced in close correlation with the degree of differentiation (Figure 3.3B 
and C). By day 3 of RA treatment, the level of Oct4 binding was reduced by almost 50%, and by 
day 6, no significant enrichment was detected. A mock ChIP using a control antibody (myeloid/ 
lymphoid leukemia; MLL) did not result in enrichment of the enhancer sequences (Figure 3.3D). 
This indicated that the antibodies recognize specific complexes found in mESCs but not in their 
differentiated derivatives. The results indicate that Oct4 and Sox2 bind to the Oct4 enhancer when 
this gene is being actively transcribed in undifferentiated, pluripotent mESCs. 
 
3.2.3 Oct4 and Sox2 bind to the SRR2 of Sox2 in mESCs 
Previous studies have demonstrated the importance of the enhancer element at the 3’ end of Sox2 
by reporter assays and mutagenesis (Tomioka et al., 2002). This SRR2 (Sox regulatory region 2) 
region contains a composite sox-oct element. Although Oct6 and Oct4 have been implicated to 
bind to SRR2 along with Sox2, it is unclear if Oct4 and Sox2 are indeed bound to the SRR2 site in 
living ESCs. The ChIP results in Figure 3.4 shows Sox2 and Oct4 bound to the SRR2 region of 
Sox2 in mESCs (Figure 3.4) and that these interactions were found specifically in undifferentiated 
ESCs. This result is similar to that for Oct4 and Sox2 binding on the Oct4 gene, in which the 
levels of Oct4 and Sox2 bindings were reduced upon differentiation (Figure 3.4B and C). A 
control antibody (myeloid/ lymphoid leukemia; MLL) showed no significant enrichment for any 
of the amplicons from any of the ESC states analyzed (data not shown). Taken together, these 




3.2.4 Oct4 and Sox2 bind to the Nanog promoter in mESCs 
To investigate if Oct4 and Sox2 interact with the Nanog promoter in vivo, ChIP experiments were 
carried out using Oct4 and Sox2 antibodies and nuclear extracts from undifferentiated mESCs and 
in mESCs differentiated with RA. ChIP DNA fragments from undifferentiated mESCs were 
enriched up to 43- and 37-fold at the Nanog proximal promoter when immunoprecipitated with 
Oct4 and Sox2 antibodies, respectively (Figure 3.5B and C). Two neighbouring regions were not 
significantly enriched. Upon retinoic acid-induced differentiation of mESCs, this enrichment was 
reduced proportionally in response to the degree of differentiation. After 3 days of differentiation, 
enrichment only reached a maximum of 10-fold above background with both Oct4 and Sox2 
antibodies, and after 6 days of differentiation, no significant enrichment was detectable (Figure 
3.5B and C). Using an antibody against MLL as a negative control, no significant enrichment was 
found for any of the amplicons from the three ESC states analyzed (data not shown).  
 
3.2.5 OCT4 and SOX2 bind to the CR4 region of OCT4, SRR2 region of SOX2 and promoter 
region of NANOG in human ESCs 
To determine if OCT4 and SOX2 bind to Oct4, Sox2 and Nanog genes in hESCs, Oct4 and Sox2 
ChIP-qPCR were carried out using HUES-6 hESCs propagated on inactivated mouse embryonic 
fibroblasts or grown in feeder-free conditions in the presence of matrigel. Both methods of 
culturing hESCs were tested using ChIP-qPCR and gave similar results. As fibroblast mouse cells 
do not express Oct4 or Sox2, the growth of hESCs on a mouse feeder cell layer did not affect the 
ChIP analysis. Moreover, the primers used to quantify the ChIP-enriched DNA were specific to 
human sequences (Figure 3.6A, C, E). Both the OCT4 and SOX2 ChIP assays on hESCs showed 
enrichment of DNA fragments in the distal enhancer of  OCT4 (Figure 3.6B). A control antibody 
did not show any enrichment of these enhancer sequences (Figure 3.6B). This shows the in vivo 
binding of OCT4 and SOX2 to the distal enhancer of OCT4 in hESCs. Furthermore, ChIP-qPCR 
also showed that OCT4 and SOX2 binds to the SRR2 region 3’ of SOX2 in hESCs (Figure 3.6D). 
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The control antibody did not show any enrichment (Figure 3.6D). Thus, OCT4 and SOX2 also 
bind to the SRR2 region of SOX2 in hESCs. To establish that OCT4 and SOX2 also interact with 
the NANOG promoter in hESCs, similar ChIP analysis was performed using HUES-6 hESCs. Six 
different amplicons (Figure 3.6E), all within close proximity to exon 1 of NANOG were used to 
detect for enrichment of OCT4 and SOX2 ChIP DNA. Three primer pairs showed significant 
enrichment with OCT4 and SOX2 antibodies (Figure 3.6F). Using the GST antibody as a negative 
control, no significant enrichment was found for any of the amplicons in these hESCs. In 
summary, these ChIP analyses demonstrate the in vivo occupancy of OCT4 and SOX2 on the 
NANOG promoter in undifferentiated hESCs. 
 
3.2.6 Conserved elements in the CR4 region of Oct4 promoter, SRR2 region of Sox2 
enhancer and promoter region of Nanog  
Multiple sequence alignment of genomic regions with Oct4 and Sox2 binding (highest ChIP 
enrichment) were carried out. A consensus motif that resembles the composite sox-oct element 
which is involved in regulating the transcription of several other ESC-specific genes was identified 
in the CR4 region of Oct4, SRR2 region of Sox2 and promoter region of Nanog of mESCs. The 
mouse elements are shown together with other Sox-Oct elements found in other studies in Figure 
3.7. This element has also been identified in the conserved DNA regions in several organisms 
(Rodda et al., 2005; Nordhoff et al., 2001; Tomioka et al., 2002). This indicates that Oct4 and 
Sox2 bind to a specific motif which is evolutionarily conserved, and thus implying that this motif 









3.3.1 Oct4, Sox2 and Nanog circuitry in ESCs 
During early embryogenesis, Oct4 and Sox2 are found to be co-expressed in several pluripotent 
cells such as the morula, ICM, epiblast, and germ cells. Gene knockout studies revealed that the 
primary defect for both the Oct4- and Sox2-null animals is in the pluripotent epiblast, though there 
are slight differences between the two null phenotypes. There is no epiblast development in the 
Oct4-null blastocyst, and the fate of all cell types is towards trophectoderm lineage (Nichols et al., 
1998). On the other hand, Sox2-null animals are capable of giving rise, at least transiently, to the 
epiblast, as epiblast-derived extraembryonic endoderm is detected (Avilion et al., 2003; Ben 
Shushan et al., 1995). However, this transient epiblast formation may be the result of maternally-
derived Sox2 protein. Therefore, Oct4- and Sox2-null blastocysts are incapable of giving rise to 
pluripotent ESCs, indicating that they are both crucial regulators for these cells. Besides Oct4 and 
Sox2, the other key regulator of ESCs is Nanog. The removal of Nanog via gene targeting or 
RNAi leads to differentiation of mESCs (Chambers et al., 2003; Mitsui et al., 2003; Rodda et al., 
2005).  
 
Results show that the enhancer elements of Oct4 and Sox2 are the direct targets of their 
respective gene products and are reciprocally bound by the other regulator. In addition, Oct4 and 
Sox2 also bind to the Nanog promoter region (Figure 3.8A). Within these binding sites, composite 
sox-oct elements were identified. This study expands the list of genes (Fgf4, Utf1, Opn, and 
Fbx15) which are potentially regulated by both Oct4 and Sox2, and is also the first to directly link 
these three transcription factors within the pluripotent cell genetic regulatory network. As the 
highest level of binding was detected in undifferentiated cells when these genes are known to be 
most transcriptionally active, they are likely associated with the transcriptional activation of these 
genes and may play a role in positively regulating expression. Moreover, gene-specific sequence 
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conservation within these sox-oct composite elements suggests functional significance. This was 
further confirmed by the knockdown of both Sox2 and Oct4 mRNAs by RNAi (Chew et al., 2005; 
Rodda et al. 2005). Knockdown of Oct4 and Sox2 caused a reduction in the Oct4 distal enhancer 
activity and in endogenous Oct4, Sox2 and Nanog transcript levels, and caused the cells to 
differentiate. This indicates that both Sox2 and Oct4 are positively regulating Oct4, Sox2 and 
Nanog. Together with the binding results obtained from this study, a regulatory network 
containing Oct4, Sox2 and Nanog was established whereby Oct4 and Sox2 autoregulate, regulate 
reciprocally and regulate Nanog. 
 
3.3.2 Network motifs in the Oct4, Sox2 and Nanog circuit 
The interactions of Oct4 and Sox2 with the respective genes can be described as a transcriptional 
regulatory network consisting of autoregulatory, multi-component, feed-forward and multi-input 
motif loops (Figure 3.8B) (Lee et al., 2002). A network motif (architecture) is a fundamental unit 
within a complex transcriptional regulatory network.  
 
In an autoregulation model, the gene product binds to its own regulatory element (Figure 
3.8B). This may allow for self-perpetuation and enhanced stability of gene expression. 
Autoregulation can be shut down by active mechanisms during differentiation. The promoter of 
Oct4 contains negative regulatory elements which are required for repression when embryonal 
carcinoma cells differentiate (Ben Shushan et al., 1995; Scholer, 1994; Schoorlemmer et al., 1994; 
Sylvester and Pikarsky et al., 1994). One example of a negative regulator is the germ cell nuclear 
factor (Gcnf) which has been shown to mediate repression of the Oct4 proximal promoter 
(Fuhrmann et al., 2001). The expression of Gcnf is inversely correlated with the Oct4 expression 
in embryonal carcinoma cells (ECCs) and in Gcnf-knockout mouse embryos, the Oct4 expression 
is no longer confined to the germ cell lineage.  
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An additional relationship between Oct4 and Sox2 is depicted by a multi-component loop 
motif whereby a regulator binds to the regulatory elements of another regulator in a closed loop 
(Figure 3.8B). Such a closed-circuit loop can efficiently generate a bi-stable system with the 
ability to switch between two different states. For ESCs, the two states may be the decision to 
undergo self-renewal or to differentiate and exit from symmetrical division. This model also 
requires that the concentrations of the two factors remain relatively constant, as any slight change 
in the abundance of one protein will destabilize the circuitry.  
 
Besides that, Oct4 and Sox2 are depicted in a feedforward loop motif containing a 
regulator that controls a second regulator and has the additional feature that both regulators bind a 
common target gene (Figure 3.8B). The feedforward loop may act as a switch that is designed to 
be sensitive to sustained inputs. Feedforward loops have the potential to provide temporal control 
of a process, because expression of the ultimate target gene may depend on the accumulation of 
adequate levels of the master and secondary regulators. In this case, the expression of Nanog is 
proposed to be regulated by an appropriate level of Oct4 and a second regulator Sox2. 
Feedforward loops may provide a form of multistep ultrasensitivity, as small changes in the level 
or activity of the master regulator at the top of the loop might be amplified at the ultimate target 
gene because of the combined action of the master regulator and a second regulator that is under 
the control of the master regulator. Interestingly, it has been shown that mESCs are exquisitely 
sensitive to the level of Oct4 (Niwa et al., 2000). Increasing the level of Oct4 by 50% is sufficient 
to induce differentiation of ESCs into primitive endoderm and mesoderm.  
 
Lastly, Oct4 and Sox2 are involved in multi-input motifs consisting of a set of regulators 
(Oct4 and Sox2) that bind together to a set of genes (Oct4, Sox2, Nanog) (Figure 3.8B). In ESCs, 
this motif may offer the potential for coordinating gene expression for maintaining the ESC state.  
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3.3.3 Conjectures  
It is apparent that Oct4 and Sox2 are important transcriptional regulators in ESCs. The binding of 
Oct4 and Sox2 may thus be instrumental in recruiting various other protein partners. However, it 
should be emphasized that not all Oct4 and Sox2 sites on the same regulatory region are 
synergistic in transcriptional activation. For example, in the Osteopontin intron, a sox site 39 bp 
away from an inverted pair of Oct4 sites acts antagonistically in transactivation by Oct4 (Botquin 
et al., 1998). Repression by Sox2 was shown to require DNA binding and a carboxy-terminal 
transactivation domain. For Fgf4, Utf1, and Fbx15, the regulatory elements contain Oct4 and Sox2 
sites in proximity (either 0- or 3-bp separation) and the Oct4/Sox2 complex is implicated in 
transactivation. This raises the interesting possibility that perhaps Oct4 and Sox2 collaborate to 
globally control ESC-specific gene expression through the sox-oct motifs. To address this 
possibility, the genome-wide targets of both regulators have to be identified.  
 
It is also possible that the Oct4/Sox2 complex interacts with another factor(s) to activate 
the network of ESC-specific genes. For example, both Oct4 and Sox2 are present in the nucleus of 
cells of the morula and their precursors (Botquin et al., 1998; Donovan and Gearhart, 2001) which 
do not express Nanog, indicating that other molecular signals, besides the appropriate cellular 
location of Oct4 and Sox2, are required for pluripotent-specific expression of Nanog. It will be 
interesting to identify other factors that act through other cis-elements within this conserved 
promoter and/or through coactivators interacting with the Oct4/Sox2 complex.  
 
It is also important to note that there are other key regulators for maintenance of the 
undifferentiated state of ESCs. The LIF/Stat3 pathway is essential for self-renewal of mESCs 
(Matsuda et al., 1999; Niwa et al., 1998; Raz et al., 1999). This was shown by the removal of LIF 
which leads to the inactivation of Stat3 and induces differentiation. Intriguingly, overexpression of 
Nanog is sufficient to bypass the LIF/Stat3 requirement. This may mean that Stat3 is regulating 
 66
Nanog. However, how Stat3 interacts with Nanog and the Oct4/Sox2 pathway remains to be 

















Figure 3.1: Specificity of αOct4 and αSox2 antibodies used in ChIP. Western 
blot analyses of mESC nuclear extracts using antibodies against Oct4 (N-19) and 




































































Figure 3.2: Oct4 and Sox2 binding to Oct4 CR4 region in mESCs. (A) Locations of the amplified 
products (numbered black boxes) of ten primer pairs used in Oct4 ChIP-qPCR on the mouse Oct4 
gene. The locations of the conserved regions, CR1-4 are indicated. Open boxes represent exons. 
(B-D) High resolution ChIP-qPCR mapping of Oct4 (B), Sox2 (C), and control (glutathione S-
transferase; GST) antibody (D) binding sites across the Oct4 promoter in mESCs by ChIP 
analysis. Fold enrichment is the relative abundance of DNA fragments at the indicated regions (A) 




























Figure 3.3: Oct4 and Sox2 binding reduces after retinoic acid differentiation of mESCs. (A) Oct4 
and Sox2 levels decreased upon retinoic acid-induced differentiation of mESCs. Western blot 
analyses of chromatin extracts using antibodies against Oct4, Sox2 and a histone deacetylase 1 
antibody (HDAC1) as a loading control in undifferentiated mESCs (ESC) and mESCs treated with 
retinoic acid for 3 and 6 days. A similar analysis of Oct4 (B) and Sox2 (C) occupancy on the Oct4 
promoter in undifferentiated mESCs and in mESCs induced to differentiate with retinoic acid for 3 
and 6 days. ChIP analysis was used as a subset (4, 6, and 7) of the amplicons described in panel 






















Figure 3.4: Oct4 and Sox2 bind to the SRR2 at the 3’ enhancer of Sox2 in mESCs. (A) Schematic 
diagram of mouse Sox2 genomic locus with its single exon represented by an open box and the 
SRR2 region indicated. The relative locations of the amplicons used to detect enriched ChIP 
fragments are shown (A to C). (B) Measurement by ChIP analysis of Oct4 occupancy in regions of 
Sox2 in undifferentiated mESCs and those induced to differentiate for 3 and 6 days by retinoic 
acid. Letters correspond to the amplicons indicated in (A). (C) Measurement by ChIP analysis of 
Sox2 occupancy in regions of Sox2 in undifferentiated mESCs and those induced to differentiate 















































Figure 3.5: Oct4 and Sox2 bind to the Nanog promoter in mESCs. (A) Schematic diagram of 
mouse Nanog genomic locus with exons represented by open boxes. The relative locations of the 
amplicons used to detect enriched ChIP fragments are shown (1-3). (B) Measurement by ChIP 
analysis of Nanog occupancy in regions of Nanog in undifferentiated mESCs and those induced to 
differentiate for 3 and 6 days by retinoic acid. Letters correspond to the amplicons indicated in 
(A). (C) Measurement by ChIP analysis of Sox2 occupancy in regions of Nanog in 




























































Figure 3.6: OCT4 and SOX2 bind to the distal enhancer (DE)/CR4 region of OCT4, the SRR2 
region of the SOX2 and promoter region of NANOG in living human ESCs. (A) Schematic 
diagram of the location of the amplicons (A, B, and C) used to detect ChIP-enriched fragments in 
OCT4 shown relative to the distal enhancer (DE)/CR4 region, to the proximal enhancer (PE), to 
the transcription start site (arrow) and to the exon (box). (B) ChIP-qPCR using OCT4, SOX2, and 
a control glutathione S-transferase (GST) antibody. (C) Schematic diagram of the human SOX2 
genomic locus with the single exon represented by an open box and the SRR2 region indicated. 
The relative locations of the amplicons used to detect enriched ChIP fragments are shown (A and 
B). (D) Measurement by ChIP analysis of OCT4 and SOX2 occupancies on SOX2 in living 
hESCs. A glutathione S-transferase antibody (GST) was used as a negative control. (E) Schematic 
diagram of the location of the amplicons (1 to 6) used to detect ChIP-enriched fragments in 
NANOG shown relative to the first exon (box). (F) Measurement by ChIP analysis of OCT4 and 
SOX2 occupancies on NANOG in living hESCs. Control glutathione S-transferase (GST) ChIP-















Figure 3.7: Multiple alignment analysis of Oct4 and Sox2 binding sites in mESCs from this study 











































Figure 3.8: Oct4, Sox2 and Nanog circuitry and network motifs. (A) Mapping of the Oct4, Sox2, 
and Nanog circuitry in ESCs. The relationship between Oct4 and Sox2 proteins (circled) and Oct4, 
Sox2 and Nanog genes (boxed). Solid arrows represent binding shown by ChIP in this study. (B) 
The network motifs in the Oct4, Sox2 and Nanog regulatory network includes autoregulation, 
multi-component loop, feed-forward loop and multi-input motif. Regulators are represented by 
circles; gene promoter/enhancers are represented by rectangles. Binding of a regulator to a 
promoter is indicated by a solid arrow. Genes encoding regulators are linked to their respective 
regulators by dashed arrows. 
 
Autoregulation Multi-component loop 
Multi-input motif Feedforward loop 
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CHAPTER 4 
Genome-wide Mapping of Oct4-DNA Interactions in Mouse Embryonic Stem Cells 
 
4.1 Introduction 
The previous chapter demonstrated that Oct4 and Sox2 bind and regulate transcription of Oct4, 
Sox2 and Nanog (Boyer et al., 2005; Chew et al., 2005; Kuroda et al., 2005; Okumura-Nakanishi 
et al., 2005; Rodda et al., 2005). Both Sox2 and Nanog are essential for maintaining the 
pluripotent phenotype, although the in vivo phenotype of both hints at a slightly later role in 
development as compared with Oct4 (Avilion et al., 2003; Chambers et al., 2003; Mitsui et al., 
2003). Results from the previous chapter suggest that Oct4 and Sox2 function through 
autoregulatory feedback loops (Sox2 and Oct4) and feed-forward mechanisms (Nanog) to maintain 
the expression of transcription factors essential to the ESC phenotype.  
 
Other targets of the Oct4-Sox2 complex in pluripotent cells include Fgf4, Utf1, and 
Fbxo15. Fgf4 is an extracellular signalling molecule synthesized by the epiblast and it plays an 
essential function in mediating signals to maintain the trophoblast stem cell (Tanaka et al., 1998). 
Utf1 is a transcriptional co-activator that has been implicated in enhancing ESC proliferation, 
thereby associating Oct4 with a proliferative regulatory network (Nishimoto et al., 1999; 
Nishimoto et al., 2005). Fbx15 is a transcription factor with no known targets or function. The 
only other known targets of Oct4 are Spp1 encoding the extracellular molecule osteopontin and 
Zfp42 encoding the transcription factor also known as Rex1 (Ben Shushan et al., 1998; Botquin et 
al., 1998). Neither of these have any known function in the pluripotent cell.  
 
The cis-regulatory element, to which the Sox2-Oct4 complex is bound, consists of 
neighbouring Sox2 (CATTGTA) and Oct4 (ATGCAAAT) binding sites. These elements are 
immediately adjacent to one another with the sox element in the 5’ position in five out of the six 
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Sox2-Oct4 target genes. The sixth target gene (Fgf4) contains 3 intervening base pairs between the 
two binding sites (Ambrosetti et al., 1997; Ambrosetti et al., 2000). For Spp1, the Oct4 site is 
important in transcriptional activation while a Sox2 site 35 bp 5’ to this is implicated in 
transcriptional repression (Botquin et al., 1998). Sox2 binding to the Zfp42 promoter has not been 
described while the binding by Oct4 is through a representative octamer motif (Ben Shushan et al., 
1998).  
 
Based on the limited knowledge in the involvement of Oct4 in cellular functions such as 
ESC maintenance and proliferation, it is anticipated that there are many more Oct4 targets yet to 
be identified. Moreover, none of the known Oct4 targets display the early phenotypic defect 
shown by Oct4-null embryos, implying that additional Oct4 targets should exist. Also, given the 
central role that Oct4 plays in ESC biology, the identification of transcriptional targets of Oct4 
would expand our understanding into its regulatory network.  
 
 In the previous chapter, ChIP-qPCR was used to discover binding sites of Oct4 and Sox2 
in a gene-by-gene approach. While qPCR detection is effective and convenient, it is limited to loci 
that are selected for study. Here, this study uses chromatin immunoprecipitation coupled with a 
paired-end ditags (ChIP-PET) sequencing technique developed in the Genome Institute of 
Singapore (Wei et al., 2006) to map the Oct4 binding sites in mESCs on a global manner. In brief, 
mESCs were fixed using formaldehyde to preserve in vivo protein-DNA interactions. Chromatin 
extracts were sonicated and subjected to immunoprecipitation using an antibody against Oct4. 
ChIP-enriched DNA was purified and cloned into a PET library. Subsequently, 36 bp sequence 
tags (PET) from both ends (18 bp from 5’ and 18 bp from 3’ end) of each individual ChIP-
enriched DNA fragment were generated. These PETs were then concatenated to allow for efficient 
sequencing. Sequenced PETs were then mapped to the mouse genome to demarcate the boundaries 
of ChIP-enriched DNA fragments. Single PETs, called singletons, were observed throughout the 
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genome and they represent background noise due to random recovery of genomic DNA. Genome 
locations derived from multiple overlapping PETs indicate bona fide transcription factor binding 
sites.  
 
In this study, 366,639 PETs mapping to unique genomic loci were generated from Oct4 
ChIP-enriched DNA from undifferentiated mESCs. ChIP-qPCR validations done on these regions 
empirically defined PET overlaps of 4 and above as high confidence Oct4 transcription factor 
binding sites (TFBS). 1083 distinct Oct4 binding sites were identified from the clusters of multiple 
overlapping PETs. Along with known targets of Oct4 such as Oct4 and Nanog, Oct4 was also 
shown to bind a variety of gene classes. A substantial number of these genes code for transcription 
factors implicated in a much broader range of cellular processes in ESCs. Genes associated with 
Oct4 binding encode products that function in an array of cellular processes, including cell 
proliferation (Mycn), transcription (Rest, Tcf3), DNA integrity (Trp53, Trp53BP1), metabolism 
(proteases and pumps), signalling (kinases) and translation (microRNAs).  
 
The strategy used here synergises ChIP, high-throughput cloning and sequencing, 
computational analyses, and comparative analyses with previous observations by other groups on 
the functions of the target genes to define the role of Oct4. The results implicate Oct4 in triggering 




4.2.1 Optimisation of large-scale ChIP 
MagnaBind™ goat anti-rabbit IgG (Pierce), Dynabeads M-450 Tosylactivated (Dynal), protein G 
and protein A magnetic beads (New England Biolabs), Dynabeads M-450 Epoxy beads (Dynal 
Biotech), peptide [Oct4 PS (N-19) sc-8628PS, Sox2 PS (Y-17) sc-17320PS, Santa Cruz)] elutions, 
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protein G sepharose (Amersham) and protein G Dynabeads (Dynal) were all tested in Oct4 ChIP-
qPCR assays. Protein G sepharose beads were chosen for its high ChIP DNA recovery 
(approximately 50ng per ChIP reaction) and high enrichment. Feeder-free mESCs grown at a 
confluency of 70% were optimal for crosslinking and ChIP assays. Large-scale mESC cultures in 
500cm2 dishes (at least 8 dishes at each time) were done to obtain sufficient chromatin extracts. 
Large-scale Oct4 ChIP of 14 reactions was carried out at each time. Input DNA (decrosslinked 
chromatin extracts) was re-purified after RNase digestion, measured for enrichment by ChIP-
qPCR and quantified before being sent for library construction by the GIS Cloning and 
Sequencing group.  
 
4.2.2 Global mapping of Oct4 binding sites in mESCs 
This study utilises a robust sequencing approach, termed the ChIP-PET technology developed by 
Dr Ruan Yi Jun’s group in GIS, which efficiently identified and positioned Oct4 ChIP DNA 
fragments onto the mouse genome. Oct4 ChIP-enriched DNA fragments were cloned into a 
primary library that preserved the original representation of ChIP-enriched DNA. The clones were 
then converted into paired-end ditags that were concatenated and cloned into a plasmid vector to 
yield the final ChIP-PET library (please refer to Chapter 2 for more details). Approximately 
80,000 randomly selected clones were sequenced, generating 10 to 15 PETs per sequence read for 
a total of 1,088,836 PET sequences. These PET sequences were then mapped to the mouse 
genome to define the boundaries of the Oct4 ChIP DNA fragments (termed as ‘cluster’). 
Definition of the terms used in ChIP-PET is illustrated in Figure 4.1. The binding data was then 
visualized through a browser maintained by the Bioinformatics Institute (http://t2g.bii.a-
star.edu.sg). With the help of large scale data prosessing by the Bioinfomatics group in GIS, 
515,717 (47%) PETs were found to map to specific locations on the mouse genome (build mm5) 
and the rest of the PETs either did not map to the genome (469,032; 43%) or were mapped to 
multiple locations (109,087; 10%) as they were derived from repetitive sequences. The 515,717 
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PET-mapped locations were grouped into 366,639 unique genomic loci. It is highly unlikely to 
have two independently generated PETs mapping to identical locations due to the random nature 
of DNA shearing used in the ChIP protocol. Any redundantly mapped PETs are likely a result of 
amplification events during the ChIP-PET cloning process. 
 
True Oct4 binding sites should be distinguishable from background noise by virtue of 
multiple overlapping PETs mapping to specific locations within the genome. Of the 366,639 PETs 
mapping to unique genome locations, the majority (276,006; 75%) were represented by single 
non-overlapping PETs (singletons). These singletons most likely represent background noise. The 
remainder of these PETs (90,633 or 24.7%) was found to overlap with others and comprised 
37,623 distinct PET clusters. The total number of PETs in these clusters ranged from 2 PETs for 
29,451 of these clusters to 17 PETs represented by one cluster. Some of these clusters, particularly 
those containing few PETs, may represent background noise from random sampling of genomic 
DNA.  
 
Subsequently, the minimum number of overlapping PET sequences required within a 
cluster to distinguish a bona fide Oct4 binding site was determined through ChIP-qPCR. Clusters 
with 2, 3, 4 and 5 overlapping PETs were randomly selected and tested for Oct4 ChIP enrichment 
by the conventional ChIP-qPCR. Out of the clusters represented by 3 overlapping PETs, only 3 
showed more than a 2-fold enrichment over background and were considered to represent 
background in the data analysis (Figure 4.2). In contrast, all clusters containing 4 overlapping 
PETs showed significant enrichment of Oct4 binding (greater than 2-fold). In addition, clusters 
with 5 or more PET overlaps were all enriched over background. Therefore, the majority of loci 
with 4 PET overlaps and above were deemed to represent authentic Oct4 binding sites. Based on 
this cut-off, 1083 distinct sites within the mouse genome were determined to be Oct4 high 
confident binding sites in undifferentiated mESCs. 
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4.2.3 Oct4 ChIP-PET experiment identifies known Oct4 binding targets 
Prior to this study, there were eight reported Oct4 DNA binding sites in mESCs (five of which 
were validated by ChIP). To verify the reliability of the Oct4 ChIP-PET data, these known sites 
were searched for positive binding. Firstly, Oct4 bindings on three key transcription factors 
essential to the ESC phenotype, namely the Oct4 gene itself, Sox2, and Nanog as previously 
characterized by this study and others (Chew et al., 2005; Kuroda et al., 2005; Okumura-
Nakanishi et al., 2005; Rodda et al., 2005; Tokuzawa et al., 2003; Tomioka et al., 2002) were 
examined. As expected, the ChIP-PET method identified Oct4 binding to these three genes where 
nine PET overlaps mapped to Oct4 gene (Pou5f1), five PET overlaps mapped to Sox2, and four 
PET overlaps mapped to Nanog. Furthermore, the PET overlap region mapping to each of these 
genes encompassed the known Oct4 binding sites as shown and confirmed by conventional ChIP-
qPCR. The Oct4 ChIP with its corresponding PET overlaps showing the binding sites on Oct4 and 
Nanog are depicted in Figure 4.3. Control ChIP using an antibody against yeast Ena-1 protein 
showed no enrichment with the same primers.  
 
In addition, the ChIP-PET method also identified a fourth previously known Oct4 target 
gene, Fbx15 (Tokuzawa et al., 2003), with four PET overlaps spanning the known Oct4 binding 
site located 530 bp 5’ to the transcription start site of this gene. Identification of these known Oct4 
binding sites by the ChIP-PET method attested to the reliability of this approach for determining 
Oct4 binding targets in mESCs. However, the other four previously reported Oct4 binding sites 
were not identified by the ChIP-PET method. There were no PETs, singletons or otherwise, 
spanning the Oct4 binding sites in Fgf4, Zfp42, or Spp1 and only a singleton spanning the known 
Oct4 site of Utf1. This omission may be due to the inadequate depth of sequencing. When 
conventional ChIP and a two step ChIP (sequential ChIP)-qPCR were carried out on these loci, 
there were indeed enrichment or positive binding on the Zfp42, Fgf4, Spp1 and Utf1 loci (data not 
shown). Therefore, the Oct4 ChIP-PET data may likely be an underestimate of the actual number 
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of Oct4 binding sites in the mouse genome. Nonetheless, the ChIP-PET method was still able to 
detect 1083 high confidence Oct4 binding loci, expanding the catalogue more than 100 times the 
number of sites previously known. 
 
4.2.4 Annotation of Oct4 binding sites to the transcriptome of ESCs 
To identify genes that are potentially regulated by these 1083 Oct4-DNA interactions, these loci 
were annotated together with Dr Leonard Lipovich to determine the nearest known gene 
(Appendix A). The ChIP-PET data identified 957 distinct Oct4-bound genes. Subsequently, these 
Oct4 binding loci were also annotated for their relative position to the respective gene (Appendix 
A). For distances of less than 100 kb, bound loci were annotated as 5’ distal (10 to 100 kb 
upstream), 5’ proximal (0 to 10 kb upstream), intragenic (contained within introns or exons of the 
respective genes), 3’ proximal (0-10 kb downstream), and 3’ distal (10 to 100 kb downstream) 
(Figure 4.4A). Loci mapping greater than 100 kb away from the nearest gene were annotated as 
gene deserts although the nearest genes were still listed.  
 
Results showed that about 44% of the Oct4 binding sites mapped within a gene, with 437 
mapping to introns and 25 to exons (Figure 4.4B). 197 loci (19%) mapped to the 5’ proximal 
region of genes (eg. Oct4) and of these, 82 (42%) were within 1 kb of the 5’ end of the gene (this 
includes Nanog and Fbx15). The binding within the 1 kb proximal promoter window represented 
7.9% of all Oct4-bound loci which indicates a significant enrichment for this immediate proximal 
promoter region (this is compared with 13% of Oct4-bound loci mapping to the 90 kb region 
classified as 5’ distal). The number of Oct4 binding sites mapped to the downstream of genes was 
79 in the 3’ proximal (including Sox2) and 104 in the 3’ distal regions. Of the 957 distinct genes 
with Oct4 binding sites, the vast majority contained a single Oct4 ChIP-PET cluster mapping to it. 
However, there were also a number of genes that contained multiple Oct4 binding sites. The 
highest number of binding sites associated with a single gene was 5. This was associated with an 
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uncharacterized transcript (2610042L04Rik). A second gene, Igfbpl1, had 4 Oct4 binding sites. 
Five genes were associated with three Oct4 binding sites and 67 genes had two Oct4 binding sites. 
The remainder (883 genes) had only one Oct4 binding site. This suggests that clustering of Oct4 
binding sites is not a common mechanism of action for transcriptional regulation by Oct4. With 
the help of Dr Paul Robson, all 957 distinct genes associated with Oct4 binding sites were further 
annotated for functional relevance with the Panther classification system (Mi et al., 2005). 714 of 
these genes were recognized in the Panther system but only 527 of these were identified with a 
molecular function. In total, there were 430 genes of unknown function in close proximity to the 
Oct4 binding sites. Understanding the association of Oct4 and these genes will unravel the 
functions of these novel genes in transcriptional regulation. Within the genes of known molecular 
functions, transcription factors were the most significantly over-represented. Within a random list 
of 527 genes generated from the 25358 genes characterized in the Panther system, 105 
transcription factors such as Trp53, Cdx2 and Mycn were indicated to associate with Oct4 binding 
sites (Table 4.1). Kinases are a second group of genes that were significantly over-represented. A 
gene that was identified as having an Oct4 ChIP-PET cluster overlap of 5 mapping to its first 
intron was Akp2. This is an alkaline phosphatase routinely used as a marker for both mouse and 
human pluripotent cells. This suggests that Oct4 is activating the transcription of Akp2 in 
pluripotent cells.  
 
The 1083 Oct4 binding sites were also annotated for indication of expression by relating 
expression profiling results from a massively parallel signature sequencing (MPSS) study (Wei et 
al., 2005) (Appendix A). MPSS generates millions of 20 bp signature sequence tags per sample 
which are quantified as transcripts per million (tpm). The frequencies of Oct4 transcript in this 
MPSS study were 388 tpm and 21 tpm in ESCs and EBs, respectively. Utilizing MPSS data for the 
genes that map closest to each Oct4 binding locus allowed the comparison of their expression 
levels between ESCs and EBs with that of Oct4 itself. Approximately 8% of the genes associated 
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with these Oct4-bound loci had greater than 100 tpm in undifferentiated ESCs. Surprisingly, the 
majority (507 genes or 52%) did not show expression in ESCs, as indicated by zero MPSS tags. 
From the relative abundance, measured by calculating the ratio of ES to EB tpm, 296 genes 
showed higher expression in ESCs than in EBs. This ES/EB ratio provides a correlation between 
pluripotent specific expression and Oct4 binding, and serves to imply potential activation, 
repression or non-regulation of these genes by Oct4. Annotation for all of the Oct4 binding sites 
are presented in the Appendix A. 
 
4.2.5 Identification of novel Oct4 bound genes and associated pathways 
The Oct4 ChIP-PET data uncovered a broad spectrum of genes previously not associated with 
Oct4 binding or regulation. These include Esrrb, Rest, Jarid2, Tcf3, Tcf7, Mycn, Zic3, Rif1, 
Ehmt1, Tcfcp2l1, FoxH1, Id3, Trp53, Trp53BP1, Dido1, Tdgf1, Sgk, RARa, RARg, Bmi1 and 
Zfp64 (Figure 4.5A). Importantly, microRNA (miRNA) genes (mir302 and mir296) were also 
identified among the candidate targets of Oct4 (Figure 4.5B). Oct4 bound to sites within 10 kb of 
both miRNA genes. For all the protein coding and miRNA genes mentioned above, Oct4 binding 
was confirmed (i.e. enrichment of at least 2-fold) by traditional ChIP with detection by real-time 
PCR as compared to that of a control ChIP using an unrelated antibody (Figure 4.5A, C). To test 
the specificity of Oct4 binding in mESCs, Oct4 ChIP-qPCR was carried out using retinoic acid 
(RA) -induced differentiated mESCs. Fold enrichment for these targets decreased when mESCs 
were treated with retinoic acid. ChIP using a control antibody showed no significant enrichment 
(Figure 4.6). This further confirmed that the detected Oct4 binding at these target sites in 
undifferentiated mESCs was authentic and that upon differentiation, Oct4 binding was reduced.  
 
The majority of genes identified in this analysis has not been identified in previous studies 
and thus represent novel targets of Oct4. These candidate target genes encode for transcription 
factors, chromatin remodellers, miRNA and other proteins. Oct4 was found to bind to genes 
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involved in the DNA damage response pathway (Trp53, Trp53BP1, Rif1). In addition, Oct4 also 
bound to genes important in cell proliferation (Mycn). Importantly, a cohort of Oct4 bound genes 
(Table 1) were those that encode for factors important in inhibiting transcription of lineage specific 
genes, such as the Rest transcription factor which is an inhibitor of neuronal genes (Ballas et al., 
2005). The repertoire of Oct4 target genes and the roles they play in different pathways may 
contribute to the ESC self-renewing and pluripotent potential.  
 
4.3 Discussion 
A total of 1083 high confidence Oct4 binding sites were identified using the ChIP-PET method. 
Apart from identifying known targets of Oct4 in ESCs, such as Oct4, Sox2 and Nanog, a cohort of 
Oct4-associated genes involved in diverse functions that include transcription regulation, cell fate 
determination pathways, cellular proliferation, metabolism, and genetic integrity were also 
discovered. Transcription factors were found to be the most enriched subset of Oct4 binding sites 
(Table 4.1), suggesting that Oct4 may be one of the most important transcription factors in the 
hierarchy of the transcriptional regulatory network in mESC. 
 
When transcripts of some of the Oct4 bound genes were tested in Oct4 RNAi-depleted 
mESCs, Esrrb, Rest, Jarid2, Tcf3, Tcf7, Mycn, Zic3, Rif1, Ehmt1, Tcfcp2l1, FoxH1, Trp53, 
Trp53BP1, Dido1, Tdgf1, Sgk, RARa and RARg transcripts were significantly downregulated after 
Oct4 knockdown (Loh et al., 2005), indicating that Oct4 binding on these targets confer 
expression. Interestingly, the trophectoderm (TE) marker genes Cdx2 and Cldn4 which were 
bound by Oct4, were dramatically upregulated upon Oct4 reduction; demonstrating that Oct4 
could also repress genes in ESCs (Chew et al. 2005). Concurringly, Oct4 was reported to directly 
prevent differentiation towards trophectoderm by interacting with Cdx2 to form a repressor 
complex (Niwa et al., 2005). This complex interferes with the autoregulation of these two factors, 
giving rise to a reciprocal inhibition system that establishes their mutually exclusive expression. 
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As such, the downregulation of Oct4 results in an upregulation of Cdx2, and vice versa - a 
mechanism that might account for the two different pathways that lead to pluripotent stem cells 
and to trophectoderm cells. Besides Cdx2, other genes important for proper TE development were 
also bound by Oct4. An Oct4 binding site was found at 88 kb proximal to Eomes, a transcription 
factor essential for proper TE development (Russ et al., 2000). In addition, Cldn4, which is 
expressed in trophoblastic stem cells and in the blastocyst, was also found to be bound by Oct4. 
This gene product is a major player in tight junction function and therefore implicated in TE 
epithelial integrity. This suggests that Oct4 also acts as a repressor of the trophoblast lineage.  
 
There are also many other genes with Oct4 binding sites which show very low or no 
expression in mouse ESCs but are upregulated in differentiating embryoid bodies as determined by 
MPSS data-mining. A number of these genes are related to lineage development such as Mid1, 
RbPms, Myo10, Cspg2, Spn2 and Nestin. This suggests that Oct4 may not only repress genes for 
trophectoderm differentiation, but it also represses genes for other lineages as well. For example, 
this data suggests that Oct4 indirectly inhibits neuronal lineages by positively regulating the 
expression of Rest. Rest encodes for a transcriptional repressor that restricts neuronal gene 
expression in neural progenitors. Ballas and coworkers demonstrated that in neural progenitor 
cells, Rest is degraded to levels just sufficient to repress transcription of neuronal genes. As 
progenitors differentiate into neurons, Rest and its co-repressors dissociate from the binding site, 
triggering activation of neuronal genes (Ballas et al., 2005). The sustained activation of inhibitors 
of lineage genes such as Rest by Oct4 suggests another mechanism utilized by ESCs to remain 
undifferentiated whereby Oct4 may repress differentiation genes.  
 
Oct4 also binds to genes important in proliferation and cell cycle such as Mycn, Esrrb, 
Rif1, Trp53 and Trp53bp1. Mycn has been reported to be among the key mediators in the self-
renewal and proliferation of ESCs (Cartwright et al., 2005). Esrrb belongs to the superfamily of 
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nuclear hormone receptors, and homozygous mutant embryos show abnormal trophoblast 
proliferation, precocious differentiation toward the giant cell lineage and reduction in primordial 
germ cells (Mitsunaga et al., 2004; Tremblay et al., 2001a). Rif1 is an ortholog of a yeast 
telomeric protein and is upregulated in mESC and germ cells (Adams and McLaren, 2004). In 
human cells, Rif1 associates with dysfunctional telomeres and has a role in DNA damage response 
(Adams and McLaren, 2004; Silverman et al., 2004; Xu and Blackburn, 2004). p53 has been 
suggested to maintain the genetic stability of ESCs by eliminating DNA damaged cells (Sabapathy 
et al., 1997; Xu, 2005). p53BP1 is a p53 binding protein and functions as a key transducer of the 
DNA damage checkpoint signal and monitoring of dysfunctional telomeres (d'Adda et al., 2003; 
DiTullio, Jr. et al., 2002; Takai et al., 2003; Wang et al., 2002). Besides genes of the cell cycle, 
Oct4 also binds to Id3, FoxH1 and Tcf3 genes which are implicated in the BMP and Wnt 
signalling pathways (Hollnagel et al., 1999; Hoodless et al., 2001; Kofron et al., 2004; Merrill et 
al., 2004; Norris et al., 2002; von, I et al., 2004;). In addition, Oct4 binding was also identified at 
microRNA genes mir296 and mir302. These microRNAs have been isolated in ESCs and their 
expression was shown by Northern blot analyses (Houbaviy et al., 2003). This finding suggests a 
role for miRNA in early embryonic development. In addition, a substantial number of Oct4-bound 
genes are related to metabolic pathways including solute carrier proteins (Slcs) and enzymes 
related to ubiquitination pathways (ubiquitin conjugating enzymes and ubiquitin specific 
proteases). These may contribute to the high proliferation rate and metabolic turnover of ESCs. 
 
In many instances, Oct4 bound to genomic sites with no apparent upstream or downstream 
genes within the range of 500 kb. These may be non-functional Oct4 sites, sites where novel 
transcription units which have not yet been defined or sites of enhancer regions acting at a distance 
due to the conformational structure of the chromatin. This demonstrates that the ChIP-PET method 
identified Oct4 binding sites in a global manner. This global manner of mapping binding sites is 
particularly important as regulatory elements do not always fall within the 5’ proximal region of 
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the first exon (Cawley et al., 2004). The location map generated in this study will serve as a useful 
guide in identifying additional components in the regulatory network important for self-renewal, 
pluripotency and differentiation of ESCs. Moreover, the data will provide clues for the selection of 















































Figure 4.1: Diagram illustrating the features of the ChIP-PET readout. Paired-end ditags (PETs) 
mapped to the genome either appear as a single PET (termed singleton) which most likely 
represent background noise, or as multiple overlapping PETs forming a PET cluster demarcating 
the boundaries of the ChIP DNA fragments. Maximum overlapping PETs (moPET) are located at 



















Figure 4.2: Determination of the minimum PET cluster size as Oct4 bona fide binding sites. Oct4 ChIP-qPCR enrichment at randomly selected 





























































Figure 4.3:  Profiles of Oct4 binding revealed by ChIP-PET. Validation of known Oct4 occupied 
genes in mESCs. An image of the T2G browser showing PET clusters at Oct4/Pou5f1 (upper panel 
of A) and Nanog (upper panel of B) with 9 overlaps and 4 overlaps respectively. Each horizontal 
green line represents a DNA fragment mapped to the genome based on the UCSC mm5 build. 
TFBS density (coloured in brown) is a plot showing the profile of the transcription factor binding 
and is based on the number of overlaps of the DNA fragments. Conventional Oct4 ChIP-qPCR 
was carried out using Oct4 and Nanog genes specific primers to confirm the Oct4 binding sites 
shown by the ChIP-PET analysis. Graphs depicting the mapping of the Oct4 (red circles) and 
control (Ena-1 antibody, light blue circles) binding sites across the chromosomal locations of PET 
clusters are shown (lower panels of A and B). Fold enrichment is the relative abundance of DNA 
fragments at the regions shown (relative to the position of the respective gene as illustrated in the 





































Figure 4.4: Annotation of Oct4 binding sites in relation to genomic locations. (A) Schematic 
diagram illustrating the definition of the location of a binding site in relation to a transcription unit. 
5’ distal, 5’ proximal, 3’ proximal and 3’ distal regions are depicted within 100kb upstream and 
100kb downstream of the transcriptional unit. (B) Locations of Oct4 binding sites relative to the 



























































Figure 4.5: Novel genes bound and potentially regulated by Oct4 in mESCs. (A) Novel and known 
Oct4-bound targets were validated by conventional ChIP-qPCR using Oct4 and control (Ena-1) 
antibodies. Con1 to con3 are control regions.  (B) Image of the T2G browser illustrating the 
binding of Oct4 on miR296 and miR302. (C) Verification of Oct4 occupancy by conventional 
ChIP-qPCR. ChIP using Oct4 (N-19) and control Ena-1 antibodies were carried out to validate 




































Figure 4.6: Retinoic-acid induced differentiation reduces Oct4 binding levels on targets in mESCs. 
Oct4 (N-19) and control (Ena-1) ChIP were carried out using formaldehyde-crosslinked mESCs 
treated with retinoic acid (+) and non-treated ESCs (-). Fold enrichment represents the abundance 
of enriched DNA fragments over a control region not enriched for the respective targets. Standard 









Genome-wide Identification of Sox2-DNA Interactions in Mouse Embryonic Stem Cells 
 
5.1 Introduction 
Similar to the previous chapter, the Sox2 genome-wide binding sites in mESCs were also mapped 
using the ChIP-PET approach. The essential function of Sox2 in ESCs is mediated through the 
genes that it transcriptionally regulates; several which have been identified. In Chapter 3, Sox2 
was shown to bind to the regulatory regions of Sox2 itself, Oct4 and Nanog. Other reports also 
corroborated with this finding (Boyer et al., 2005; Kuroda et al., 2005; Okumura-Nakanishi et al., 
2005). The autoregulatory loop and feed-forward mechanisms of Sox2 action implicated its 
function in the regulation of these three transcription factors that are essential to the pluripotent 
phenotype. In addition, Sox2 is known to bind regulatory regions of Fgf4, Utf1 and Fbxo15 
(Ambrosetti et al., 1997; Botquin et al., 1998; Nishimoto et al., 1999; Yuan et al., 1995) to drive 
their pluripotent-specific expression. In all these six known target genes, Sox2 binds 
synergistically with Oct4 to neighbouring sox and octamer elements, implying that Sox2 may also 
bind to many of Oct4 target genes. To investigate this possibility, the genome-wide binding sites 
of Sox2 in mESCs (and the genes associated with them) were identified to establish the extent in 
which these binding sites overlap with those of Oct4. 
 
In this study, 1133 high confidence Sox2 binding sites and numerous other lower affinity 
sites were identified using the ChIP-PET method. Of these high affinity sites, 49% are located 
within 20 kb of a gene whereas a surprisingly high number (15%) are more than 100 kb away. A 
number of sites mapped to the proximal promoters of uncharacterized transcripts. As with Oct4, 
transcription factors such as FoxD3, Mycn, Rif1, Rest, and Tcf3, were the most significantly 
represented targets of Sox2 binding. Novel binding sites such as those from the Oct4-bound loci, 
which was not detected in the gene-by-gene examination in Chapter 3, was identified here. Results 
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show that Sox2 binding sites associate with a diverse array of genes encoding transcription factors, 





5.2.1 Optimisation of ChIP and global mapping of Sox2 binding sites in mESCs 
Single-step Sox2 ChIP did not yield high enrichments. Therefore, a two step ChIP using the Sox2 
antibody was carried out to obtain good quality ChIP DNA for cloning and sequencing. Since 
sequential ChIP only gave approximately 5 ng of DNA per ChIP reaction, multiple reactions were 
carried out to acquire enough DNA (at least 500 ng for ChIP-PET and minimum validations). 
Purified Sox2 ChIP-enriched DNA was cloned into a primary library that preserved the original 
representation of the ChIP-enriched DNA by the GIS Cloning and Sequencing group led by Dr 
Ruan Yijun. As with the Oct4 ChIP-PET process, sequence tags (18 bp) from both ends of each 
cloned DNA fragment were generated and ligated together to form a paired-end ditag (PET). 
Subsequently, these PETs were concatenated and cloned into a second library in which each clone 
contained 5-6 PETs in tandem. Clones from this library were randomly picked and single-pass 
sequenced by the Cloning and Sequencing group, GIS.   
 
A total of 115,443 clones were sequenced from the Sox2 ChIP-PET library, generating 
616,299 PETs. These PET sequences were mapped to the mouse genome (build mm5) to 
demarcate Sox2 binding sites. Of these PETs, 50.85% (313,418) were successfully mapped, 
40.68% did not match any sequence in the genome, and 8.46% hit repetitive sequences and was 
therefore omitted. Multiple identical PETs are most likely the result of library amplifications of 
one original genomic fragment. 203,987 unique PETs were successfully mapped to the mouse 
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genome. The majority of these mapped genomic loci (91.8%) were represented by single non-
overlapping PETs (singletons) and considered to be background.  
 
 Out of the 16,729 non-singleton loci, the number of PET overlaps ranged from those 
containing two overlaps (PET2) (13,798) to a single cluster containing twenty six (PET26). Those 
clusters with a lower number of overlapping PETs most likely contained Sox2 binding sites of a 
lower affinity and therefore, such DNA fragments were pulled down less frequently than those 
sites of greater affinity for Sox2. To determine the minimum number of PET overlaps (cutoff) that 
definitively identified a bona fide Sox2 binding site, 25 PET3 and 29 PET4 and above clusters 
were randomly selected to test for enrichment using conventional ChIP-qPCR (Figure 5.1). The 
majority of PET3 clusters produced no more than a 2-fold enrichment whereas all PET4 and above 
clusters showed significant enrichment (i.e. greater than 2-fold) over background for Sox2 binding 
(Figure 5.1). Sampling of clusters with 5 or more PETs (PET5+) indicated that the number of 
PETs within a cluster was generally proportional to the fold-enrichment as detected by ChIP-
qPCR. 
 
Clusters with 4 and more overlapping PETs (PET4+) were taken to be high-confidence 
Sox2 binding sites. However, there is likely to be a significant number of true Sox2 binding loci in 
clusters containing PET2 and 3 as 32% of the PET3 clusters tested by ChIP-PCR had significant 
enrichment. From this percentage, it is assumed that 575 out of the 1799 total PET3 clusters are 
likely to be Sox2 binding sites. Additional binding sites may also be represented by some of the 
13,798 PET2 clusters. From the set of high-confidence Sox2 binding sites represented by PET4+ 
clusters, of which 83% fall within the PET4-6 range, 1133 distinct Sox2 binding sites were 




5.2.2 Sox2 ChIP-PET experiment identifies known Sox2 targets 
To investigate the reliability of the Sox2 ChIP-PET data, the data were analysed for known Sox2 
targets. In Chapter 3, in vivo binding of Sox2 was demonstrated on Oct4, Nanog and Sox2 itself 
(Chew et al., 2005; Rodda et al., 2005) and these loci were detected in the Sox2 ChIP-PET data. 
For the Oct4 loci, a cluster containing 11 PET overlaps mapped to the known Sox2 binding site 
located 1977 bp upstream of the transcription start site (TSS). Interestingly, a second Sox2 binding 
site was detected 862 bp downstream of this first site in the CR2 region and is represented by a 
cluster of 5 PET overlaps (Figure 5.2A). Conventional ChIP-qPCR using primer sets scanning this 
entire region reiterated a similar profile as detected by the ChIP-PET data (Figure 5.2B), 
demonstrating that the ChIP-PET method is more efficient and comprehensive in identifying 
binding sites in a global manner. At the known Sox2 binding sites of Sox2 and Nanog, there were 
5 and 3 Sox2 PET overlaps, respectively (Figure 5.3A, B). These regions have previously been 
shown to bind Sox2 by ChIP-qPCR in Chapter 3. Hence, the identification of these 3 known 
binding sites confirmed, to some extent, the reliability of the ChIP-PET data that contained Sox2 
binding targets. 
 
5.2.3 Linking the Sox2 binding sites to the transcriptome of mESCs 
As with the Oct4 ChIP-PET data, the 1133 Sox2 binding sites were annotated to the nearest genes 
that they may potentially regulate (with the help of attachment students, Amanda Ang and Yong 
Chun). 957 distinct Sox2 associated genes were identified. Binding sites were then categorized by 
their location to their respective genes (Figure 5.4A). Surprisingly, a significant number of Sox2 
binding loci were further than 100 kb away from the nearest gene. However, the majority of sites 
fall within 20 kb of the nearest gene (Figure 5.4B). These results signify the global nature of the 
ChIP-PET approach based on its ability to detect Sox2 binding irrespective of gene location.  
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 With the help of Dr Paul Robson, the genes were classified according to the Panther 
classification system (Mi et al., 2005) to identify their corresponding molecular function 
(Appendix B). 550 of 717 genes have recognizable molecular functions. Similar to Oct4, the most 
significantly over-represented molecular function (with p=2.99x10-10) in the Sox2 binding dataset 
was transcription factors which include Otx2, Rarb, Tcf3, Phc1, JunB, Mycn, Sall4, Id2, Id4, Ets1, 
Smad7, Gbx2, Sp1, Dido1, and Lef1.  
 
 To investigate if the Sox2-associated genes are transcriptionally active or inactive in 
mESCs, expression data from massively parallel signature sequencing (MPSS) was integrated into 
the Sox2 ChIP-PET analysis annotation. The Sox2 annotations were carried out together with 
attachment students, Yong Chun and Amanda Ang (GIS). MPSS generates millions of 20 bp 
sequence tags per sample and these are expressed as transcripts per million (tpm). Data from the 
previously profiled transcriptomes of mESC were used (Wei et al., 2005). Sox2, Oct4 and Nanog 
transcripts have tpm counts of 105, 388, and 112 in mESCs, respectively. 67.4% of the Sox2 
associated genes had 0-3 tpm in ESCs (Appendix B). Only the MPSS tags with a single genome 
hit were included in the computation of the percentage of Sox2 associated genes that are not 
expressed in ESCs to ensure specificity. A large number of Sox2-associated genes appear not to be 
expressed in ESCs, suggesting that Sox2 is negatively regulating these genes. There were 54 genes 
with tpm of 100 or more in ESCs, suggesting that these relatively abundant genes were positively 
regulated by Sox2. Genes that fall into this category include Rest, Rcor2, Otx2, Rif1, Lefty1, 
Lefty2, Dppa5, Spp1 and Esrrb. 
 
 In addition to the above mentioned genes, other classes of protein-coding genes that were 
identified proximal to Sox2 binding include chromatin remodellers (Pcaf), phospholipases 
(Pla2g1b), phosphatases (Ppm1b), kinases (Stk38), cell surface receptors (Notch1) and cell 
adhesion molecules (Ncam2). Pathways which were implicated to involve Sox2 regulation 
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included cell proliferation (Mycn), apoptosis (Cradd), ubiquitination (Uble1a), FGF (Fgf1) and 
Wnt (Lef1) signalling pathways. Besides protein coding genes, Sox2 binding sites were also 
located proximally to genes encoding microRNAs (miRNAs) (Figure 5.5). 
 
5.2.4 Comparative location analyses of Sox2 and Oct4  
In Chapter 4, the ChIP-PET method was used to map the DNA binding sites of Oct4 in mESCs. 
Interestingly, many of Sox2 binding sites identified in this study are located near the Oct4 binding 
sites identified in Chapter 4. Among the genes which had DNA regions demonstrating Oct4 and 
Sox2 binding are Rest, Mycn, Oct4, Sox2 and Esrrb (Figure 5.6). 
 
5.3 Discussion 
In this study, 1133 high-affinity Sox2 binding sites (PET4+) were identified in the mESC genome. 
This is likely an under-representation of all Sox2 binding sites in ESCs as there might be false 
negative targets that have been omitted amidst the noise in overlaps of 2 or 3 PETs. An example of 
a true target in this lower range of PET overlaps is Nanog, a known Sox2 binding target (Chapter 
3; Rodda et al., 2005) that is represented by a 3 PET overlap in this study. Nonetheless, this 
expanded list of Sox2 binding sites represented a more than 100-fold expansion of the previously 
known targets of Sox2. This expanded list would be a good starting point to elucidate the 
mechanism of Sox2 action in its role in maintaining the pluripotent cell.  
 
The distribution of Sox2 binding sites showed a preference for proximity to genes with a 
substantial number of these sites falling within 20 kb of a known gene. The actual number of 
Sox2-bound genes may be even higher as many more genes would be identified upon the 
completion of the fully annotated mouse genome. Although the 5’ proximal regions of many genes 
are enriched for Sox2 binding, there were more Sox2 binding sites within intragenic regions of 
genes. However, not all Sox2 binding sites are located proximally to genes, as some of them were 
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also found to be greater than 100 kb away from the nearest gene (gene desert). This suggests that a 
cis-regulatory module associating with Sox2 can function over large linear genomic distances to 
regulate gene expression.  
 
In addition, a subset of the Sox2 binding sites was found proximal to genes of unknown 
function. An example of such a gene is 1700019D03Rik (PET cluster ID chr1.53325798). Indeed, 
there were 5 and 9 PET sequence overlaps in Sox2 and Oct4 PET clusters, respectively within the 
1 kb proximal promoter region of this full-length transcript. Such associations between these 
transcription factor binding sites on genes of unknown function should aid in the functional 
characterizations of these genes. These associations as well as those binding sites associated with 
gene deserts highlight the advantage of using a global approach for transcription factor binding site 
discovery. 
 
Besides Oct4, Sox2 and Nanog, FoxD3 which encodes another transcription factor 
essential in the maintenance of the pluripotent phenotype in ESCs, was also found to have a Sox2 
binding site with PET4 located at the 5’ region (Hanna et al., 2002). This indicates that Sox2 is 
involved in the regulation of these transcription factors. In addition, a large cohort of Sox2-
associated genes has been implicated in many ESC functions such as self-renewal and 
pluripotency. These include those in the Wnt/β-catenin/Tcf signalling pathway (eg. Lef1, Tcf3, 
Tcf7, and Ctnnbl1) (Reya and Clevers, 2005). In addition, several genes associated with Sox2 
binding have been established to be functionally important in early development (i.e. in the egg 
cylinder) and include those that have a role in pattern formation (Nodal, Lefty1, Lefty2) and 
members of the fragilis family (Ifitm1, Ifitm2, Ifitm6, and Ifitm7) which are thought to be involved 
in germ cell specification (Saitou et al., 2002).  
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Sox2 was also shown to bind genes encoding for miRNAs. Studies have indicated that 
miRNAs have important roles in gene regulation as more than a third of mammalian protein-
encoding genes are conserved miRNA targets (Bartel, 2004; Lewis et al., 2005). Moreover, ESCs 
that lack the machinery that processes miRNA transcripts are unable to differentiate 
(Kanellopoulou et al., 2005).  
 
  Sox2 binding was identified at genes that play important roles in cell cycle and 
proliferation. A PET7 Sox2 binding site located 2 kb 5’ to Mycn was identified in this study. Mycn 
is functionally equivalent to Myc in ESCs which possesses a proliferative function (Malynn et al., 
2000). In addition, a binding site located 592 bp 5’ to Rif1 was identified as one of the most highly 
represented Sox2 binding loci (PET16). Oct4 was also previously found to associate highly with 
this gene, with an Oct4 PET overlap of 17. Rif1 has been implicated in the DNA damage response 
at the intra S-phase checkpoint (Silverman et al., 2004). Other Sox2-associated genes involved in 
maintaining DNA integrity either through DNA repair or cell cycle control included Msh6, Pms1, 
Xpa, Gadd45g, Cdc37l1, Ches1, Cdk6, Syk38, and Terf1. Terf1 has been shown to be essential for 
development beyond the peri-implantation stage (Karlseder et al., 2003). Earlier data had singled 
out Trp53 and Trp53bp1 as Oct4 target genes. Together, this indicates that Sox2 and Oct4 are 
involved in DNA-damage response ensuring only DNA of high integrity is passed on from the 
pluripotent cells to the somatic cell lineages and to the next generation. 
 
As with Oct4, several Sox2 targets have been identified to be involved in the regulation of 
ESC differentiation and commitment. One example is the Rest transcriptional repressor that acts at 
the terminal stage of the neuronal differentiation pathway and blocks the transcription of several 
differentiation genes. Ballas and coworkers (2005) demonstrated that regulation of the Rest 
transcriptional repressor plays a fundamental role in the progression of pluripotent cells to lineage-
restricted neural progenitors. Sox2 (PET14) and Oct4 (PET5) were found to bind within a 100 bp 
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of each other at a genomic region located 3.1 kb 5’ to Rest. In addition, Oct4 and Sox2 also bind to 
the Rest corepressor Rcor2. 
 
Sox2 binding was also identified on genes encoding chromatin remodeling factors such as 
PCAF, Ehmt1, Phc1 and Nsd1. p300/CBP-associating factor (PCAF), a ligand-dependent 
coactivator, belongs to the histone acetyltransferase (HAT) group of enzymes that are critical in 
the regulation of chromatin structure and gene expression (Santos-Rosa et al., 2003). The 
polyhomeotic-like 1 (Phc1)/Rae28-like protein helps in maintaining transcription states upon 
initiation by generating heritable higher-order chromatin structures. Less is known of the 
euchromatic histone methyltransferase 1 (Ehmt1) but it has been suggested to play a role in 
histone modification (Okazaki et al., 2002). Nsd1 has been found to be essential for early post-
implantation development and possesses intrinsic methyltransferase activity (Rayasam et al., 
2003). Thus, Sox2 is implicated in the control of numerous proteins involved in chromatin 
remodeling. 
 
 From this study, it is evident that many of the Sox2 binding sites co-localise with those of 
Oct4, which was previously described in Chapter 4. It will be noteworthy to examine the extent in 
which Sox2 interacts with Oct4 on DNA in ESCs and to characterize the Oct4 and Sox2 binding 











Figure 5.1: Determination of PET cluster size as Sox2 bona fide binding sites. Sox2 ChIP-qPCR enrichment at randomly selected regions containing 













Figure 5.2: Validation of Sox2 binding profiles at the Oct4 (Pou5f1) upstream regulatory regions. 
(A) An image capturing the T2G browser showing PET clusters at Oct4. Each horizontal green 
line represents a DNA fragment mapped to the genome. TFBS density (coloured in brown) shows 
the profile of the transcription factor binding and is based on the number of overlaps of the DNA 
fragments. (B) Conventional ChIP-qPCR was carried out using Oct4 gene primers to confirm the 
Sox2 binding sites shown by the ChIP-PET analysis. The locations of the amplified products of the 
primer sets used to detect the ChIP-enriched fragments are shown in the context of the genomic 
structure of Oct4. Fold enrichment is the relative abundance of DNA fragments at the regions 













Figure 5.3: Sox2 binding on Sox2 and Nanog from the ChIP-PET data. Images from the T2G 



































Figure 5.4: Annotation of Sox2 binding sites in relation to genomic locations. (A) Schematic 
diagram illustrating the definition of the location of a binding site in relation to a transcription unit. 
5’ distal, 5’ proximal, 3’ proximal and 3’ distal regions are depicted within 100kb upstream and 
100kb downstream of the transcriptional unit. (B) Locations of Sox2 binding sites relative to the 















Figure 5.5: Binding of Sox2 on microRNA genes. Sox2 ChIP-PET data for (A) miR124a, (B) 
miR128b, (C) miR153 are shown. Vertical arrow represents Sox2 binding loci and diagonal arrow 
represents the position of the microRNA.  
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A    Sox2 and Oct4 binding profiles at Rest 











B             Sox2 and Oct4 binding profiles at Mycn 



























E       Sox2 and Oct4 binding profiles on Esrrb 
chr12:81,786,235-81,858,459 (72,225 bp) 
 
Figure 5.6: Sox2 and Oct4 ChIP-PET binding profiles at (A) Rest and (B) Mycn (C) Oct4, (D) 
Sox2 and (E) Esrrb. 
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CHAPTER 6 
Analyses of the Combined Oct4 and Sox2 DNA Binding Sites 
 
6.1 Introduction 
Oct and Sox proteins have been shown to selectively interact with each other and bind to DNA via 
their conserved domains, POU and HMG, respectively (Herr and Cleary, 1995; Wegner, 1999). 
Their functional partnership on regulatory elements have been shown to exist in several species 
including that of the human and mouse (Dailey and Basilico, 2001; Kuhlbrodt et al., 1998). 
Moreover, during early development and in ESC lines, Oct4 and Sox2 genes are co-expressed and 
their combinatorial function is critical in specifying the first three lineages in the mammalian 
embryo (Avilion et al., 2003; Nichols et al., 1998; Niwa et al., 2000).  
 
The synergistic partnership between Oct4 and Sox2 on DNA has been demonstrated on 
Fgf4 (Ambrosetti et al., 1997; Yuan et al., 1995), Nanog (Kuroda et al., 2005; Rodda et al., 2005), 
Oct4 (Chew et al., 2005) and Sox2 (Chew et al. 2005) gene loci. In addition, Oct4 and Sox2 
elements have been found in the enhancers of Opn (Botquin et al., 1998), Utf1 (Nishimoto et al., 
1999) and Lefty1 (Nakatake et al., 2006). The data from the ChIP-PET study described in Chapters 
4 & 5 has also facilitated the recent characterisation of two composite sox-oct binding sites within 
the first intron of Zfp206 where Oct4 and Sox2 are involved in activating its transcription in a 
synergistic manner (Wang et al., 2007). With the use of homology modelling tools to analyze the 
crystal structure of Oct1-Sox2/Fgf4 ternary protein-enhancer complex, Remenyi et al. (2003) 
derived a structural model of the Oct4-Sox2 heterodimer interaction on the Fgf4 and Utf1 
enhancers. The specific assemblies of these factors are reported to rely on the cis-regulatory 
elements on the DNA (Remenyi et al., 2003). 
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In this study, a significant number of the same genes were found in the Oct4 and Sox2 
ChIP-PET datasets, indicating that Oct4 and Sox2 may target genomic sites through a joint cis 
element. Here, the approach taken was to merge both sets of Oct4 and Sox2 binding site data in 
order to obtain a list of genes that possess both Oct4 and Sox2 binding sites. A selection of 
overlapping genes was then experimentally verified for co-occupancy of Oct4 and Sox2. 
Subsequently, sequences from the Oct4 and Sox2 bona fide DNA binding sites were search for the 
presence of Oct4 and Sox2 DNA binding motifs. The DNA motifs were then characterised for 
specificity in conferring Oct4 and Sox2 DNA binding ability and in providing functional activity 




6.2.1 Oct4 and Sox2 co-occupy shared binding sites 
 
6.2.1.1 Comparative location analyses of Oct4 and Sox2 
The Oct4 and Sox2 ChIP-PET datasets were used to investigate the relationship between Sox2 and 
Oct4 occupancies on a global scale in mESCs (Chapters 4 & 5). A list of genes (based on known, 
Refseq and MGC) associated with Sox2 and/or Oct4 PET4+ clusters and within 50 kb upstream 
and downstream of the transcription start site was generated by a bioinformatics colleague, 
Vinsensius Vega. While Oct4 and Sox2 were predicted to bind to genes independently of each 
other (540 genes for Oct4, 508 genes for Sox2), a significant proportion of the genes 
(approximately 30% or 242 genes of Oct4-associated and Sox2-associated genes) were also 
predicted to be bound by both Oct4 and Sox2 (Figure 6.1). These included Rest, Dido1, Phc1, Id3, 
Mycn, Tcf3, Esrrb, Otx2, Lefty1, Rif1, as well as Sox2, Oct4, and Nanog. Although the 
bioinformatic search showed that Oct4 and Sox2 may bind to the same genes, further verifications 
are needed to show that they bind to cis elements in close proximity with one another. This is 
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because Oct4 and Sox2 may be binding individually at the same gene loci but on different DNA 
molecules or different populations of cells.  
 
6.2.1.2 Oct4 and Sox2 co-occupy on the same DNA molecules  
Six genes were selected from the 242 genes possessing both Oct4 and Sox2 binding sites in Figure 
6.1 to test for Oct4 and Sox2 co-occupancy. A two-step ChIP (termed sequential ChIP; seqChIP) 
was used to pull down DNA fragments (approximately 500 bp) bound by both Oct4 and Sox2. 
Crosslinked chromatin extracts were first immunoprecipitated with either the Oct4 or Sox2 
antibody. Recovered material from this first ChIP was then subjected to a second ChIP using the 
other antibody (Figure 6.2A). Subsequently, qPCR using primers amplifying 150-250 bp products 
specific to binding sites on selected genes in the Oct4 and Sox2 overlap data were carried out to 
measure ChIP fold enrichments. Significant enrichment after the second ChIP was indicative of 
Oct4 and Sox2 co-occupancy. 
 
Oct4 or Sox2 binding was still detectable after this first round of ChIP, although 
enrichment was reduced due to the process of crosslinking of the antibody to the protein G 
sepharose using dimethyl pimelimidate (DMP). The fold enrichments after the 2nd ChIP (Oct4 
followed by Sox2 and vice versa) were significantly higher than Oct4 or Sox2 single ChIPs and 
control ChIPs using a non-specific antibody (Ena-1) (Figure 6.2B). This demonstrates that Oct4 
and Sox2 co-occupy the same DNA molecules of Oct4, Sox2, Nanog, Tcf3, Trp53 and Mycn in 
very close proximity to each other. 
 
6.2.2 Regulation of target genes by Oct4 and Sox2 
Selected gene loci that were co-bound by Oct4 and Sox2 were shown to be active in mESCs by the 
presence of histone 3 trimethylated lysine 4 (H3K4Me3) marks which denote active regions of the 
chromosome. To examine genes that are bound by both Oct4 and Sox2, seqChIP using Oct4 
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followed by Sox2 antibodies were carried out. Oct4-Sox2 sequential ChIP and GST mock ChIP 
DNA were amplified, labelled with Cy dyes, and hybridised onto NimbleGen gene microarrays 
designed by Dr Ng Huck Hui. The chips (25 x 75 mm each) contain 50-mer probes (50 bp apart) 
spanning about 600 genes represented by 385000 features (16 μm x 16 μm) in an array size of 
17.4 mm x 13 mm. The same procedure was repeated using the H3K4Me3 ChIP DNA and mock 
ChIP DNA.  
 
SeqChIP-on-chip data showed that Oct4 and Sox2 co-occupy Oct4, Sox2, Nanog, Tcf3, 
Mycn, Trp53, Rest and Tcf7 (Figure 6.3, blue peaks) while mock ChIP-on-chip did not show any 
peaks at these regions (Appendix F). These ChIP-on-chip results confirm the seqChIP-qPCR 
results in section 6.2.1. In addition, the seqChIP-on-chip results showed that Oct4 and Sox2 co-
occupy at the 5’ and 3’ enhancer regions of Sox2 as well as both the promoter and 5’ enhancer 
region of Nanog demonstrating the sensitivity of using sequential ChIP coupled to microarray. 
Moreover, these genes are also bound by H3K4Me3 at the 5’ or throughout the transcribed regions 
(Figure 6.3, green peaks), indicating that the bound genes are active. In contrast, Oct4-Sox2 and 
H3K4Me3 did not show occupancy on Hoxa9 and Hoxa10, which are part of the repressed Hox 
cluster genes in ESCs. H3K4Me3 and Oct4-Sox2 binding do not always occur together. One 
example is the binding on the Sox15 loci. Sox15 was reported to be expressed in mESCs but is not 
essential for ESC self-renewal (Maruyama et al., 2005). Concurringly, H3K4Me3 peaks were 
detected on the Sox15 loci. However, Oct4-Sox2 binding was not detected, suggesting that Sox15 
is not a downstream target of Oct4 and Sox2.  
 
These data indicates that Oct4 and Sox2 regulate the genes that are bound. Gene activity 
increases when histone 3 lysine 4 (H3K4) is converted from a di- to a tri-methyl state (Santos-
Rosa et al., 2002). However, recent studies have suggested that both active as well as repressive 
chromatin marks may be closely juxtaposed at promoters of highly conserved genes in ESCs 
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(Bernstein et al., 2006), hence other methods of inferring regulation have been utilized. Firstly, 
MPSS data correlated with those of ChIP-PET binding as shown in the previous chapters as well 
as other studies have confirmed that these genes are highly expressed in undifferentiated mESCs 
(Pritsker et al., 2006). Moreover, RNAi-mediated depletion of Oct4 or Sox2 was found to also 
perturb the expression of these genes (Loh et al., 2006 & Loh et al. unpublished data).  These data 
collectively suggest that Oct4 and Sox2 DNA binding may be important for gene regulation in 
mESCs. The next step was to identify and characterize the cis elements that determine the binding 
of both Oct4 and Sox2. 
 
6.2.3 Identification of the joint Sox2-Oct4 DNA binding motif 
To look for consensus sequences that may be present in the Oct4 and Sox2 bound genes, DNA 
sequences of enriched regions on selected genes were aligned using the VectorNTI multiple 
sequence alignment tool together with previously identified elements from Oct4, Sox2, Nanog, 
Utf1 and Fbx15. A 15 nucleotide consensus sequence CATTGTTATGCAAAT, which resembles 
the Sox2 and Oct4 motif joint in tandem, was identified (Figure 6.3A, Chew et al., 2005).  
 
Subsequently, a comprehensive motif search was carried out by our collaborator, 
Vinsensius Vega, using the de novo motif discovery algorithms Weeder (Dempster et al., 1977; 
Pavesi et al., 2004). Sequences from PET7+ clusters of the Oct4 and Sox2 ChIP-PET datasets 
(total of 90 Oct4 and 191 Sox2 clusters) were extracted and their repeat regions (as annotated by 
the USCS mm5 mouse genome browser) were masked. The CATTGTTATGCAAAT sequence 
was the predominant motif found in both the Oct4 and Sox2 datasets (Figure 6.3B). This motif is 
similar to the Sox2-Oct4 composite consensus element derived earlier (Figure 6.3A). 69% of 
PET6+ Oct4 binding loci and 62% of PET9+ Sox2 binding loci contained this motif, indicating 
that Sox2 and Oct4 may act together as a complex in the mESC genome.  
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6.2.4 Characterization of the Sox2-Oct4 DNA binding motif 
ChIP-qPCR, ChIP-PET and ChIP-on-chip experiments can only identify DNA binding regions of 
about 100-300 bp. Therefore, in order to investigate the specificity of the 15 nucleotide Sox2-Oct4 
joint motif and to examine its functionality in conferring binding and activity, selected motifs from 
the ChIP-PET datasets were characterized using a series of EMSA and luciferase reporter assays.  
 
6.2.4.1 Interactions of Sox2 and Oct4 with the Sox2-Oct4 joint motifs 
 
6.2.4.1.1 Sox2 and Oct4 bind to the Sox2-Oct4 DNA motif in vitro  
Transcription factors are capable of binding to a basic consensus sequence of various 
permutations. EMSA relies on the ability of a protein to bind to a DNA probe in vitro, followed by 
electrophoretic separation of DNA-protein complexes from the unbound DNA (free probes) on 
non-denaturing polyacrylamide gels.  
 
To test whether Sox2 and Oct4 proteins bind to the Sox2-Oct4 joint element, EMSA was 
carried out using Sox2-Oct4 motifs found at Ebf1, Rest, Rif1 and Tcf7 loci. A 33 bp biotin-labelled 
double-stranded DNA containing the 15 nucleotide composite Sox2-Oct4 elements and 18 
nucleotide flanking sequences (Figure 6.5A) was incubated with Sox2 or Oct4 over-expressed 
protein from HEK293T cells that do not express endogenous Oct4 and Sox2. When the Oct4 
protein was incubated with the probes, a single Oct4/DNA complex was detected (Figure 6.5B, 
lane 2). This complex was supershifted (retardation in mobility) upon addition of anti-Oct4 
antibody (Figure 6.5B, lane3). Anti-Sox2 and anti-JunB (control) antibodies did not affect the 
mobility of the complex (Figure 6.5B, lane 4 & 5). This demonstrates that Oct4 binds to the 
dsDNA probe. Similar observations were noted when Sox2 protein was added to the probe, 
demonstrating that Sox2 also binds to the same dsDNA probe (Figure 6.5B, lanes 6-9). Control 
lysates from HEK293T cells transfected with the vector alone did not form any specific complex 
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with the DNA probes (Figure 6.5B, lanes 10-13). For all the probes, except Rif1, the anti-Sox2 
supershifted complex showed weaker bands than that formed by the anti-Oct4 antibody, 
suggesting that the Sox2 antibody may have interfered with the protein-DNA interaction. 
 
The Ebf1 probe, which contains the exact consensus sequence, was also used to test for 
binding with native proteins extracted from the nuclei of mESCs (nuclear extract). A major 
complex between the probe and native proteins was detected as shown in Figure 6.6, lane 2. The 
addition of anti-Oct4 or -Sox2 antibodies led to a supershift of this complex (Figure 6.6, lanes 3 & 
4). Conversely, the control anti-JunB antibody did not affect the mobility of this complex. 
Therefore, this indicated that the DNA probe was bound specifically by endogenous Oct4 and 
Sox2. The addition of a 200-fold excess unlabelled probe successfully competed for binding to the 
Sox2/Oct4 complex (Figure 6.6, lane 6), while addition of an unrelated probe had no effect (Figure 
6.6, lane 7). When an excess of unlabelled probe was added, the DNA binding protein will bind to 
both the unlabelled probe and biotin-probe, resulting in a decrease in the amount of factor 
available for binding to the probe by competition from the unlabelled site, and subsequent 
reduction in the intensity of the retarded band. When an unrelated probe was used, there was no 
difference in the intensity of the retarded band because the competing probe is unable to bind to 
the factor.  
 
Thus, in vitro, Oct4 and Sox2 have been demonstrated to bind specifically to the Sox2-
Oct4 joint motifs of these targets as a ternary complex.  
 
6.2.4.1.2 Mutations of Sox2 and Oct4 DNA motif sequences abolished binding  
Subsequently, the importance of each DNA sequence within the Sox2-Oct4 element in mediating 
the formation of the DNA-protein complex was examined. EMSA was carried out using the wild-
type Rest probe and Rest probes containing mutations within the Sox2 and Oct4 elements (Figure 
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6.7A). Mutations within the Oct4 element prevented the formation of the Oct4-DNA complex, 
indicating that these sequences are crucial for Oct4 binding. Mutations within the Sox2 element 
also abolished the formation of the Sox2-DNA complex, except for mutation E at the 7th position 
(Figure 6.7B), which is the last nucleotide of the Sox2 element. Instead, more Sox2-DNA complex 
was formed when wild type G was mutated to A at that position. Upon inspection of the consensus 
motif matrix generated from the ChIP-PET datasets (Figure 6.7C), the 7th position of the consensus 
motif contained nucleotides T and A (square box in Figure 6.7C). This showed that changing the 
consensus sequence from G to A increased the efficiency of forming the Sox2-DNA complex, 
further validating the joint Sox2-Oct4 consensus motif. However, it does not rule out the 
possibility that the 7th position may be dispensable for Sox2 (or Oct4) binding. Nonetheless, these 
results indicate that all but one of the sequences in the motif is crucial for Oct4 or Sox2 binding 
and that Oct4 and Sox2 are capable of binding on this element in vitro.     
 
6.2.4.1.3 Sequences flanking the Sox2-Oct4 DNA motif are not essential for binding 
Mutation of the motif sequences investigates the requirement of the particular sequence in the 
formation of DNA-protein complex. However, differences in the sequence of flanking DNA 
outside the core consensus binding site may also affect binding of the protein onto DNA. To 
examine whether the flanking sequences of the Sox2-Oct4 motifs affect Sox2 and Oct4 binding, 
EMSA was carried out using dsDNA probes containing the joint motifs with mutations in the 
flanking sequences (Figure 6.8A). All of the probes carrying flanking sequence mutations could 
form Oct4/DNA and Sox2/DNA complexes (Figure 6.8B). This demonstrates that the flanking 






6.2.4.2 The Sox2-Oct4 joint motif sequences are functional 
 
6.2.4.2.1 The Sox2-Oct4 motifs confer reporter activities which are Oct4 and Sox2-dependent 
To study the role of these specific sequence elements in the activation of pluripotent cell 
transcription, Sox2-Oct4 DNA motifs from Ebf1, Tcf7, Rest and Rif1 were cloned in three tandem 
repeats upstream of the pGL3-Oct4 pp vector (Wu et al. 2006) which contains the ESC-specific 
Oct4 proximal promoter upstream of the luciferase gene (pGL3-3x element-Oct4pp, Figure 
6.10A). The constructs were then transfected into mESC and assayed for luciferase activity after 3 
days. All the four Sox2-Oct4 elements caused a two to seven-fold increase in reporter activity 
compared to the empty pGL3-Oct4 pp vector control, indicating that the presence of the joint DNA 
motifs can augment the activity of the Oct4 promoter in driving the expression of the luciferase 
gene in mESCs (Figure 6.9B). The luciferase reporter assay was also carried out using only one 
copy of each motif. Luciferase activity was measured to be two-fold above that of the empty 
pGL3-Oct4 pp vector (data not shown). However, this is less compared to that which was 
observed when the motifs were present in three tandem repeats. The proportional increase in 
activity observed with increasing number of copies of motifs indicated that the activity measured 
was specific, i.e. luciferase activity is induced by the presence of the DNA motifs. The Sox2-Oct4 
DNA motifs are therefore functional. 
 
To further evaluate whether the activity conferred by the motifs were caused by the 
presence (and therefore binding as shown by EMSA) of Oct4 and Sox2 proteins, mESCs were co-
transfected with pGL3-3x element-Oct4pp plasmids together with Oct4 or Sox2 RNAi plasmids. In 
the cells, Oct4 and Sox2 shRNAs mediate depletion of endogenous Oct4 and Sox2, respectively. 
The specificity of these shRNAs has been previously confirmed (Chew et al., 2005), showing that 
the Oct4 and Sox2 shRNA specifically depletes the transcript and protein levels (also shown in 
Chapter 7) of Oct4 and Sox2, respectively. The constructs were transfected into mESC and after 
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12 hr, the cells were cultured in media containing puromycin for two additional days before 
assaying for luciferase activity. The use of puromycin was to selectively remove non-transfected 
mESCs. All the non-transfected cells (control) were killed after 2 days of puromycin selection. 
Activities of all the four reporter plasmids carrying the joint motifs were reduced upon Oct4 and 
Sox2 knockdown (Figure 6.9B). Oct4 RNAi significantly reduced reporter activities to almost 
basal levels, whereas Sox2 RNAi reduced reporter activities by approximately 20% (Ebf1) to 60% 
(Rif1), suggesting that the activities conferred by the motifs were dependent on Oct4 and Sox2 
proteins.   
 
The cells were harvested for luciferase activity at a relatively short time to reduce the 
indirect effects caused by differentiation. This is because silencing of Oct4 or Sox2 lead to 
differentiation of mESCs that will subsequently cause endogenous Oct4 and Sox2 levels to 
decrease. In addition, the effects of RNAi on the reporters may also constitute indirect effects as 
Oct4 and Sox2 reciprocally regulate each other, and thus the depletion of one factor may deplete 
the other. These are inherent disadvantages of the RNAi approach. However, since the specificity 
of the shRNAs was confirmed, the reporter activities conferred by the motifs are at least dependent 
on the presence of the Oct4 and Sox2 proteins. Moreover, since Oct4 and Sox2 have been shown 
to bind to these Sox2-Oct4 joint motifs by both EMSA and ChIP, the results indicate that the 
functionality of the DNA elements is dependent on Oct4 and Sox2.  
 
6.2.4.2.2 The orientation of the Sox2-Oct4 DNA motif is important in conferring reporter 
activity 
To test whether the orientation of the Sox2-Oct4 motif is important, the order of the Sox2 and 
Oct4 elements were swapped and tested for reporter activity. Oligos containing Oct4-Sox2 
(instead of Sox2-Oct4) motifs were cloned into the pGL3-Oct4 pp in three tandem repeats and 
transfected into mESCs for luciferase reporter assay. The Oct4-Sox2 motifs showed a significantly 
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lower reporter activity compared to the original Sox2-Oct4 motif (Figure 6.10). This implies that 
the binding of Sox2 and Oct4 on their respective consensus motifs may be context-dependent or 
that the Sox2-Oct4 motif configuration is entailed by the heterodimer structure of the Sox2-Oct4 
protein complex in mESCs. Therefore, these results indicate that the Sox2-Oct4 joint motif has to 
be in this particular orientation to be functional.  
 
6.3 Discussion 
Merging of the Oct4- and Sox2-associated genes (50 kb downstream to 50 kb upstream) obtained 
from individual ChIP-PET datasets revealed a core set of 242 candidate genes that are bound by 
both Oct4 and Sox2. Sequential ChIP-qPCR carried out on selected loci showed that Oct4 and 
Sox2 indeed co-occupied the same DNA molecule at close proximity. This suggests that Oct4 and 
Sox2 work in tandem to regulate gene expression of a majority of their target genes. However, 
there are still exceptions where some Oct4 and Sox2 binding sites uncovered by ChIP-PET did not 
contain any Sox2-Oct4 motif. This may be due to indirect Oct4 or Sox2 recruitment to genomic 
DNA independent of sequence-specific DNA recognition or indirect binding through a protein 
complex loop (further explained in Chapter 7). In addition, the Oct4 binding motif does not always 
exist joint to the Sox2 motif. Although the sox and oct elements in the enhancer regions of known 
targets Fgf4, Utf1, Oct4, Nanog, Fbx15, and Sox2 are <3 bp apart (Botquin et al. 1998; Catena et 
al., 2004; Dailey et al., 1994; Nishimoti et al., 1999; Tomioka et al., 2002; Tokuzawa et al., 2003; 
Yuan et al., 1995), a recent study found that oct and sox elements in Zfp206 are separated by 11 
bp (Wang et al., 2007). 
 
Subsequently, ChIP-on-chip using Oct4-Sox2 sequential ChIP also demonstrated that Oct4 
and Sox2 co-occupy the same location on many genes. In addition, the ChIP-on-chip approach 
could detect Oct4/Sox2 co-bound sites that were not previously detected using the ChIP-PET 
method, such as Myc, Jarid2 and Sgk, which were found in one library but not the other. This is 
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because ChIP-on-chip is a more sensitive method that can detect as low as 2-fold ChIP enrichment 
(NimbleGen), while many targets may be missed out using the ChIP-PET approach due to low 
ChIP enrichment or insufficient sequencing of PETs. Therefore, the ChIP-on-chip approach was 
used as a complementary approach to further examine the Oct4-Sox2 co-occupancy. The Oct4 and 
Sox2 co-occupied targets identified using ChIP-PET and ChIP-on-chip included those that are 
important in the maintenance of pluripotency (eg. Zic3, Oct4, Nanog, Sox2), cell cycle regulation 
(eg. Trp53, Rif1, Myc) and transcriptional regulation (eg. Esrrb). Furthermore, many of these 
target genes are transcriptionally active as indicated by H3K4Me3 marks shown by H3K4Me3 
ChIP-on-chip on selected gene loci. The wide range of Oct4 and Sox2 targets, which are crucial 
for cell maintenance and survival, further implicates them as key factors of the ESC transcriptional 
regulatory network.   
  
The ChIP-PET method provides a resolution of binding site location of approximately 100 
bp (based on the Oct4 and Sox2 PET cluster sizes), thus allowing the use of de novo discovery 
algorithms to identify specific cis-elements enriched in the ChIP fragments. Both multiple 
alignment of selected binding site sequences and computerised de novo motif discovery from both 
ChIP-PET datasets identified a predominant 15 nucleotide consensus sequence, 
CATTGTTATGCAAAT. This sequence contains the Sox binding site motif, CATTGTT, followed 
immediately by the Oct binding motif, ATGCAAAT. Since this consensus motif does not contain 
any spacing between the Sox and Oct elements, it is postulated that there may be many more 
permutations of sox-oct binding sites present such as the sox-oct binding site with 3 bp separation 
found in Fgf4. The identification of a high frequency of Sox2-Oct4 joint motif in the genome from 
both the Oct4 and Sox2 ChIP-PET datasets, in addition to the sequential ChIP evidence, suggest 
that one of the main mechanisms for targeting Oct4 and Sox2 to their genomic sites is through the 
Sox2-Oct4 motif via a cooperative interaction between Oct4 and Sox2.  
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In vitro characterisation by EMSA and reporter assay also verified that the 
computationally-derived Sox2-Oct4 joint motif was bound by both Sox2 and Oct4. Moreover, the 
motif was found to be specific and transcriptionally functional. These results corroborated with 
previous studies showing that maximal transcriptional activity of the Oct4 promoter in mESCs 
requires the cooperative binding of both Oct4 and Sox2 to the composite joint element (Chew et 
al., 2005). The joint motif may enable Oct4 and Sox2 to interact with each other while binding 
onto DNA. The DNA-binding domains of these transcriptional regulators may play a key role in 
gene regulation by tethering activation domains and coordinating the assembly of the factors on 




























































Figure 6.1: Venn diagram indicating the extent of overlap between genes associated with Sox2 and 
Oct4 binding in mESCs. Common targets (overlap) between Oct4 and Sox2-bound genes covered 
50 kb upstream to 50 kb downstream of each gene. *Significant at Binomial Test with p-value < 
































































Figure 6.2: Co-occupancy of Oct4 and Sox2 on target sites. (A) Schematic diagram illustrating 
Oct4 and Sox2 co-occupancy as carried out in sequential ChIP. First ChIP using Oct4 antibody 
will purify for fragments bound by Oct4, as well as non-specific DNA. A second ChIP using the 
Sox2 antibody will further purify the pool of DNA to yield DNA fragments bound by both Oct4 as 
well as Sox2. Sequential ChIP using (B) Oct4 antibody followed by Sox2 antibody and (C) Sox2 
antibody followed by Oct4 antibody. Fold enrichment represents the abundance of enriched DNA 
fragments over a control region not enriched for the respective targets. O: Oct4 ChIP, C: control 
Ena-1 ChIP, S: Sox2 ChIP, OS: Oct4 ChIP followed by Sox2 ChIP, OC: Oct4 ChIP followed by 
control Ena-1 ChIP, SO: Sox2 ChIP followed by Oct4 ChIP, SC: Sox2 ChIP followed by control 
Ena-1 ChIP. Standard deviations representing technical replicates are shown. 
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Figure 6.3: ChIP-on-chip data showing occupancy of Oct4 and Sox2 on genes marked by 
H3K4Me3. Oct4-sox2 sequential ChIP (seqChIP) and H3K4Me3 ChIP were carried out and 
hybridised on Nimblegen customised DNA ChIP. NimbleGen ChIP-on-chip arrays are run as two 
colour experiments, one channel representing the experimental ChIP sample, the other 
representing the control non-specific GFP antibody ChIP sample. SignalMap readout showed 
peaks representing binding on Oct4, Sox2, Nanog, Tcf3, Mycn, Trp53, Rest, and Tcf7 loci. 
Negative controls are also shown. No Oct4-Sox2 and H3K4Me3 peaks were detected at the Hoxa9 
and Hoxa10 loci, while the Sox15 loci showed H3K4Me3 peaks but no Oct4-Sox2 peak. Y axis 
represents enrichment which is the ratio between the intensities of ChIP over control probe. 
Bottom track of every panel shows transcribed regions of genes, with blocks above the x axis (+) 
representing the sense strand, and blocks below the x axis (-) representing antisense strand. 
Replicates shown are on-chip technical replicates of probes separated into physically distinct 







































A             
               
Oct4  CTTTGTTATGCATCT 
Sox2  CATTGTGATGCATAT     
Nanog  CATTGTAATGCAAAA 
Utf1  CATTGTTATGCTAGT 
Fbx15  CATTGTTATGATAAA 
Zic3  CACTGTTTTGCAGAT 
Jarid2 CTGTATTGTGCAAAA 
Zfp57  CATTGAAATATTAGG 
Phc1  TATTGTTATGCAAAT 
Ctnnbl1 TATTGTCTCCTTGTT 
 
   Sox2    Oct4 














Figure 6.4: Identification of the 15 nucleotide Sox2-Oct4 joint consensus motif in the Oct4 and 
Sox2 ChIP-PET datasets. (A) The Sox2-Oct4 joint motifs were found by multiple alignment 
analysis of sequences from Oct4 and Sox2 binding sites on the Oct4, Sox2, Nanog, Utf1, Fbx15, 
Zic3, Jarid2, Zfp57, Phc1 and Ctnnbl1 loci. (B) De novo identification of Sox2-Oct4 consensus 


















             Sox2   Oct4 
Ebf1    5’-gcaacaccgCATTGTTATGCAAATtgttcctat-3’  
Rest   5’-agtccttcgTATTGTGATGCAAATaggccaatg-3’  
Rif1   5’-tttccaggcCTTTGTTATGCACGCcatgggtct-3’  









Figure 6.5: Binding of Oct4 and Sox2 overexpressed (OE) proteins on biotin-labelled DNA probes 
containing Oct4 and Sox2 binding sites using EMSA. (A) Sequences of corresponding probes 
containing the Sox2-Oct4 joint motifs. (B) Oct4 and Sox2 containing expression plasmids as well 
as an empty plasmid were transfected into HEK293T cells and the cell lysates were harvested. 
Specific anti-Oct4, anti-Sox2 and JunB (control) antibodies were used to obtain supershifts in 




















Figure 6.6: Endogenous native Oct4 and Sox2 bind to the composite Sox2-Oct4 joint motif of 











       Sox2    Oct4  
Rest WT  5’ agtccttcgTATTGTGATGCAAATaggccaatg 3’ 
Sox2 motif mutations: 
A  5’ agtccttcgTATaGTGATGCAAATaggccaatg 3’   
B  5’ agtccttcgTAaTGTGATGCAAATaggccaatg 3’   
C  5’ agtccttcgggTTGTGATGCAAATaggccaatg 3’   
D  5’ agtccttcgTATTtaGATGCAAATaggccaatg 3’   
E  5’ agtccttcgTATTGTaATGCAAATaggccaatg 3’   
Oct4 motif mutations: 
F  5’ agtccttcgTATTGTGATGCAAtaaggccaatg 3’   
G  5’ agtccttcgTATTGTGATGCttATaggccaatg 3’   
H  5’ agtccttcgTATTGTGATcgAAATaggccaatg 3’   
















Figure 6.7: Mutations within the Sox2-Oct4 element of Rest abolished the Sox2/Oct4-DNA 
complex. (A) Sequence of the Rest composite element and corresponding mutations (lower case 
and shaded) used in this study. (B) EMSA using 10 μg cell lysate containing Sox2 and Oct4 over-
expressed proteins from HEK293 cells with 3 ng wild type (WT) and corresponding probes with 
mutation. Control denotes 10 μg lysate from HEK293 cell transfected with vector control. EMSA 
with WT probe detected Sox2-DNA and Oct4/DNA complexes, while probes with Sox2 mutations 
A, B, C, D did not show the Sox2/DNA complex. EMSA with Sox2 mutation E detected both 
Sox2/DNA and Oct4/DNA complexes. EMSA with Oct4 mutations F, G, H, I detected low or no 
Oct4/DNA complex. (C) De novo motif discovery of the Sox2-Oct4 element from the Oct4 (left) 
and Sox2 (right) ChIP-PET data. The height of the alphabets represents frequency of sequence 





f-Ebf1  5’ gggggggggCATTGTTATGCAAATggggggggg 3’ 
f-Tcf7  5’ gggggggggTATTGTTATGCAAATggggggggg 3’ 
f-Rest  5’ gggggggggTATTGTGATGCAAATggggggggg 3’ 









Figure 6.8: Flanking sequences of the Sox2-Oct4 joint motif do not affect Sox2 or Oct4 binding. 
(A) DNA probes containing mutations (lower case and shaded) in the 9 bp flanking sequences at 
both sides of the Sox2-Oct4 motifs of Ebf1, Tcf7, Rest and Rif1. (B) EMSA using 10 μg cell lysate 
containing Sox2 and Oct4 over-expressed proteins in HEK293 cells with 3 ng wild type (WT) 
probe (shown here as an example is Ebf1) or Ebf1, Tcf7, Rest, Rif1 probes carrying mutation in the 
flanking sequences (represented with a prefix f-). Control denotes 10 μg lysate from HEK293 cell 
transfected with vector control. EMSA with WT probe and probes with flanking sequence 
mutation detected Sox2-DNA and Oct4-DNA complexes.  
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Figure 6.9: Increased reporter activity conferred by the Sox2-Oct4 elements. Three copies of 
Sox2-Oct4 elements were cloned upstream of the Oct4 promoter in the luciferase plasmid system 
(A) and transfected into mESCs.  Increased reporter activity in Sox2-Oct4 elements-containing 
plasmids compared to control is shown (B). The enhancer activities are reduced upon knockdown 








Figure 6.10: Swapping the orientation of Sox2-Oct4 motifs to Oct4-Sox2 abolished enhancer 





CHAPTER 7  
Discovery of Oct4 and Sox2 Collaborating Factors and Demonstrating a Link between 
Different Pathways in Mouse Embryonic Stem Cells 
 
7.1 Introduction  
Many questions regarding the mechanism of pluripotency remain unanswered, such as how are the 
transcriptional pathways of Oct4, Stat3 and Nanog regulated, and whether there is crosstalk 
between these pathways. Is there a link between the extrinsic signalling pathways and intrinsic 
transcription factors? This chapter attempts to answer these questions by utilizing the Oct4 and 
Sox2 binding site datasets obtained in Chapters 4 and 5.  
 
Nanog is an essential determinant of pluripotency that induces activation of ES state 
genes, represses visceral-parietal state genes, or both (Figure 7.1). Overexpression of Nanog in 
mESCs enables maintenance of pluripotency in the absence of LIF (Chambers et al., 2003), 
suggesting that Nanog may be a downstream target of the LIF signalling pathway. Oct4 is unable 
to prevent differentiation of mESCs upon LIF withdrawal. This implies that Oct4 and LIF 
probably activate two different pathways of gene activation, with the latter relying on Stat3 for 
downstream signalling. On the other hand, both LIF withdrawal and Oct4 up-regulation lead to the 
same pattern of ESC differentiation, suggesting that there may be crosstalk between the two 
pathways (Niwa et al., 2000) (Figure 7.1). Niwa et al. (2001) proposed that increase in Oct4 
expression or LIF withdrawal induces downregulation of a group of genes either by squelching of 
the co-activators lying downstream of the Stat3 pathway or by downregulation of a Stat3-induced 
transcriptional programme, which results in a differentiation into the mesoderm-endoderm lineage. 
Stat3 is hypothesized to either activate ESC state genes, to suppress endodermal-mesodermal 
genes, or both. Activated Stat3 and subtle changes in Oct4 expression go hand in hand in the 
maintenance of a pluripotent ESC fate. In this model proposed by Niwa et al. (2001), Stat3 may 
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activate the expression of an Oct4 partner to maintain ESC self-renewal. This model is supported 
by the existence of the E1A-like activities postulated to exist in ESCs (La Thangue and Rigby, 





















Figure 7.1: Model of the integrated roles of Oct4, Nanog and LIF (Stat3) on embryonic stem cell 
fate specification, according to different Oct4 and Nanog levels. (Mes: mesoderm, PE: parietal 
endoderm, PrE: primitive endoderm, TE: trophectoderm, VE: visceral endoderm). Figure was 
adapted from Lanza (2004). 
 
 
Transcription factors are known to form multi-protein complexes on DNA, thereby 
orchestrating the precise temporal and spatial expression of specific genes. Therefore, Oct4 and 
Sox2 are likely to work in tandem with other co-factors in maintaining mESC pluripotency and 
self-renewal. To study these questions, a computational method was used to search for potential 
co-motifs that are present in the vicinity of Sox2-Oct4 overlapping binding sites. Two extrinsic 
signalling pathway proteins, Stat3 and Smad1, were identified as Oct4 and Sox2 collaborative 
factors by various methods: ChIP-qPCR, ChIP-on-chip, seqChIP, co-IP, RA induction of cell 
differentiation as well as RNAi-mediated depletion of Oct4 and Sox2. Subsequently, Stat3-
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depletion via ligand removal in a serum-free culture system was carried out to study the roles of 
Stat3 on the regulation of Oct4, Stat3 itself and Nanog. The collective results suggest a 
mechanistic model that links the Oct4, Stat3 and Nanog transcriptional pathways in governing 
pluripotency and self-renewal in mESCs.  
 
7.2 Results  
 
7.2.1 Stat3 and Smad1 as Oct4 and Sox2 collaborative factors 
 
7.2.1.1 Expansion of the combined Oct4 and Sox2 ChIP-PET binding data 
Previously, the Oct4 and Sox2 ChIP-PET datasets only included binding sites with clusters 
containing maximum overlap (mo) PET 4 and above as high confidence binding sites. This cutoff 
threshold was stringent and many true binding sites may have been omitted. Therefore, the Oct4 
and Sox2 ChIP-PET datasets were expanded to include moPET of 2 and 3, and were subsequently 
merged to obtain the dataset of Oct4/Sox2 overlapping binding sites with the help of our 
Bioinformatics colleague, Vinsensius Vega. A total of 37625 PET clusters contained 2 or more 
Oct4 moPETs, 16794 clusters contained 2 or more Sox2 moPETs and 1507 clusters contained both 
Oct4 and Sox2 overlapping moPETs (Figure 7.2). These 1507 clusters represent binding sites 
shared by both Oct4 and Sox2.   
 
Several binding sites that contained low moPETs from the overlapping 1507 clusters were 
validated by ChIP-qPCR. As expected, many sites that contain low moPETs also tested positive 
for binding (Figure 7.3). For example, the cluster chr10.45045909 which contained two Oct4 and 
two Sox2 moPETs yielded good enrichment of 10-fold for Sox2 ChIP and 30-fold for Oct4 ChIP. 
The enriched bindings for both Oct4 and Sox2, including those with moPET2 in both datasets 
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provide confidence that these 1507 overlapping binding sites contain both Oct4 and Sox2 
bindings.    
 
7.2.1.2 Matching of binding site sequences against TRANSFAC database identified putative 
co-motifs 
To identify putative transcription factor partners for Oct4 and Sox2, masked sequences (sequences 
with masked repetitive sequences) from the 1507 overlapping clusters were matched against 
TRANSFAC matrices (motif sequences) by our Bioinformatics colleague, Vinsensius Vega. 
TRANFAC is a database containing more than 18000 transcription factor binding site matrices. 
500 bp sequences centered on the 1507 high-confidence Sox2-Oct4 binding regions were extracted 
and scanned for putative transcription factor binding matrices that were provided by TRANSFAC. 
This scan generated 67 matching matrices (p=0) representing putative motifs present in the Sox2-
Oct4 binding site loci (Table 7.1). From this list of putative Oct4 and Sox2 collaborative factors, it 
was interesting to find that two transcription factors, Stat3 and Smad1, which are activated by 
signalling pathways, may be working in collaboration with intrinsic factors Oct4 and Sox2.  
 
7.2.1.3 Co-localisation of Stat3 and Smad1 to Oct4 and Sox2 binding sites 
To examine whether Stat3 and Smad1 bind to DNA within the vicinity of Oct4-Sox2 binding sites, 
Stat3 and Smad1 ChIPs were carried out. Both protein G sepharose and Dynal magnetic beads 
were used to optimize Stat3 and Smad1 ChIPs. Protein G Dynal beads worked more efficiently in 
these ChIPs (data not shown) and were used throughout this study. Western blots using antibodies 
against Stat3 and Smad1 detected a band of the correct size (92 kDa and 56 kDa, respectively) in 






Stat3 and Smad1 ChIP DNA were hybridized onto Nimblegen customized DNA arrays designed 
by Dr Ng Huck Hui based on mouse genomic sequences build mm5. The chips (25 x 75 mm each) 
contain 50-mer probes, 50 bp apart spanning the loci of 200 mESC genes, miRNAs and house 
keeping genes, 385000 features (16 μm x 16 μm) with an array size of 17.4 mm x 13 mm. The 
results were compared with that of Oct4-Sox2 sequential ChIP-on-chip. Results demonstrated that 
Oct4, Sox2, Stat3 and Smad1 bind to the same genomic regions on the Mycn and Sgk loci as 
shown by the ChIP-on chip results (Figure 7.5). ChIP-on-chip using a control antibody showed no 
peaks for these regions (Appendix F). 
   
7.2.1.5 Scanning ChIP-qPCR 
Subsequently, Stat3 and Smad1 ChIP-qPCR were carried out on loci containing Oct4 and Sox2 
binding sites in order to obtain a scanning profile of the respective binding. Six loci (Rest, Tbx3, 
Dido1, Mycn, Nanog and Sgk), which contained Oct4 and Sox2 binding sites as identified by 
ChIP-PET and ChIP-on-chIP, were selected. Stat3 and Smad1 were shown to bind to all these six 
Oct4 and Sox2 binding sites (Figure 7.6), with peaks corresponding to Oct4 and Sox2 binding 
peaks. All loci showed enrichment of more than 20-fold except for Stat3 binding on Tbx3 and 
Nanog, which showed lower enrichment. This may be due to a lower binding affinity. 
 
7.2.1.6 ChIP-qPCR of Oct4, Sox2, Stat3 and Smad1 on 25 loci 
Using primers that gave the highest ChIP enrichments (binding peaks), 25 gene loci were tested 
for Oct4, Sox2, Stat3 and Smad1 binding using ChIP-qPCR. A colour-coded heat map is shown in 
Figure 7.7, where the darker regions represent higher ChIP enrichments. Two independent 
antibodies for Stat3 (Stat3a,b) and Smad1 (Smad1a,b) were used in the ChIP assays. Stat3 ChIP 
showed positive enrichment on all loci bound by Oct4 and Sox2, while Smad1 showed enrichment 
for all with the exception of Etv1, Tulp4 and Zfp64.  
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Smad1 has been implicated in influencing the expression of Id genes (Ying et al., 2003) 
whereas Zfp57 and Myc have previously been identified as candidates of Stat3 targets (Akagi et 
al., 2005; Cartwright et al., 2005). This further validates the results here which included Id3 as a 
Smad1 binding target and Zfp57 as a Stat3 binding target. Control ChIPs using mock antibodies 
(GFP, cFos, NFκB, JunB) and the p53 antibody did not yield any significant enrichment for all the 
25 loci. Control genomic regions tested for binding of these factors (Test regions 1-5 and p21 loci) 
showed that Oct4, Sox2, Stat3 and Smad1 did not bind to these regions. p53 has been shown to be 
highly expressed in mESCs (Sabapathy et al., 1997). As p21 is a known target of p53, it was used 
as a positive control locus to ensure that the p53 ChIP worked.  
 
The genes associated with binding of all the four factors (Oct4, Sox2, Stat3 and Smad1) 
are involved in various functions including governing pluripotency, self-renewal, cell cycle and 
cell survival (Table 7.2). This suggests that Oct4 and Sox2 collaborate with Stat3 and Smad1 to 
maintain pluripotency and self-renewal of mESCs.  
 
When all these 25 loci were scanned for the presence of Stat3 and Smad1 motifs with the 
help of our Bioinformatics colleague Vinsensius Vega, Stat3 motifs were found in the Atbf1, Esrrb 
and Trp53 loci while Smad1 motifs were present in the Ctnnbl1, Esrrb, Id3, Jarid2, mir296, Mycn, 
Nanog, Rest, Rif1 and Sgk loci. All loci that contained the motifs tested positive for the binding of 
the respective factors. However, control regions p21, test regions 1, 3 and 4 were also found to 
contain the Smad1 motif. This may be due to the possibility that the TRANSFAC motif sequence 
is not very defined (AGACNBCNN for V$SMAD_Q6 and NNNTTCCN for V$STAT3_02), 
increasing the probability of identifying false positives in the computational search. Thus, the 
computational method only provides a rough guide in the search for putative co-motifs. Another 
possibility is that Oct4 and Sox2 binding may be a prerequisite for Stat3 and Smad1 to bind, as 
none of the control regions contain Oct4, Sox2, Stat3 and Smad1 binding although some may 
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contain the Smad1 motif. Experiments involving the differentiation of mESCs and depletion of 
Oct4 and Sox2 were subsequently carried out to further support the notion of Stat3 and Smad1 
binding dependency on Oct4 and Sox2.    
 
7.2.1.7 Co-occupancy of Oct4 with Stat3 and Smad1 on the same DNA molecule 
To further examine if Stat3 and Smad1 are binding onto the same DNA molecule as Oct4, 
sequential ChIPs (seqChIPs) using Oct4 followed by Stat3 or Smad1 antibodies were carried out. 
Significant enrichment was observed after Oct4-Stat3 and Oct4-Smad1 seqChIPs, as compared to 
low enrichment in the Oct4-control seq ChIPs (Figure 7.8). This indicates that Stat3 and Smad1 
are binding to the same molecule as Oct4. This experiment omits the possibility that Oct4 and 
Sox2 may bind independently on the same DNA region of different DNA molecules.   
 
7.2.1.8 Retinoic acid differentiation affects Stat3 and Smad1 binding 
To examine the effect of Stat3 and Smad1 binding upon induction of differentiation, mESCs were 
treated with retinoic acid (RA) as described in Chapter 2. Upon RA induction, the cells begin to 
differentiate. Oct4 and Sox2 protein could not be detected in RA-treated cells (Figure 7.9A). 
Concurrently, binding of Oct4 and Sox2 on the Nanog locus was also reduced (Figure 7.9B). In 
mESCs treated with RA, Stat3 and Smad1 protein levels remain relatively unchanged (Figure 
7.9C). However, Stat3 and Smad1 bindings on Nanog, Mycn, Sgk, Dido1, Tbx3 and Rest loci were 
abolished (Figure 7.9D,E). Reduction in Stat3 and Smad1 binding were also observed in ChIP 
experiments using embryoid bodies and mESCs grown without LIF (data not shown). These 
results indicate that Stat3 and Smad1 binding on these loci are specific in undifferentiated mESCs. 
In addition, it also suggests that Stat3 and Smad1 could no longer bind to these loci due to the 




7.2.1.9 RNAi-mediated depletion of Oct4 and Sox2 affects Stat3 and Smad1 binding 
To investigate whether Stat3 and Smad1 bindings are dependent on Oct4 and Sox2, mESCs were 
depleted of Oct4 and Sox2 proteins and were assayed for Stat3 and Smad1 binding. Cells were 
transfected with RNAi plasmids (shRNA) that targeted Oct4 and Sox2. The cells were then 
cultured in media containing puromycin to remove non-transfected cells. Cells transfected with 
vector plasmid and plasmid carrying the luciferase gene did not show any significant 
differentiation (Figure 7.10a,b). Knockdown of Oct4 and Sox2 caused the cells to flatten and 
change morphology into distinct individual epithelial-like cells (Figure 7.10Ac,d). All non-
transfected cells died after 2 days of puromycin selection (Figure 7.10Ae). Oct4 and Sox2 protein 
levels were also shown to be reduced significantly in RNAi-treated cells (Figure 7.10B). A slight 
reduction in Sox2 protein levels was also observed in Oct4 RNAi-treated cells (Figure 7.10B). 
Similarly, there was also a slight reduction in Oct4 protein levels in Sox2 RNAi-treated cells 
(Figure 7.10B). These observations can be attributed to the indirect effects of RNAi as Oct4 and 
Sox2 reciprocally regulates each other in a positive manner. However, Oct4 and Sox2 RNAi-
mediated depletion can still be used as a model for study as the primary effects caused by the 
specific shRNAs were much more significant. As expected, ChIP-qPCR showed that upon Oct4 
and Sox2 RNAi, Oct4 and Sox2 binding reduced significantly on the Mycn and Nanog loci as 
compared to cells treated with luciferase shRNA (Figure 7.10C). 
 
The protein levels of Stat3 and Smad1 were noted to remain relatively unchanged in both 
Oct4 and Sox2 knockdown cells (Figure 7.11A). The same shRNA-treated cells that were selected 
for 2 days were crosslinked and harvested for ChIP. Results show that although their protein levels 
remain unchanged, Stat3 and Smad1 binding on the Mycn and Nanog loci were reduced 
significantly in Oct4 and Sox2-depleted cells, as compared to the cells treated with control 
luciferase shRNA (Figure 7.11B). The RNAi-ChIP experiment was repeated for cells selected for 
4 days in puromycin-containing media. Similarly, Stat3 and Smad1 binding were reduced 
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significantly on the Mycn and Nanog loci in Oct4 and Sox2 depleted mESCs (Figure 7.11C). Stat3 
and Smad1 were not present in the Oct4 and Sox2 ChIP-PET datasets, indicating that they are not 
regulated by Oct4 and Sox2. These data suggests that Stat3 and Smad1 binding may be dependent 
on the presence of Oct4 and Sox2.  
 
7.2.1.10 Stat3 and Smad1 are Oct4 protein partners  
To examine whether Stat3 and Smad1 are Oct4 protein partners, co-immunoprecipitation (co-IP) 
was carried out using nuclear extracts (input) from undifferentiated mESCs. IP carried out using 
Oct4 antibodies could pull down all protein complexes containing Oct4, and subsequently these 
complexes can be analysed by Western blotting. As control, the Oct4 protein was detected in the 
Oct4 immunoprecipitate (Figure 7.12A). Smad1, Stat3 and their phosphorylated forms were also 
detected in Oct4 immunoprecipitates, while none of these proteins were detected in GST 
immunoprecipitates (control IP) (Figure 7.12B). This indicates that Stat3 and Smad1 are present in 
Oct4 protein complexes, and may likely be Oct4 partners in mESCs. A limitation of the co-IP 
experiment is that it does not discriminate between direct and indirect protein-protein interactions.  
 
7.2.2 The connection between Stat3, Oct4 and Nanog pathways 
 
7.2.2.1 Culturing mESCs in defined media containing BMP4 and LIF 
To investigate the role of Stat3 binding, depletion of Stat3 via ligand removal was carried out. 
Cells were first acclimatized in serum-free media containing BMP4 and LIF (Clonal media from 
Chemicon; as optimsed by Ying et al. 2003). After 3 passages, mESCs form densely packed 
colonies (Figure 7.13Ab). A low density colony forming assay was performed using 1x103 cells in 
a 10 cm culture dish. After 5 days of culture, densely packed colonies emerged (Figure 7.13Aa), 
verifying the quality of the mESCs grown in this serum-free media. The mESCs could be cultured 
in Clonal media for more than 6 passages.     
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7.2.2.2 Stat3 depletion in mESCs  
Cells cultured in serum-free clonal media were then treated with basal media containing LIF, 
BMP4 or both. The morphology of cells cultured in different media for 24 hr is shown in Figure 
7.13B. Some differentiation was observed in cells cultured in Basal media, while cells cultured in 
LIF, BMP4, LIF and BMP or Clonal media still formed densely packed colonies and showed no 
signs of differentiation after 24 hr. Cells grown in LIF, BMP4 and basal media all differentiated 
after 36 hr (data not shown).   
 
Cell lysates were obtained from mESCs grown in Clonal media, Basal media and Basal 
media containing 1000 U/ml LIF, 30 ng/ml BMP4, 50 ng/ml BMP4 or a combination of 1000 
U/ml LIF and 30 ng/ml BMP4 at 15 min, 2 hr, 6 hr and 12 hr. Western blot using these lysates 
were carried out to detect phosphorylated Stat3 (p-Stat3) proteins (Figure 7.14). Significant 
reduction of p-Stat3 proteins was observed in cells cultured without LIF, that is in media with 
BMP4 alone and Basal media (Figure 7.14, lanes 3, 4, 6, 7, 10, 12, 13, 15, 16). Stat3 is a substrate 
in the LIF-Stat3 signalling pathway. According to the LIF/STAT3 pathway model, removal of the 
LIF ligand may not allow Stat3 to be phosphorylated or translocated into the nucleus, and thus 
reduced the levels of phosphorylated Stat3 in cells cultured without LIF.  
 
7.2.2.3 Stat3 binds to but does not regulate Oct4 
Using mESC cultured in defined media for 24 hr, the effects of Stat3 depletion on Oct4 was 
examined. Stat3 ChIP was carried out using crosslinked chromatin extracts from cells treated with 
(i) Clonal, (ii) Basal, (iii) Basal media with 50 ng/ml BMP4, (iv) Basal media with 1000 U/ml LIF 
and (v) Basal media with 30 ng/ml BMP4 + 1000 U/ml LIF. ChIP-qPCR of Stat3 on the Oct4 loci 
showed high enrichment (15-25 fold) using extracts from Clonal, LIF + BMP4, and LIF alone, 
indicating that Stat3 binds to the Oct4 loci in these cells (Figure 7.15A). In cells grown without 
LIF (BMP and Basal media), Stat3 binding was significantly lower (about 5-fold), indicating that 
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Stat3 binds to the Oct4 loci in the presence of LIF (Figure 7.15A). However, the expression level 
of Oct4 remains relatively unchanged in all these cells as shown by RT-PCR analysis of Oct4 
transcript levels (Figure 7.15B). Only after 24 hr, Oct4 transcript level in cells grown in Basal 
media started to show some reduction compared to the other samples. This is probably due to 
differentiation of mESCs. These results collectively indicate that although Stat3 binds to the Oct4 
loci, it does not regulate Oct4 transcription.   
 
7.2.2.4 Stat3 binds to its own gene, providing a model for autoregulation 
Next, to examine the effects of Stat3 depletion on its own regulation, ChIP-qPCR of Stat3 on the 
Stat3 loci was carried out. Enrichment of 150-250 folds were detected in Clonal, LIF+BMP and 
LIF samples, indicating that Stat3 binds to the Stat3 loci in cells grown in the presence of LIF. In 
cells grown without LIF (BMP4 only and Basal media), enrichment for Stat3 binding was 
comparatively lower (about 25-fold) (Figure 7.16A). Stat3 transcript levels were then measured. 
The expression of Stat3 remained relatively unchanged for Clonal, LIF+BMP and LIF samples 
(Figure 7.16B). On the other hand, Stat3 transcript levels were significantly reduced in cells grown 
in BMP4 and basal media after 1hr (Figure 7.16B). Therefore, Stat3 binding and expression levels 
reduced concurrently in mESCs grown without LIF, suggesting that Stat3 regulates its own gene.     
 
7.2.2.5 Stat3 regulates Nanog 
Oct4 ChIP-qPCR on the Nanog loci did not show significant difference in fold enrichment for all 
treated samples, indicating that Oct4 binds to Nanog in the presence or absence of LIF (Figure 
7.17A). To test the effects of Stat3 depletion on Nanog, Stat3 ChIP-qPCR on the Nanog loci was 
carried out. ChIP enrichment of 25-40 fold was detected in Clonal, LIF+BMP and LIF samples, 
indicating that Stat3 binds to the Nanog loci in cells grown in media containing LIF (Figure 
7.17B). Enrichment was low (<10-fold) for Stat3 on the Nanog loci in cells grown without LIF 
(BMP4 and Basal media) (Figure 7.17B). RNA Polymerase II ChIP-qPCR on the Nanog loci was 
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also carried out and results showed that ChIP enrichment was approximately 16-24 fold in Clonal, 
LIF+BMP and LIF samples, and less than 3 fold in BMP4 and Basal media samples (Figure 
7.17C). RNA Polymerase II binding pattern correlated with the Stat3 binding pattern, indicating 
that RNA Polymerase II and Stat3 were present together in cells grown in the same condition. The 
presence of RNA Polymerase II on Nanog in Clonal, LIF+BMP and LIF cells indicates that Nanog 
is being actively transcribed in these cells as the occupancy of RNA polymerase II is tightly 
correlated to the level of transcription activity and is a strong indicator of in vivo transcription 
elongation (Knight et al., 2003).   
 
Subsequently, the kinetics of Nanog expression in these cells were measured. There was a 
significant drop in the Nanog transcript levels at 6 hr and 24 hr (Figure 7.17D). The reduction in 
Nanog transcripts is correlated with the reduction in RNA polymerase II binding in these cells. 
These results suggest that Stat3 binds to and regulates the expression of Nanog. Oct4 and Sox2 
have also been shown to partly regulate Nanog (Kuroda et al., 2005; Rodda et al., 2005); hence 
Stat3, Oct4 and Sox2 may work in collaboration to regulate Nanog. Oct4 and Sox2 binding may be 




7.3.1 Cofactors collaborating with Oct4 and Sox2 in cis-regulatory modules 
Oct4 and Sox2 may carry out their functions by collaborating with other factors. Motif search 
through TRANSFAC identified that two transcription factor binding sites, Stat3 and Smad1 were 
significantly enriched in the subset of Oct4-Sox2 overlapping binding sites. These extrinsic 
signalling pathway factors were distinguished after screening of the Oct4-Sox2 overlapping 
PET2+ clusters from mouse transcription factor motifs in the TRANSFAC database (version 9.1) 
(Wingender et al., 2000). Results revealed 67 putative transcription factor matrices (p=0). The 
 150
large number of potential co-motifs identified using computational methods can only serve as a 
guide for forming biological hypotheses.  
 
Stat3 and Smad1 are transcription factor substrates of extrinsic signalling pathways which 
are important in mESC self-renewal, while Oct4 and Sox2 are intrinsic key transcription factors 
essential in maintaining the pluripotency of mESC. Results from ChIP-qPCR and ChIP-on-chip 
indicated that Stat3 and Smad1 may co-localise to the same binding regions of Oct4 and Sox2, as 
shown on 25 gene loci. The genes targeted by the four factors play important roles in maintaining 
both self-renewal and pluripotency of mESCs. Further evidence showed that Oct4 co-occupied the 
same ChIP DNA fragment as Stat3 and Smad1, and that Stat3 and Smad1 are partners of Oct4 in 
mESCs. Subsequently, RA-induced differentiation and RNAi-depletion of Oct4 and Sox2 assays 
provided evidence that Stat3 and Smad1 bindings may be dependent on the presence of Oct4 and 
Sox2 on the genomic sites. Collectively, these results strongly suggest that Stat3 and Smad1 are 
cofactors collaborating with Oct4 and Sox2 in cis-regulatory modules.  
 
7.3.2 Molecular mechanisms in the maintenance and differentiation of mESCs 
This study presented strong evidence that Stat3 regulates itself. Autoregulation is one of the key 
features of transcription factors positioned at the top in the hierarchy of the transcriptional 
regulatory network. They act to regulate other transcription factors as well as auto-regulate 
themselves in order to maintain their own transcript level. Stat3, being a downstream factor of 
extrinsic LIF signalling pathway, may act to regulate intrinsic factors that are crucial in 
maintaining undifferentiated mESCs. Concurringly, a LIF dose-response study indicated the 
presence of a positive feedback loop in mESCs, whereby Stat3 activation may control the 
expression of Stat3, gp130 and LIFR (Davey et al., 2007). Stat3 autoregulation was also shown in 
murine myeloid leukemic cells (Ichiba et al., 1998).  
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Depletion of Stat3 (or LIF) and Nanog, as well as overexpression of Oct4, led to the 
differentiation of mESC into the endodermal lineage (Figure 7.1). Results from this study showed 
that Stat3 co-binds with Oct4 on many ESC genes, including Nanog. This study also demonstrated 
that depletion of Stat3 down-regulated Nanog expression. In concurrence, previous studies have 
also showed that over-expression of Nanog can maintain mESCs in the absence of LIF, which is a 
ligand for activation of Stat3 in the LIF-Stat3 signalling pathway. Therefore, a model linking Oct4, 
Stat3 and Nanog is proposed whereby Stat3 regulates itself and binds together with Oct4 to 
regulate Nanog.   
 
Since both the inhibition of Stat3 activity and the overexpression of Oct4 stimulate 
mESCs to differentiate into primitive endoderm-like cells (Figure 7.1) (Niwa et al., 1998; Niwa et 
al., 2000), the function of Stat3 could be disrupted by an excess level of Oct4, which might act to 
block Stat3 from binding to the neighbouring genomic site via the saturation of protein 
interactions. This will then disrupt the functions of the ternary complex (consisting of Oct4, Stat3 
and a general transcription unit, which activates target genes). This mechanism is substantiated by 
the evidence that the over-dosage effect of Oct4 on mESC differentiation does not require Oct4 
DNA-binding activity (Niwa et al., 2002).  
 
Nanog has been reported to prevent mESCs from differentiating into primitive endoderm 
by repressing the trigger factor, Gata6 (Chambers et al., 2003; Mitsui et al., 2003). Moreover, 
Gata6 promoter sequences are bound by Nanog (Wang et al., 2006) and Nanog-null mESCs was 
shown to differentiate into Gata6-positive parietal endoderm-like cells, which have a morphology 
that is similar to that of Gata6-induced cells (Mitsui et al., 2003). In this model, depletion of Stat3 
down-regulates Nanog which then may allow the cells to differentiate towards the endodermal 
lineage. This study provides evidence of crosstalk and interdependence between the Oct4, Stat3 
and Nanog pathways in mESCs. 
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Another group showed similar conclusion of Stat3 regulating Nanog, but they identified 
Stat3 binding and Stat3 motif at about 5 kb upstream from the transcription start site (Suzuki et al., 
2006) (Figure 7.18A). In contrast, results from this chapter demonstrated Oct4, Sox2, Stat3 and 
Smad1 binding near the Sox2-Oct4 motif, which is about 500bp upstream from the transcription 
start site. Integrating these findings with evidence that Stat3 binding may be dependent on Oct4 
(and Sox2 binding); a conformational model is derived whereby a loop containing these factors 
may be formed during transcription of this gene (Figure 7.18B). These results indicate that Oct4 
and Sox2 have multiple DNA binding sites for a single transcription factor molecule and work in 































































Figure 7.2: Expansion of the combined ChIP-PET data. Clusters containing maximum overlapping 
PET (moPET) 2 or more from both Oct4 and Sox2 binding datasets were merged by Vinsensius 
Vega (Bioinformatics, GIS). An overlap of 1507 clusters was obtained assuming that the 
maximum overlapping span is ~10 kb. *The p-value of observing 1507 Oct4/Sox2 overlapping 











Figure 7.3: Validation of Oct4 and Sox2 overlapping binding sites containing low PET overlaps. 
Oct4 (A) and Sox2 (B) ChIP followed by qPCR at sites containing 2 or more PET overlaps were 
carried out. Open (white) bars represent Oct4 or Sox2 ChIP and solid (black) bars represent 




Table 7.1: List of putative Oct4 and Sox2 co-occurring motifs denoted by their TRANSFAC 
matrix ID. Oct4 and Sox2 overlapping ChIP-PET masked sequences were matched against the 
TRANSFAC database. 67 potential co-occurring motifs (matrix ID) with p-values representing the 
expected rate of occurrence per random bp calculated as zero are listed. The list represents binding 
































Figure 7.4: Specificity of Stat3 and Smad1 antibodies used. Western 
blot analysis of mESC chromatin extracts using antibodies against 
Stat3 (92kDa, Santa Cruz C-20) and Smad1 (56kDa, Santa Cruz A-4). 






































































Figure 7.5: Co-localisation of Oct4-Sox2, Stat3 and Smad1. ChIP-on-chip SignalMap diagram 
showing co-localisation of Oct4-Sox2, Stat3 and Smad1 on the Mycn and Sgk loci. Oct4 and Sox2 
sequential ChIP, Stat3 and Smad1 ChIP were hybridized on the Nimblegen DNA microarray. 
Peaks represent enrichment of ChIP DNA on the loci (transcription factor binding on that 
particular region). Block replicates for each ChIP-on-chip are shown. Control ChIP-on-chip is 






















Figure 7.6:  Co-localisation of Stat3 and Smad1 on Oct4 and Sox2 overlapping binding sites. 
ChIP-qPCR scanning of putative collaborating transcription factors at loci bound by Oct4 and 
Sox2. Binding profiles of Stat3 (open diamond) and Smad1 (open square) on A: Rest, B: Tbx3, C: 
Dido1, D: Mycn, E: Nanog, F: Sgk loci. Control ChIP (cross) using the GST antibody is also 
shown.  Standard deviations represent biological replicates. Axis y represents coordinates relative 























               
                            Figure Legend: 
 
Figure 7.7: Co-localisation of Oct4, Sox2, Stat3 and Smad1 on 25 loci. A heat map showing ChIP-qPCR validations 
of Stat3 and Smad1 co-localisation on Oct4 and Sox2 binding sites identified from ChIP-PET (black) and ChIP-on-
chip (grey) studies. Different antibodies targeting the same protein are symbolized as a and b. These were Stat3a (C-
20), Stat3b (K-15), Smad1a (A-4) and Smad1b (ab33902). Oct4 and Sox2 enrichment of ChIP DNA are depicted in 
shades of green, Stat3 in shades of red, and Smad1 in shades of yellow. The colours represent fold enrichment as 
shown in the figure legend on the right. The p21 locus is a positive control for p53 (Pab246) mock ChIP to 
demonstrate that the ChIP worked. Mock 1, 2, 3 and 4 are ChIP using irrelevant antibodies GFP (FL), cFos (6-2H-
2F), NF B (C-20), and JunB (C-11). Test regions 1-5 are randomly picked genomic regions. Coordinates of loci are 






 Table 7.2: Function of genes associated with the binding of Oct4, Sox2, Stat3 and Smad1 in mouse embryonic stem cells as shown by ChIP-qPCR 











































Figure 7.8: Co-occupancy of Oct4 with Stat3 and Smad1 on the same DNA molecule. Sequential 
chromatin immunoprecipitation (seqChIP) using antibodies against Oct4 followed by antibodies 
against (A) Stat3 and (B) Smad1 followed by qPCR on the respective gene loci. Control seqChIP 
using α-Oct4 followed by α-GST antibody are also presented. Biological replicates are shown as 






















D: Stat3 ChIP 
 
E: Smad1 ChIP 
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Figure 7.9: Retinoic acid differentiation of mESCs reduces Oct4 and Sox2 levels and binding, and 
abolishes Stat3 and Smad1 binding. (A) Oct4 and Sox2 protein levels reduced significantly after 
retinoic acid treatment. Western blot analysis of retinoic acid-treated (+RA) and untreated (-RA) 
E14 mESC chromatin extract using α-Oct4 and α-Sox2 antibodies. (B) Oct4 and Sox2 bindings on 
the Nanog loci were abolished after RA treatment. Oct4 and Sox2 ChIP-qPCR on the Nanog loci 
using chromatin extracts from non-treated (ES) and retinoic acid-treated (+RA) mESC. (C) 
Minimal changes in Stat3 and Smad1 protein levels after retinoic acid treatment. Western blot 
analysis of retinoic acid-treated (+RA) and untreated (-RA) mESC chromatin extract using α-Stat3 
and α-Smad1. (D) Stat3 and (E) Smad1 binding abolished after RA treatment. ChIP using 
antibodies against Stat3 and Smad1, followed by qPCR on the respective gene loci were carried 





































































Figure 7.10: Knockdown of Oct4 and Sox2 in mESCs differentiates the cells, significantly reduces 
Oct4 and Sox2 protein levels and concurrently reduces Oct4 and Sox2 binding on the Mycn and 
Nanog loci. (A) Morphology of the cells after RNAi-mediated depletion of Oct4 and Sox2. Mouse 
ESCs were transfected with shRNA plasmids targeting a) luciferase as control, b) empty pSUPER 
vector as control, c) Oct4 and d) Sox2. Non-transfected mESCs died upon puromycin selection (e). 
Images were taken at 20x10x magnification, 3 days post-transfection. (B) Western blot analysis 
using chromatin extracts from Oct4 and Sox2 knockdown cells after 2 days of selection. Mouse 
ESCs were transfected with shRNA plasmids targeting luciferase as control, Oct4 and Sox2. The 
chromatin extracts were analysed by Western blot for changes in Oct4 and Sox2 protein levels. 
The same blots were detected for β-actin as loading control. (C) ChIP-qPCR analysis using 
chromatin extracts from Oct4 and Sox2 knockdown cells after 2 days of selection. Mouse ESCs 
were transfected with shRNA plasmids targeting luciferase as control, Oct4 and Sox2, followed by 
puromycin selection for 2 days. Chromatin extracts were analysed by ChIP-qPCR for changes in a: 




































































































Figure 7.11: Knockdown of Oct4 and Sox2 in mESCs does not significantly affect Stat3 and 
Smad1 protein levels but reduces Stat3 and Smad1 binding on the Mycn and Nanog loci. (A) 
Western blot analysis using chromatin extracts from Oct4 and Sox2 knockdown cells after 2 days-
selection. Mouse ESCs were transfected with shRNA plasmids targeting luciferase as control, 
Oct4 and Sox2 and the chromatin extracts were analysed by Western blot for changes in Stat3 and 
Smad1 protein levels. The same blots were detected for β-actin as loading control. (B&C) ChIP-
qPCR analysis using chromatin extracts from Oct4 and Sox2 knockdown cells. Mouse ESCs were 
transfected with shRNA plasmids targeting luciferase as control, Oct4 and Sox2, followed by 
puromycin selection for (B) 2 days and (C) 4 days. The chromatin extracts were analysed by ChIP-









































Figure 7.12: Stat3 and Smad1 are Oct4 partners. Co-immunoprecipitation (Co-IP) of Oct4 
complex. Immunoprecipitation (IP) of 200 ug mESC nuclear extract was carried out using α-Oct4 
and control α-GST (con) antibodies. Input represents mESC nuclear extract. IP was followed by 
Western immunoblot (IB) using (A) α-Oct4 and (panel B) α-Smad1, α-phosphorylated Smad1, α-
Stat3, α-phosphorylated Stat3 antibodies. Arrows point to bands representing proteins detected by 











































Figure 7.13: Feeder-free serum-free mESCs. (A) Culturing mESC in serum-free media containing 
LIF and BMP4 (Clonal media, Chemicon). a) Low density colony forming assay at 1000 
cells/10cm dish and b) culture after 3 passages at 1:5 plating ratio using Clonal media. Images 
taken at 20X 10X magnification. (B) Morphology of mESCs cultured in defined media. Cells were 
acclimatized using clonal media for 2 passages, plated in clonal media for 24 hr, washed with 
PBS, and cultured with A: clonal, B: 1000 U/ml LIF and 30 ng/ml BMP4 (LB), C: 50 ng/ml 














Figure 7.14: Stat3 and Smad1 depletion in mESCs cultured in defined media. Cells were grown in 
clonal media (Clonal), basal media (Basal), and basal media containing 1000 U/ml LIF and 30 
ng/ml BMP4 (LIF+BMP30), 30 ng/ml BMP4 (BMP30), 50 ng/ml BMP4 (BMP50) and 1000 U/ml 
LIF for 15min, 2hr, 6hr and 12hr. Western blot analysis of the mESC cell lysates using antibodies 























Figure 7.15: Stat3 does not regulate Oct4. (A) Stat3 binding on the Oct4 loci. Stat3 ChIP using 
chromatin extracts from mESCs cultured in clonal media (Clonal) from Chemicon, basal media 
(Basal), and basal media containing LIF and BMP4 (LB), BMP4 (BMP4) and LIF (LIF) for 24 hr. 
ChIP is followed by qPCR on the Oct4 locus. Standard deviations represent technical replicates. 
Fold enrichment represents the abundance of enriched DNA fragments over a control region not 
enriched for the respective targets. (B) Kinetics of Oct4 expression in mESC cultured in basal, 
clonal, LIF and BMP4, BMP4 and LIF containing media over a time course of 30 min to 24 hr. 
Standard deviations represent technical replicates. The levels of transcripts were normalized 









































Figure 7.16: Stat3 binds to its own gene and autoregulates. (A) Stat3 ChIP using chromatin 
extracts from mESCs cultured in clonal media (Clonal) from Chemicon, basal media (Basal), and 
basal media containing LIF and BMP4 (LB), BMP4 (BMP4) and LIF (LIF) for 24 hr. ChIP is 
followed by qPCR on the Stat3 locus. Standard deviations represent technical replicates. Fold 
enrichment represents the abundance of enriched DNA fragments over a control region not 
enriched for the respective targets. (B) Kinetics of Stat3 expression in mESCs cultured in basal, 
clonal, LIF and BMP4, BMP4 and LIF containing media over a time course of 30 min to 24 hr. 
Standard deviations represent technical replicates. The levels of transcripts were normalized 








































Figure 7.17: Stat3 regulates Nanog. (A) Stat3 ChIP using chromatin extracts from mESCs cultured 
in clonal media (Clonal) from Chemicon, basal media (Basal), and basal media containing LIF and 
BMP4 (LB), BMP4 (BMP4) and LIF (LIF) for 24 hr. Oct4 (A), Stat3 (B) and RNA polymerase II 
(C) ChIP-qPCR on the Nanog locus. Standard deviations represent technical replicates. Fold 
enrichment represents the abundance of enriched DNA fragments over a control region not 
enriched for the respective targets. (D) Kinetics of Nanog expression levels in mESC cultured in 
basal, clonal, LIF and BMP4, BMP4 and LIF containing media over a time course of 30 min to 24 
hr. Standard deviations represent technical replicates. The levels of transcripts were normalized 





























































Figure 7.18: Looping mechanism of Nanog regulation by collaborating transcription factors. A 
conjecture presenting how a loop may form linking DNA elements bound by a protein complex is 
shown. Stat3 binding and Stat3 motif were identified at -4785 bp from the Nanog transcription 
start site by Suzuki et al. (2006) (shown in black fonts), whereas this present study identified 
Sox2, Oct4, Stat3 and Smad1 bindings as well as the Sox2-Oct4 (s2o4) motif at -507 bp from the 









8.1 Implications of the study 
In this study, the DNA binding sites of Oct4 and Sox2 were identified. Transcriptional network 
involving Oct4, Sox2 and Nanog was established (Chapter 3). In addition, Oct4 and Sox2 were 
shown to bind to novel targets including transcription factors important in maintaining mESC 
pluripotency and self-renewal (Chapters 4 and 5). A joint Sox2-Oct4 motif was identified and 
characterized in Chapter 6, suggesting that these two factors collaborate to globally control mESC 
gene expression through the Sox2-Oct4 motif. Subsequently, Oct4 and Sox2 were found to 
collaborate with extrinsic signalling transcription factors Stat3 and Smad1 to activate the network 
of ESC specific genes. Finally, this study demonstrated the relationship between the Stat3, Nanog 
and Oct4/Sox2 pathways in mESCs (Chapter 7).  
 
The results showed that a fraction of Oct4, Sox2, Stat3 and Smad1 binding sites did not 
contain consensus motifs. These binding sites could represent a novel DNA binding motif or the 
transcription factors could be tethered to the DNA independent of their DNA binding properties. 
In addition, this study also discovered Oct4 and Sox2 binding sites which were located far away 
from known genes. The absence of DNA motifs and the observation of distal binding sites may be 
explained by the looping model described in Chapter 7. Due to the chromosomal conformation, 
these sites may be indirect binding sites that associate with direct binding sites via transcription 
factor complexes. All genomic fragments that are associated with a particular protein, whether 
bound directly or indirectly through a complex are isolated by ChIP assays through formaldehyde 
crosslinking. Further studies need to be carried out in order to validate this model.  
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The presence of Oct4 and Sox2 may play a role in recruiting other factors that directly 
regulate the gene as shown in Chapter 7. This may be the reason why some of the Oct4 and Sox2 
bindings do not seem to affect the regulation of the bound genes (as described in Chapters 4 and 
5). It may also explain a recent study by Masui et al. (2007) which reported that Sox2 is 
dispensable for the activation of the Sox-Oct enhancers. 
 
 In addition, this study identified Stat3 and Smad1 as factors collaborating with Oct4 and 
Sox2 on cis-regulating modules (Chapter 7). Stat3 and Smad1 are downstream effectors of the LIF 
and BMP signalling pathways, respectively. This suggests that extrinsic signalling factors LIF and 
BMP4 activate Stat3 and Smad1, which then work together with Oct4 and Sox2 to regulate certain 
genes important in maintaining pluripotency and self-renewal. Indeed, Stat3 was shown to bind 
with Oct4 to regulate Nanog, providing evidence of a crosstalk between the Oct4, Stat3 and Nanog 
transcriptional pathways in mESCs. In addition, this study showed that Oct4, Sox2 and Stat3 
autoregulate, thus confirming their importance as key regulatory factors in mESCs.  
 
There are other studies that reported genome-wide mapping of key transcription factor 
binding sites in ESCs. A colleague, Wu Qiang, mapped the binding sites of Nanog in mESCs 
using ChIP-PET (Loh et al., 2006). When the ChIP-PET datasets from Oct4, Sox2 and Nanog 
were compared (Appendix C), the three transcription factors were shown to bind a set of shared 
genes. The three transcription factors co-occupied genes in various arrangements. An example is 
where both Sox2 and Oct4 bind 3’ of the Sox2 gene whereas Nanog binds 3.8 kb 5’ to its 
transcription start site. Further investigation into these different binding configurations may offer 
clues into regulatory mechanisms in addition to perhaps uncovering differential transcriptional 
responses. Triple sequential ChIP validated co-occupancy of the three factors on 7 genes 
(Appendix D). It appears that pluripotency and self-renewal of mESCs is achieved through the 
combination of a few key transcription factors that control the activation and repression of specific 
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genes. Boyer et al. (2005) also mapped the binding sites of Oct4, Sox2 and Nanog in hESCs using 
promoter microarrays. However, the binding sites generated by ChIP-PET/mESCs (this study) and 
ChIP-on-promoter chip/hESCs (Boyer et al. 2005) only overlapped by 6.9% for Oct4 and 9.5% for 
Sox2 when comparative analysis was done using both datasets by our Bioinformatics collaborator, 
Guillaume Bourque. The large discrepancies from these two binding sites study may be due to 
differences in (1) biological factors (mouse versus human ESCs) and (2) approaches used (ChIP-
PET versus ChIP-on-promoter chip). Despite the small overlap, these sites may regulate core ES 
genes that are conserved between both mouse and human, and may represent the most important 
genes in controlling ESCs. Further studies on these genes will be important in discovering more 
transcriptional switches in the control of the ESC states. Identifying targets of key factors and 
investigation on the roles of these genes using mouse ESCs as a model system would be of 
importance to eventually develop switches in differentiating human ESCs, and hopefully bring us 
a step closer to achieve control of the human ESC fate for use in regenerative medicine.  
 
8.2 Future studies 
This study presents many interesting questions and future directions to be explored. Studies should 
be conducted to characterize the functions of identified Oct4 and Sox2 target genes. Core Oct4, 
Sox2 and Nanog shared genes which are conserved between mouse and human are likely to have 
important roles in ESCs. It will also be intriguing to dissect the roles of microRNAs which are 
targeted by these transcription factors in ESCs. Further examination of the interactions among all 
these crucial genes will provide a more thorough understanding of cell fate determination.  
 
Besides that, further studies need to be done to verify long range interactions and the 
looping model proposed in Chapter 7. Transcriptional activation involves physical association of 
genes and their regulatory elements. Previous studies have demonstrated that active β-globin genes 
physically interact with multiple cis-regulatory elements (Tolhuis et al., 2002) and this has led to 
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the proposal of an active chromatin hub (de Laat and Grosveld, 2003) (Figure 8.1). Moreover, 
long-range chromosomal interactions between genomic elements have been shown to regulate 
active gene expression (Levings et al., 2006; Vernimmen et al., 2007). Therefore, a higher 
chromosome organization may be a major determinant of gene regulation (Levings et al., 2006). It 










Figure 8.1: A chromatin hub formed by long-range 
interactions between the haemoglobin β-chain complex 
(Hbb) genes and the locus control region. Figure was 





One of the methods that can be used to analyze the spatial organization of chromosomes is 
the Chromosome Conformation Capture (3C) assay (Figure 8.2a). In the 3C methodology, ChIP is 
carried out, followed by ligation to fuse nearby DNA fragments. Primer pairs consisting of one 
primer in the promoter region and the other at the enhancer region are then used to PCR-amplify 
potentially ligated fragments of DNA. Many variations of the 3C method, including coupling with 
microarray detection or high throughput DNA sequencing, have been employed in various studies 
(Dostie and Dekker, 2007; Simonis et al., 2006; Zhao et al., 2006). They have used this method to 
discover long range interactions such as interactions between the estrogen receptor and Forkhead 
protein Fox1A (Carroll et al., 2005), an enhancer on mouse chromosome 14 and multiple olfactory 
receptor genes (Lomvardas et al., 2006), and (Igf2)/H19 regulation (Ling et al., 2006). In mESCs, 
Wurtele and Chartrand (2006) identified HoxB1-associated loci throughout the genome.  
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One of the disadvantages of the 3C method is that sites separated by less than 8 kb may 
not be detected (Dekker et al., 2002). In these cases, the RNA TRAP (tagging and recovery of 
associated proteins) assay may be used to detect long-range interactions indirectly by identifying 
loci that are in the vicinity of nascent RNA (Dekker, 2003). Horseradish peroxidase which is 
targeted to a specific nascent RNA, catalyzes local deposition of biotin tags on proteins. DNA 
segments cross-linked to biotinylated proteins are then purified on streptavidin-agarose and 





Figure 8.2: Approaches used for 
detecting long range protein-DNA 
interactions are (a) the Chromosome 
Conformation Capture (3C) method and 
(b) the RNA tagging and recovery of 
associated proteins (RNA TRAP) 






Besides transcription factors, maintaining ESC identity ultimately depends on many other 
aspects such as the accurate replication of the specific covalent modifications to the histones and 
DNA as well as associated transcription factors that structure the chromatin and define the ESC. 
To date, the involvement of the epigenome in the maintenance and establishment of ESC 
pluripotency remain unclear. Further studies will be necessary to find out how epigenetic 
mechanisms determine the pluripotent epigenome and how it functions to maintain the ESC 
transcription factor network.  
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The advent of new sequencing technologies will be able to help expedite the identification 
of transcription factor-DNA or modified histone-DNA binding sites. New sequencing platforms 
such as the Genome Analyzer from Illumina and SOLiD from Applied Biosystems are now able to 
sequence short DNA fragments, such as ChIP DNA and micro RNAs. In addition, development to 
sequence up to a single DNA molecule will be the future challenge. Currently, a company called 
Helicos is developing this new platform technology and if successful, it will be a powerful 
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 Appendix A: Coordinates of 1083 Oct4 binding loci and their associated genes. 
 
This table shows a list of 1083 Oct4 bound loci, sorted by the numbers of overlapping PETs at each locus. Cluster ID is a unique ID that was 
generated for each Oct4 binding locus. MPSS (ES) column indicates the number of unique MPSS tag associated with each candidate Oct4 bound 
gene in ES cells. MPSS (EB) and MPSS (NS) columns show the quantification of MPSS tags in embryoid bodies and neurospheres respectively. 







































 Appendix B: Coordinates of 1133 Sox2 binding loci and their associated genes. 
 
This table shows a list of 1133 Sox2 bound loci, sorted by the numbers of overlapping PETs at each locus. Cluster ID is a unique ID that was 
generated for each Oct4 binding locus. MPSS (ES) column indicates the number of unique MPSS tag associated with each candidate Oct4 bound 
gene in ESCs. MPSS (EB) and MPSS (NS) columns show the quantification of MPSS tags in embryoid bodies and neurospheres respectively. The 








































APPENDIX C: Overlapping Sox2, Oct4 and Nanog associated genes (triple overlaps) viewed in 







Venn diagrams indicate the extent of overlap between genes associated with Sox2, Oct4 and 
Nanog binding in mESCs. A core set of genes, 127 and 179 using the 20 and 50 kb cut-offs, 
respectively, which were bound by all three factors were identified. These included Rest, Rcor2, 
Phc1, Id3, Nmyc1, Tcf3, Dppa5, Esrrb, Otx2, Ilst6, Lifr, Pum1, Lefty1, Rpe, Uck2, Rif1, as well as 
Sox2, Pou5f1, and Nanog, themselves. All three transcription factors also bound to genes 





























Schematic diagram of triple sequential ChIP (seqChIP). The eluate for Oct4 ChIP was used for 
Sox2 ChIP, followed by Nanog ChIP. Triple sequential ChIP for selected triple bound genes 
Pou5f1, Nmyc1, Rest, Nmyc1, Jarid2, and control. O: Oct4, OS: Oct4-Sox2, OC: Oct4-control, 
OSN: Oct4-Sox2-Nanog, OSC: Oct4-Sox2-control seqChIPs .  
There are a number of examples where the PET clusters from all three transcription factors 
overlap, indicating their respective binding sites do lie in close (100 bp) proximity with one 
another. This apparent clustering of Sox2, Oct4, and Nanog binding sites at a number of genomic 
loci does not necessarily mean these transcription factors are all simultaneously binding the same 
DNA (ie. co-occupancy) as all binding data was generated from a pool of cells within which there 
was no way to calculate the percentage with which these protein-DNA interactions were occurring. 
Chapter 5 reported a quantitative measure of co-occupancy for Sox2 and Oct4 on a number of 
target genes in mESCs. This protocol was extended to include a third round of ChIP with the 
Nanog antibody and thereby demonstrating that a triple sequential ChIP experiment can show 
three proteins simultaneously co-occupying the same stretch of DNA in vivo. As Pou5f1, Nmyc, 
Rest, and Jarid2 were all identified as targets of Sox2, Oct4, and Nanog by ChIP-PET and the PET 
clusters of each overlapped with the other, these loci were tested for triple co-occupancy. After 
Oct4-Sox2-Nanog sequential ChIP there was a drastic increase in fold enrichment for each of the 
gene loci tested, demonstrating that the three factors indeed co-occupy these loci. Control 
sequential ChIPs using Oct4-Ena1 and Oct4-Sox2-Ena1 showed no significant (<2-fold) increase 


















3x Ebf1 swap 
cgcgtATGCAAATCATTGTTtagtATGCAAATCATTGTTtcacATGCAAATCATTGTTa  
3x Tcf7 swap 
cgcgtATGCAAATTATTGTTtagtATGCAAATTATTGTTtcacATGCAAATTATTGTTa  
3x REST swap 
cgcgtATGCAAATTATTGTGtagtATGCAAATTATTGTGtcacATGCAAATTATTGTGa  

































Appendix F: Control ChIP-on-chip (H4K20Me3) for ChIP-on-chip experiments in 









































































































ChIP-on-chip SignalMap diagram show that H4K20Me3 binding peaks were not present 
in all test regions except Gtl12 which serves as a positive control for H4K20Me3 ChIP. 
Binding peaks are represented as bell-shape peaks. Single points showing enrichments are 
regarded as background. 
 
 





















Appendix G: Coordinates for ChIP-qPCR amplicons representing peak enrichments in 
Figure 7.6 and Figure 7.7 
 
 
 
 
 
